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REVIEW ARTICLE

Aluminum reproductive toxicity: a summary and interpretation of
scientific reports
Robert A. Yokel
Department of Pharmaceutical Sciences, University of Kentucky Academic Medical Center, Lexington, KY, USA
ABSTRACT

ARTICLE HISTORY

Publications addressing aluminum (Al)-induced reproductive toxicity were reviewed. Key details were compiled in summary tables. Approximate systemic Al exposure, a measure of bioavailability, was calculated
for each exposure, based on the Al percentage in the dosed Al species, Al bioavailability, and absorption
time course reports for the exposure route. This was limited to laboratory animal studies because no controlled-exposure human studies were found. Intended Al exposure was compared to unintended dietary
Al exposure. The considerable and variable Al content of laboratory animal diets creates uncertainty about
reproductive function in the absence of Al. Aluminum-induced reproductive toxicity in female mice and
rats was evident after exposure to 25-fold the amount of Al consumed in the diet. Generally, the additional daily Al systemic exposure of studies that reported statistically significant results was greater than
100-fold above the typical human daily Al dietary consumption equivalent. Male reproductive endpoints
were significantly affected after exposure to lower levels of Al than females. Increased Al intake increased
fetus, placenta, and testes Al concentrations, to a greater extent in the placenta than fetus, and, in some
cases, more in the testes than placenta. An adverse outcome pathway (AOP) was constructed for males
based on the results of the reviewed studies. The proposed AOP includes oxidative stress as the molecular
initiating event and increased malondialdehyde, DNA and spermatozoal damage, and decreased blood
testosterone and sperm count as subsequent key events. Recommendations for the design of future studies of reproductive outcomes following exposure to Al are provided.
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Focus
This review focuses on the pre-natal effects of aluminum (Al)
exposure on female and male reproduction, the embryo/
fetus, and offspring up to the time of birth. It does not
include developmental effects.

Value of this review
It has been some time since an extensive review and assessment of the literature assessing Al effects on female and
male reproduction was published. Many studies on this topic
have been published recently. There is considerable current
interest in the potential for Al to produce reproductive toxicity, fueled in part by the controversy concerning its safety
as an adjuvant in vaccines. This has been addressed by the
proposed Cochrane Library assessment of the benefits and
harms of Al adjuvants used in vaccines versus placebo or no
intervention (Djurisic et al. 2017; Weisser et al. 2017).

Search strategy and literature reviewed
Prior reviews of this topic were obtained and the reports
cited therein reviewed (Tariq 1993; Domingo 1995; Domingo
et al. 2000; Domingo 2005; Krewski et al. 2007; ATSDR 2008;
Domingo 2011; Pandey and Jain 2013; Willhite et al. 2014;
Berihu 2015). A SciFinder search for “aluminum reproductive
toxicity” (no qualifiers) and SciFinder and PubMed searches
for “aluminum reproduction human” were conducted.
English-language reports of mammalian organisms, excluding
nanoscale Al forms, were reviewed. The introduction and discussion of reports cited herein were reviewed to identify citations to other reports that were reviewed.
Descriptions of female and male reproduction, including
illustrations, are available in physiology textbooks, such as
Ganong’s (Barman et al. 2019). The summaries below were
prepared to focus on and include the endpoints of the
reviewed studies.

Female reproduction as it relates to reported
Al effects
The development of an oocyte begins as a primordial germ
cell. Early in embryonic development these cells migrate into
the future site of the ovaries, undergo meiotic cell division,
and multiply, resulting in primary oocytes (primordial follicle)
within the ovary. Their development is arrested until puberty,
when follicle stimulating hormone (FSH) produced by the
pituitary gland stimulates some to begin to mature, developing through follicle stages (primary, secondary, and if fertilized tertiary (Graafian) follicles), in the process of
folliculogenesis. Most die (atresia) during these stages.
During the resumption of cell division, the oocyte’s nucleus
(germinal vesicle) breaks down and the first polar body (that
forms concomitantly during oocyte division) is extruded.
Follicle cells secrete and release estrogen that feeds back to
the pituitary gland to decrease FSH release and increase
luteinizing hormone (LH) release. This causes the follicle to

rupture, resulting in release of the egg (ovulation), that
migrates into the fallopian tubes where it can be fertilized by
sperm. The ruptured follicle forms a corpus luteum, a transitory endocrine organ that secretes estrogen and progesterone. The latter feeds back to the pituitary gland to decrease
LH release. The fertilized oocyte forms a mature egg cell
(ovum). When the oocyte and sperm chromosomes combine,
it becomes a zygote, which divides as it migrates into the
uterus, creating the pregnant (gravid) state.
In animal species that give birth to multiple offspring at
the same time (multiparous), the fetuses are implanted
evenly down the uterine horns, where the fallopian tubes
and uterus meet. The zygote develops into an embryo then a
fetus. If fertilization does not occur, decreasing estrogen
feeds back to the pituitary gland to increase FSH to repeat
the cycle. FSH and LH act on their receptors. In addition to
estrogen, which effects ovarian follicle growth and development, and progesterone, which effects embryo development
and implantation, the ovary synthesizes testosterone that
serves as a precursor to estrogen, promotes follicular growth,
and corpus luteum formation.

Male reproduction as it relates to reported
Al effects
The testes (singular testis) have two primary functions, to
produce sperm and hormones including testosterone. The
testes are composed of multiple seminiferous tubules and
interstitial tissue, housed within a fibrous covering, the tunica
albuginea. During embryonic development within the seminiferous germinal epithelium, Sertoli cells, which surround the
developing germ cells, associate with the latter to form seminiferous tubules after birth. The seminiferous tubules are
coiled masses that produce sperm cells through spermatogenesis, the maturation of germ cells to haploid spermatozoa. At birth, the seminiferous tubules contain
spermatogonial stem cells. During the first round of spermatogenesis, Sertoli cells join to form tight junctions that compartmentalize the seminiferous epithelium into basal and
luminal compartments. Spermatogonia, which are in the
basal compartment, divide into type A spermatogonia that
remain to replenish the precursor cells or type B spermatogonia. The latter, through meiosis in the luminal compartment,
become (primary) spermatocytes. These divide to form secondary spermatocytes which meiotically divide to from spermatids, which are initially round. Multinucleated giant cells in
the seminiferous tubules are degenerating germ cells.
Spermatids
become
spermatozoa
during
late
spermatogenesis.
Spermatozoa travel from the seminiferous tubule lumen
through efferent ductules to enter the head of the epididymis, a long, coiled tube (duct) on the backside of each testis
that transports and stores the spermatozoa. The epididymis
is composed of its initial segment and head (caput) which is
characterized by its thick epithelium, body (corpus), and tail
(cauda), where spermatozoa are stored. Within the epididymis, sperm mature while gaining mobility. During sexual
arousal, contractions force the sperm into the vas deferens.
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The vas deferens is a long, muscular tube that travels from
the epididymis into the pelvic cavity to transport mature
sperm to the urethra in preparation for ejaculation. Seminal
vesicles are sac-like pouches attached to the vas deferens.
They produce fructose that provides sperm with an energy
source and assists the sperms’ motility. Seminal vesicle fluid
provides most of the ejaculate volume.
The prostate gland is composed of many secretory acini
that contain epithelial cells, which produce prostatic fluid,
and line a central lumen that is filled with fluid.
Fibromuscular stromal tissue surrounds the acini. The seminal
vesicles and prostate gland produce seminal fluid which
mixes with sperm to form semen. The accessory organs are
internal organs (in contrast to the penis and scrotum containing the testes) of the male reproductive system, including
the vas deferens, seminal vesicles, prostate gland, and bulbourethral glands. The bulbourethral glands produce a clear,
slippery fluid that empties into the urethra. It lubricates the
urethra and neutralizes acidity from urine in the urethra.
Testes interstitial tissue contains connective tissue and
Leydig cells. LH and FSH, produced by the pituitary gland,
stimulate Leydig cells to release androgens, including testosterone, synthesized from cholesterol. Testosterone stimulates the
testes and prostate gland during embryological development
to adulthood and, with FSH and other factors, regulates spermatogenesis. Estradiol, synthesized by Leydig and Sertoli cells
and mature spermatocytes, modulates spermatogenesis in a
complex manner. Testosterone acts on the androgen receptor.

Aluminum exposure
Aluminum is ubiquitous, quantifiable in all exposure sources
and biological materials. The main source of exposure for
humans and laboratory animals is food. Additional sources
for humans include beverages, air-borne particulates and
fumes, pharmaceuticals such as antacids and cosmetics, and
vaccines with Al as an adjuvant. Typical exposures from these
sources, estimated percentage absorbed, and resulting daily
Al absorbed are summarized in a mini-review (Yokel and
McNamara 2001). The calculation of daily Al absorption is
applied in this review.

Bioavailability expressed as approximate systemic
Al exposure
A challenge in relating the results of studies that used different routes of exposure/administration is the different percent

of Al that enters systemic circulation (bioavailability) and,
therefore, potentially enters the reproductive organs or other
sites affecting reproduction. It has been suggested that testing in animals to determine the effects and human risks of
environmental toxicants could be improved if test substances
were administered to achieve pharmacokinetically equivalent
serum levels in the animal and the human (Brent 2004). To
relate Al uptake from different routes of administration, calculation of approximate systemic Al load was based on the
extent of absorption from the site of absorption and absorption time course (WHO 2012). For this review, an approximate
systemic Al load was determined for the exposure and
administration routes used in studies assessing Al reproductive toxicity. This approach goes beyond the typical report of
Al exposure, that is often the amount added to drinking
water or the diet without documentation of actual intake;
normalizes the amount of Al in the different chemical species
of Al studied that can have Al content varying by 6-fold; and
takes into account absorption from the exposure route, that
can vary by 500-fold; to generate systemic exposures that
can be compared. Assumptions had to be made in some
cases, such as when the chemical species was ambiguously
reported or actual consumption was not reported.
Bioavailability was based on reported values, for which there
is often a range. For oral exposure, values were usually
obtained under conditions that have some differences from
the study to which the value is applied, e.g. a different Al
species was studied, in a different dose, in a different mammalian strain or species, in a different status of gastric contents, and/or in a different dosing schedule. Nevertheless,
this approach advances the ability to compare the cited studies. The values used are in Table 1 and are based on
the following.
After orogastric intake or intragastric delivery of aqueous
solutions 0.2% of Al was assumed to enter into systemic circulation (the blood stream) in the first 24 h, based on reports
€eke et al. 1997;
of oral Al bioavailability (Hohl et al. 1994; Dru
Jouhanneau et al. 1997; Priest et al. 1998; Stauber et al. 1999;
Yokel et al. 2001; Zhou et al. 2008). Studies we conducted
found oral bioavailability of 26Al incorporated into acidic
SALP in a biscuit or 1.5% basic SALP in cheese to be 0.1%
(Yokel and Florence 2006; Yokel et al. 2008). Comparison of
normal urinary Al excretion to daily Al intake (the vast majority being in the diet) resulted in estimated Al absorption of
0.1 to 0.3% (Ganrot 1986), 0.1% (Priest 1993), and 0.1%
(Nieboer et al. 1995). Therefore, the percent of Al entering
systemic circulation from food was assumed to be 0.1%. No

Table 1. Approximate systemic Al exposure for the first 24 h and total for the exposure/administration routes cited in this article.
Exposure/administration route
Oral, intragastric (i.g.)
Intramuscular (i.m.) aluminum hydroxide
Intramuscular (i.m.) aluminum phosphate and
amorphous aluminum hydrophosphate sulfate in
Merck aluminum adjuvant
Intraperitoneal injection (i.p.)
Subcutaneous injection (s.c.)
Topical application
The generation of these values is described in the text.
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Approximate systemic Al exposure for the first 24 h
0.2% from solutions, 0.1% from food
0.5%
1.8%
100%
21%
0.01%

Total approximate systemic Al exposure for the
exposure/administration
0.2% from solutions, 0.1% from food
0.5% daily up to 100% of the dose
1.8% daily up to 100% of the dose
100%
21%
0.01%
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absorption from oral intake was assumed after 24 h. Al exposure assessment for the orogastric route did not consider possible accumulation following multiple day dosing.
Many studies using the in situ rat gut preparation and
determination of Al in animal and human urine and plasma
and animal organs showed higher Al concentrations when
citrate was co-administered with Al, suggesting citrate
increased Al absorption from the gastrointestinal tract. The
increase, and number of demonstrations, with co-administered citrate was greater than co-administration of other carboxylic acids (Yokel and McNamara 1988; Domingo et al.
mez et al. 1994; Cunat et al. 2000; Poirier et al.
1993; Go
2011). Using the preferred method to quantitate oral bioavailability, comparison of area under the curve after oral versus intravenous (i.v.) administration of the test substance, it
was shown that Al citrate absorption was twice that of the Al
ion (Zhou et al. 2008). Therefore, the percent of Al assumed
to enter into systemic circulation in the presence of citrate
was assumed to be 2-fold that in its absence.
It has been shown, with presumably similar daily Al intake
over time, mouse brain Al concentration increased severalfold from 1 to 4 weeks of age, was then fairly constant until
1 year of age, then declined several-fold from 1 to 2 years
of age. Similar changes were not seen in rat brain (Takahashi
et al. 2001). Results of studies of Al concentration in humans
that presumably represent the general public showed lung,
liver, and kidney Al concentration in 1–12-year olds were
4-, 1.5-, and 2-fold of that in 0 to 3-month-olds (Stitch
1957). Serum Al increased with age from 20 to 80 years in
healthy humans (Zapatero et al. 1995). Brain Al was 2.3-fold
higher in 80–99 year olds compared to premature infants to
6 month olds (Markesbery et al. 1984). Bone Al increased >
4-fold from the first to fourth quartile of 16–98-year-olds
€m et al. 2005). No reports of longitudinal studies of
(Hellstro
Al concentration in male or female reproductive organs were
found. The duration of increased Al exposure in most studies
that assessed its effect on reproductive function was much
shorter than the test subject’s life span. Expressing orogastric
route Al exposure on a daily basis without consideration of
sex organ Al accumulation over time when there is continued
Al exposure perhaps underestimates the resultant reproductive organ Al concentration.
The approximate systemic Al exposures after intramuscular
(i.m.) injection of Al hydroxide (0.5%) and aluminum phosphate and amorphous aluminum hydrophosphate sulfate in
Merck aluminum adjuvant (1.8%) are based on a study in rabbits (Flarend et al. 1997). The time course of Al absorption
from the injection site appears to depend on its chemical
species. In their, albeit limited, study addressing the rate and
extent of Al absorption after injection, Flarend et al. (1997)
gave i.m. injections of 26Al-labeled aluminum hydroxide and
aluminum phosphate adjuvants to rabbits and determined
the area under the curve (blood concentration x time) for
26
Al compared to i.v. injection (which delivers 100% into the
blood) of 26Al-labeled aluminum citrate. After i.m. 26Allabeled aluminum hydroxide adjuvant injection, 17%
appeared in the blood within 28 days. After the initial burst
of blood 26Al at 10 h, blood 26Al was fairly constant for
28 days, suggesting a relatively stable absorption rate. This

would equate to 0.5% of the dose per day. After i.m. 26Allabeled aluminum phosphate adjuvant injection the amount
in the blood was fairly constant for 28 days, representing a
total of 51% of the injected 26Al, equating to 1.8% of the
dose per day. The daily approximate systemic Al exposure
after i.m. injection was assumed to be 0.5 or 1.8%, to a maximum of 100% if there was sufficient time.
After intraperitoneal (i.p.) injection 100% absorption in the
first 24 h was assumed, because absorption from the peritoneal cavity is typically quite rapid and complete (Lukas et al.
1971; Br€aunlich et al. 1988; Suzuki et al. 1995). This is supported by a study showing liver had 13% of an i.p. dose
5 days later. Extrapolation to t ¼ 0 from the near linear liver
Al concentration at days 5, 10, and 25 suggests 29% in the
liver (Kobayashi et al. 1990); this exceeds the percentage of
the human Al body burden in the liver (Krewski et al. 2007),
suggesting efficient Al absorption from the peritoneal cavity.
Absorption in the first 24 h after subcutaneous (s.c.) injection was taken to be 21%, based on Al lactate (Yokel and
McNamara 1985). After s.c. injection, no absorption from the
injection site was assumed after the first day based on the
92% of injected Al (as the lactate) in the carcass (Al not
accounted for in 7 soft organs that did not include the skeleton, the major site of Al accumulation) after 20 injections
over 2 weeks (Melograna and Yokel 1984).
Following topical application, 0.01% of Al was assumed to
be absorbed based on reports of dermal Al absorption from
Al chlorohydrate in humans (Flarend et al. 2001; de Ligt
et al. 2018).
Once Al enters tissues and organs, it is slowly cleared.
Estimated half-lives for the rabbit liver, lung, and spleen were
74, 44, and 113 days, respectively (Yokel and McNamara 1989)
and 150 days for rat brain (Yokel et al. 2001). After human
i.v. injection of 26Al citrate, approximately 50% of the 26Al was
eliminated in the first day, 70% in the first 5 days, and 98%
after approximately 3,000 days. Estimated whole body 26Al
half-lives were 1.4, 40, and 1700 days, with a possible fourth
half-life of approximately 50 years (Priest et al. 1995). Given
these long half-lives and the short interval between completion of Al exposure and termination of subjects in the studies
cited herein, the reduction of organ Al due to clearance would
be negligible and was not considered.

Animal diet Al content and daily food and water
consumption
Non-purified laboratory animal diets contain more Al than
the typical human diet due to their high grain content. Table
2 contains the reported Al concentration in laboratory animal
diets. Fifteen of the studies cited in Tables 3 and 6 reported
the source of the diet and its Al concentration (Table 2).
Some studies cited the diet source, but not its content or Al
concentration.1 A few studies reported the diet contents but
not the Al concentration (McCollum et al. 1928; Myers and
Mull 1928; Yousef 2004; Yousef et al. 2005; Yousef et al. 2007;
Sakr et al. 2017). The rest of the studies cited in this report
did not state the diet source, contents, or Al concentration.
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Table 2. Reported Al concentration of laboratory animal diets, as mg/kg diet.
Species

Al (mg/kg)

Referencea

Source

Mouse
160–180
100
25
200
209–280
Essentially Al free
134
7
257
350
3
64.5
370
3.2

Larsen diet
Standard mouse chow
Dyets semi-purified diet
Purina laboratory mouse chow
Panlab
Purified diet
Commercial rodent chow
Dyets purified diet
Panlab
Purina 5001C
Purified diet
Commercial mouse chow
Purina 5001 rodent chow
AIN-76 A purified diet for mice and rats

Ondreicka et al. (1966)a
Golub et al. (1987)a
Donald et al. (1989)a
Golub et al. (1992)
Domingo et al. (1993)
Fosmire et al. (1993)
Fosmire et al. (1993)
Golub et al. (1996) and Golub and Germann (2001)a
Colomina et al. (1998)
Oteiza et al. (1993)
Oteiza et al. (1993)
Długaszek et al. (2000)
Guo et al. (2001, 2002, 2005b, 2006, 2009)a
https://altromin.com/products/specialdiets/aindiets/AIN-76A

119
100
8300
190
270
7.3
66
60
100
121 and 135
10.5
103
27.9
110

Lab Blox

McCormack et al. (1979)a
Gupta et al. (1986)
Fleming and Joshi (1987)
Gawlik et al. (1987)
Gawlik et al. (1987)
Gawlik et al. (1987)
Hicks et al. (1987)
Domingo et al. (1987b)a
Fulton et al. (1989)
Provan and Yokel (1990)
Greger and Powers (1992)
Wilhelm et al. (1992)
Hsu and Hsu (1994)
Kandiah and Kies (1994)

Rat

5
50
7–10
20
227
<9
22–29
988
203
Guinea pig

Purina Rodent Chow 5001
Altromin 1320
Sniff diet
Altromin C
Purina Certified 5002 rodent chow
Panlab
Wayne Lab Blox
Purina rat chow
AIN-76 rat diet with lactalbumin as protein source
Nohrlin
AIN-76 rat diet
Ralston Purina Rodent
Chow
Semi-synthetic feed
Animal diet
Semi-purified AIN-76 diet with lactalbumin (Teklad Test Diet)
Purified diet
Agway rat chow

R/M-H, extruded (V1536)

Glynn et al. (1995)
Deng et al. (1998)
Sutherland et al. (1996) and Sutherland and Greger (1998)
Deng et al. (2000)
Yokel et al. (2001)
Poirier et al. (2011)
Hirata-Koizumi et al. (2011a, 2011b)a
Wu et al. (2012)
Weisser et al. (2019)

60
10
47

Proprietary chow
Special diet services, Ltd.
Purina guinea pig chow 5025

Owen et al. (1994)
Owen et al. (1994)
Golub et al. (1996)

1215
5.4
297
7–9

Purina rabbit chow
Wayne rabbit feed
Purina rabbit chow
Bio-Serv purified rabbit diet

Yokel (1985)a
Du Val et al. (1986)a
Fulton and Jeffery (1990)
Yokel and McNamara (1990)

Standard rat diet (CRF-1; Oriental Yeast Co., Ltd.)

Rabbit

a

Aluminum reproduction studies that are summarized in this review.

Unless a semi- or purified diet was used, the diet may have
contained  100 mg Al/kg.
Typical daily food consumption for both male and female
mice is 0.2 kg/kg body weight/day. Daily food and water
intakes are based on the average default values for rats and
mice (TERA). Assuming 100 mg Al/kg food and consumption
of 0.2 kg food/kg/day, a mouse would take in 20 mg Al/kg/
day from dietary sources. If absorption from the gastrointestinal tract is 0.1%, 20 lg Al/kg would enter systemic circulation daily. An assumption that oral Al bioavailability from
grain-based laboratory animal feed is comparable to other Al
sources is based on the fate of orally consumed Al. It is
assumed to be solubilized at low gastric pH to a common
species that is then precipitated in the upper intestine due
to its pH being close to that of the nadir of Al solubility

(Reiber et al. 1995; Harris et al. 1996). It was speculated that
metal bioavailability from a purified diet would be considerably greater than from commercial grain-based chows that
contain metal ligands (Donald et al. 1989). There are no
reports of Al bioavailability from grain or purified animal
diets to verify either assumption.
For rats, typical daily food consumption by males and
females is 0.09 and 0.1 kg/kg body weight/day, respectively
(TERA). Assuming 100 mg Al/kg food and consumption of
0.1 kg food/kg/day, a rat would take in 10 mg Al/kg/day from
the diet. This is consistent with calculations conducted in
two studies that estimated daily Al intake from drinking
water (which provides 5% of daily Al intake in humans and
would represent <1% in laboratory animals due to much
higher dietary Al content) and food (containing 22–29 mg Al/
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kg) to be 2 mg Al/kg bw/day (Hirata-Koizumi et al. 2011a,
2011b). If absorption from the gastrointestinal tract is 0.1%,
this would produce a systemic Al intake (approximate systemic Al exposure) of 10 lg/kg/day in the rat.2
The primary source of Al intake in the general human
population is from foods and beverages, with over 95% most
commonly from food. Daily Al intake by adults from 70
English-language published studies since 1990 averaged
7.4 mg, with a median of 5.3 mg (calculated by the author).
Assuming 70 kg body weight, 7.4 mg/day results in a daily
intake of 106 lg/kg. Assuming 0.1% Al absorption, the daily
systemic Al exposure would be 0.1 lg/kg, or 0.5 to 1% of
that calculated for the mouse and rat. However, some people
consume much more dietary Al than these averages. The
highest average reported in these studies is 28.5 mg/day
(Gharib 2004) and one individual’s daily consumption was
reported to be 176 mg (Aung et al. 2006). Major contributors
to Al in food are the approved food additives acidic sodium
aluminum phosphate as a leavening agent, resulting in high
Al levels in baked goods; basic sodium aluminum phosphate
as an emulsifying agent in cheese; and sodium aluminosilicate as an anticaking agent, in non-diary creamer and single
packets of salt (Yokel 2013). In China, fried bread, and in
Japan jellyfish treated with alum, often contain very high Al
levels. Tea beverage typically contains 1–4 mg/L and can
significantly increase daily Al intake. Consumption of
Al-containing pharmaceuticals, such as antacids/phosphate
binders, can result in ingestion of up to 5000 mg Al/day
(Yokel and McNamara 2001). Because >90% of Al is eliminated by the kidneys, reduced renal function and end-stage
renal disease can increase Al accumulation and the risk of Alinduced adverse effects.
The average age of first-time mothers and fathers in the
United States is 26 and 31 years, respectively. Typical total
dietary Al intake in the first 26 years of life for a female is
1500 mg/kg and for a 31-year old male 1700 mg/kg.
Assuming 0.1% absorption, total systemic Al exposures would
be approximately 1500 and 1700 lg/kg, respectively. Some of
the studies assessing Al reproductive toxicity in mice and rats
provided calculated Al exposures during gestation that
exceeded these values.

Al exposure was expressed as mass of feed or volume of consumed water. The ratios of Al mass/Al species mass are in a
footnote to Table 3. Systemic Al exposure was calculated
from the daily Al exposure times the Al mass/Al species mass
times the fraction absorbed, as described in a footnote to
Table 3.
Addition of Al to drinking water can decrease water
intake, possibly due its astringent property (Marcussen et al.
2013). For example, control mice consumed 6 ml water daily
whereas mice consuming 750 mg/L Al2(SO4)318H2O (providing 61 mg Al/mL) in the drinking water consumed 4.4 ml
water daily (Clayton et al. 1992). Addition of 3000 ppm
Al2(SO4)3 decreased water consumption 30–35% (HirataKoizumi et al. 2011b). As most studies did not report fluid
consumption, it was assumed that the target dose
was delivered.
All available literature was included in the tables, without
inclusion/exclusion or ranking based on quality. Some studies
were conducted following more rigorous protocols, providing
more confidence in their results. The European Union
enacted a chemical regulation (REACH; Registration,
Evaluation, and Authorization of Chemicals) that includes
requirements for reproductive toxicology for substances manufactured in or imported into the European Union at 10
metric tons/year (Scialli 2008). The requirements for such
high production volume chemicals include screening tests for
reproductive toxicity (OECD Test Guideline 421 or 422) in one
animal species and for importation of 100–1000 metric tons/
year an extended one-generation reproductive toxicity test
(OECD Test Guideline 443) or a 2-generation reproductive
study if it was initiated before 13 March 2015 (OECD Test
Guideline 416). Three studies were conducted following an
OECD Test Guideline (Beekhuijzen 2007; Hirata-Koizumi et al.
2011a, 2011b). Four studies were conducted following good
laboratory practice (GLP) (Beekhuijzen 2007; Wise et al. 2008;
Hirata-Koizumi et al. 2011a, 2011b). When studies included
several treatment conditions, the results are presented in the
same order as the treatment conditions.

Introduction to the tables of study summaries

Studies and experimental conditions that did not
appreciably increase Al exposure above that
provided by the diet

The reports of studies assessing Al reproductive toxicity often
included some measure of variability. For this review, only
average (mean) values are reported. Endpoint-specific
responses of Al-treated subjects were calculated as a percentage of control subjects by the author, when not provided in
the report, from the report tables and/or figures. All indications of statistical significance are from the original reports.
In studies of Al in drinking water and other exposure/administration routes, concentration/dose entries of 0 indicate no
added Al. Daily Al exposure was calculated from the added
Al concentration in the food, water, or as administered by
another route to the subject; times the mass of Al/mass of
the Al species when the exposure was expressed as mass or
moles of Al species; and adjusted for body weight when the

There were many studies that included added Al exposures
that, by calculation, contributed less to systemic Al exposure
than the diet (20 and 10 lg Al/kg/day for mice and rats,
respectively). These exposures are marked in italics in Tables
3 and 6. None of the female exposure studies using added Al
exposures that contributed less to the approximate systemic
Al exposure than the diet resulted in statistically significant
differences from controls, with the exception of the two
reports by Trif et al. (2008, 2010) and some significant differences in the Miska-Schramm et al. (2017) report. These low
additional Al exposures raise doubt about results that were
reported as significantly different from control (no added
Al) exposure.
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Table 3. Results of studies of females exposed to additional Al.

Al-treated subjects

Al exposure

Rats, 45–55 g, females
and males

0, 0.067, or 0.063% Al as AlCl36H2O or
baking powder in the diet started as
young rats and raised to maturity
0 or 2 mg of Al as KAl(SO4)2 added to
the stock diet daily for 100 days
that delivered an average of 8 mg Al/
kg bw/day
Bread estimated to deliver 10.5–30 mg
Al/day (Lyman and Scott 1930)
Fed several generations a diet containing
2–4% sodium Al sulfate baking
powder for 2 years
Fed three generations a diet containing 2
to 3.4% sodium Al sulfate
baking powder
0 or 19.3 mg/kg/day Al as AlCl3 in the
drinking water and 170 ppm Al in the
diet for 180–390 days

A mixture of pied and
albino rats, females
and males
Mice
Albino rats,4 weeks, 30 to
50 g, females and males
Rats, 50 to 100 g, females
and males
Dobra Voda strain mice,
females and males

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

McCollum
et al. (1928)

9 (800)

Four generations were raised consuming the diet. Average litter
size of the first and second litters was 120 and 112% of
controls. No gross abnormalities were seen at autopsy

Myers and
Mull (1928)

85–240 daily
220–468 daily

Decreased number of offspring (fertility), ovarian atrophy, and
histological changes in the ovaries
No appreciable effect on reproduction

Schaeffer and
Fontes (1928)
Lyman and
Scott (1930)

235–400 daily

No effect on fertility

Mackenzie(1932)

7.8
(1403 over 180 days)

No significant differences in number of litters or offspring
between treated and control mice. Al-dependent growth
retardation was seen in the second and third generation. No
pathological tissue changes were seen.
After the single injection on GD 9 or 13 GD 20 fetal weight was
104 and 103% of controls.
The number of (a) implantations, (b) resorptions, and (c) normal
fetuses from GD 9 or 13 injection was (a) 122 and 134,
(b) 43 and 267, and (c) 111 and 100% of controls.
Repeated treatment with 100 and 200 mg/kg caused some
maternal death, with ascites, adhesions between organs, and
periheptic granulomas.
Fetal weight after (a) 75 mg/kg GDs 9–13 or 14–18, (b) 100 mg/
kg GDs 9–13 or 14–18, or (c) 200 mg/kg GDs 9–13 or 14–18
was (a) 83 and 98, (b) 110 and 106, and (c) 87 and 53%
of controls.
Fetal crown-rump length was (a) 92 and 99, (b) 98 and 98,
and (c) 91 and 69% of controls.
Implantations were (a) 110 and 81, (b) 60 and 93, and (c) 60
and 11% of controls.
Resorption percent was (a) 17 versus 0 and 3 versus 2, (b) 1
versus 3 and 10 versus 0, and (c) 37 versus 0 and 12 versus
5 compared to controls.
Malformation percent was (a) 0 and 0, 0 and 0; (b) 1 and 0, 8
and 1; and (c) 0 and 0, and 0 and 0 compared to controls
Live and resorbed or dead fetuses were 93 and 93, and 200 and
213% of controls.
Fetal body weight and crown-rump length were 101 and 104,
and 100 and 103% of controls.
There were no statistically significant increases of any
abnormalities
There were no adverse effects on the dam, embryo, or fetus

Ondreicka
et al. (1966)

Single treatment: 0 or 40 mg/kg AlCl3 i.p.
on GD 9 or 13
Repeated treatment: 0, 75, 100, or
200 mg/kg on GDs 9–13 or 14–18

8080–40,400
(8080–210,080)

Sprague Dawley
rats, females

119 ppm Al in the diet supplemented
with 0, 500, or 1000 ppm Al as AlCl3
on GD 6, 9, 12, 15, and 18

16 or 32
(80 or 160)

Sprague Dawley rats and
New Zealand white
rabbits, females

74 or 1600 mg/kg Zeolite (20.1% Al) by
gavage GD 6–15 (rats) or 74, 345, or
1600 mg/kg by gavage GD
6–18 (rabbits)
112, 361, or 1087 mg sodium aluminum
phosphate/kg/ day in the diet for
6 months
0.1 ml of 50 or 100 mM AlCl36H2O on
GD 3 or 50 mM on GD 8 i.v.

30 or 643
(297 or 6432)
30, 139, or 643
(387, 1803, or 8362)
9.5, 30, or 92
(1738, 5600, or 16,862)

NMRI strain mice, 6–8
weeks, 24–26 g, females

Rats, females
New Zealand white rabbits,
3.3–5.5 kg, females

1:4 mixture of Maalox TC and water
starting GD 2
0, 25, 100, or 400 mmol Al/kg as Al
lactate s.c. GD 2–6, 9–13, 16–20
and 23–27

Reference

The growth, reproduction, external appearance, and autopsy of
rats on the Al-added diets were the same as controls

Holtzman rats,
200–240 g, females

Beagle dogs, 7–9 months,
females and males

Study results

45 (945)

621 or 1242
(621 or 1242)

142, 567, or 2268 per injection
(2268, 9072, or 36,288)

BALB/c mice, 43–50
days, females

0, 100, 150, or 200 mg/kg AlCl3 i.p. or
200 or 300 mg/kg i.g. GD 7 to 16

20,200, 30,300, 40,400, 81, or 121
(202,000, 303,000, 121,200, 808,
or 1212)

Sprague Dawley rats,
240–280 g, females
and males

0, 180, 360, or 720 mg/kg Al(NO3)3
9H2O i.g. daily for 60 days before mating
(males) and 14 days before and
throughout mating (females)

26, 52, or 104
(700, 1400, or 2800 through GD 13)

Sprague Dawley rats,
240–280 g, females

0, 180, 360, or 720 mg/kg/day Al(NO3)3
9H2O i.g. GD 14 through lactation day 21

26, 52, or 104
(207, 415, or 829 through GD 21)

Swiss Webster mice, 6–8
weeks, 30 g, females

81–90 (100) [control], 413 (500), or 844
84, 171, 2100, 4200, or 8400
(1000) ppm Al as Al lactate in diet
(1425, 2913, 14,700, 29,400,
from GD 0 to PND 21
or 58,800)
0, 10, 20, or 40 mg Al/kg as Al lactate s.c.
GD 3, 5, 7, 9, 11, 13, and 15

Benett
et al. (1975)

McCormack
et al. (1979)

Nolen and
Dierckman
(1983)

Gross autopsy and histopathological exam showed the normal
range of variations of the gonads

Katz et al. (1984)

On GD 17 the % of injected mice with implantations was 130,
106, and not reported; % resorptions 114, 214, and 86%;
fetal body weight 98, 94, and 97; fetuses with less mature
skeletons 147, 57, and 180; and fetuses with internal
hemorrhage 18, 424, and 200% of controls
Pilot study showed 40% failed to deliver pups.
Offspring weighed 91% of controls
The percentage of does bred producing offspring were 86, 90,
and 108; number of offspring 95, 90, and 80; and % of
stillborn or dead offspring within 2 days postpartum 57, 171,
and 828% of controls
Does died on the third day of 200 mg/kg/day i.p. dosing.
Placental and fetal weight was 53, 107, no result, 112, and 108;
and 62, 90, no result, 83, and 90% of controls.
Resorptions were 291,1609, no result, 581, and 939% of controls
The fertility index was 78, 111, and 111; corpora lutea 93, 87,
and 80; total implants 96, 91, and 102; early resorptions
700, 100, and 800; late resorptions 60, 93, and 73; live
fetuses 92, 89, and 89; and dead fetuses on GD 13 400, 200,
and 300% of controls
Number of living offspring/litter after 1 day of nursing was 100,
69, and 88% of controls.
Number of dead offspring/litter after 1 day of nursing was 0,
0.3, 1.1, and 1.6.
Offspring body weight was 99, 96, and 81; body length 100,
98, and 91; and tail length 104, 100, and 84% of controls
Diet Al did not affect fertility.
Pup weights and crown-rump lengths at birth in 500 and 1000
groups were significantly lower than controls.
Completed pregnancies of s.c. injected females were 89, 71, and
31% of controls.
Al treatment did not affect fetal resorption; number of fetuses;
or fetal, placental, or uterine weight. No major

Wide (1984)

Anderson
et al. (1985)
Yokel (1985)

Cranmer
et al. (1986)

Domingo
et al. (1987a)

Domingo
et al. (1987b)

Golub
et al. (1987)
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Table 3. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

Sprague Dawley rats,
240–280 g, females

0, 180, 360, or 720 mg/kg Al(NO3)3
9H2O i.g. GD 6–14

26, 52, or 104
(233, 467, or 933)

Wistar rats,
200 g, females

0, 96, 273 or 399 mg Al/kg/day as AICl3
or 0, 96, 195, or 378 mg Al/kg/day as
Al lactate in the diet from GD1 to
parturition

96, 273, or 399
(2016, 5733, or 8379)
96, 195, or 378
(2016, 4095, or 7938)

Swiss mice,
28–32 g, females

0, 66.5, 133, or 266 mg/kg/day Al(OH)3
i.g. GD 6–15

46, 92, or 184
(460, 920, or 1841)

Swiss Webster mice, 8–12
weeks, females

25 (control), 500, or 1000 mg Al/kg diet
as AI lactate from GD 0
through lactation

102 or 203
(2030 or 4060)

Wistar rats, females

0, 192, 384, or 768 mg/kg/day as Al(OH)3
i.g. GD 6–15

133, 266, or 531
(1329, 2657, or 5315)

Wistar rats,
220 g, females

0 or 400 mg Al/kg/day as Al lactate in
the diet GD 1–7, 1–14, or GD
1–parturition

400
(2800, 5600, or 8,000)

Humans

88 pregnant women exposed to excess
Al in the drinking water

Excess Al2(SO4)3 in the drinking
water raising the maximum
recorded Al concentration to
600 mg/l. The EU guideline is
<0.1 mg/l

Sprague Dawley rats,
230–260 g, females
and males

0 or 133 mg Al/kg as Al(OH)3, Al citrate,
or Al(OH)3 with citric acid (62 mg/kg)
i.g. GD 6–15

266
(2660) as Al(OH)3
532
(5320) as Al citrate, or Al(OH)3 with
citric acid

CBA mice, 25 g, females

0 or 200 mg/kg Al2(SO4)3
18H2O i.p GD 10–13 or 0 or 750 mg/l
Al2(SO4)3
18H2O i.g. GD 10–17

648,000
(2,592,000)
4860
(38,880)

Swiss albino mice,
28–32 g, females

0 or 57.5 mg Al/kg as Al(OH)3 or Al
lactate, or Al(OH)3 with lactic acid
(570 mg/kg) i.g. GD 6–15

115
(1150)

Study results
malformations were seen. Minor abnormalities in 10 and
20 mg/kg offspring were 192 and 275% of controls. Fetal
crown-rump length was lower in the 20 mg/kg offspring
On GD 20 doe gestational weight gain was 81, 80, and 81%
and placental weight was 101, 78, and 85% of controls.
The number of litters was 80, 70, and 80; corpora lutea 96, 108,
and 106; implants 82, 106, and 107; resorptions 150, 250,
and 250; and live fetuses 76, 102, and 109% of controls.
There were 0, 0.7, 0.2, and 0.1 dead fetuses/doe.
The percent of litters with runt fetuses was 0, 25, 43, and 62.
The fetal weight was 86, 84, and 66; body length 86, 84,
and 66; and tail length 88, 90, and 85% of controls.
Of 19 assessed malformations and variations, significant Al
effects were seen in micrognathia (360 mg/kg); and
decreased supraoccipital bone ossification, hypoplastic
deformed ribs, vertebral alterations, and sternebral variations
(all 3 groups). Significant hematomas were seen in the
768 mg/kg in the abdominal area, thorax, and limbs
Litter size at birth was 123,123, and 131; and 93, 96, and 96%
of controls.
Mortality PND 1 was 177, 1986, and 1470; and 46, 31, and
520% of controls.
Pup weight PND 1 was 97, 84, and 78; and 101, 100, and
85% of controls.
On GD 18 the number of litters was 90, 95, and 90;
implantations 108, 103, and 97; resorptions 775, 625, and
350; live fetuses per litter 85, 83, and 88%; male/female sex
ratio 71, 76, and 84; fetal body weight 101, 102, and 101;
and fetal body length 100, 104, and 100% of controls.
There were no remarkable external malformations, internal softtissue defects, or skeletal abnormalities
There were no differences in pregnancy rate, litter size, sex
ratio, birth weight, body length, or perinatal mortality.
Gestation length was shorter or longer than the controls in 4 of
17 litters.
Gravid uterine weight was 99, 101, and 95; number of litters 95,
95, and 100; corpora lutea/doe 109, 113, and 108; implants/
litter 107, 111, and 111; preimplantation loss 113, 104, and
94; live fetuses/litter 103, 96, and 105; post-implantation loss
662, 2269, and 900; non-viable implants/litter (early and
late resorptions and dead fetuses) 675, 2375, and 1025; fetal
body weight 90, 95, and 93; and male/female sex ratio were
85, 119, and 89% of controls.
The litter size was 93, 89, and 81; post-natal mortality 212, 288,
and 154; and fetal body weight one day after parturition
were 91, 91 and 93% of controls.
There were no significant effects on the number of dead pups
or offspring sex
Births up to 42 weeks after the contamination showed a
significant reduction of the percentage with spontaneous
onset of labor among the exposed compared to unexposed,
but no difference in percentage of premature rupture of
membranes, mean gestation, pregnancies estimated to be <
37 weeks, or miscarriages in hospital.
Newborns showed no difference in mean birth weight;
percentage with low birth weight, admitted to special care
baby unit, or congenital defects; head circumference, male/
female ratio, or Apgar score among the exposed compared
to unexposed
GD 20 percent pregnant rats was 106, 88, and 112; gravid
uterine weight 106, 90, and 100; number of litters 106, 88,
and 112; corpora lutea/doe 101, 99, and 102; implantations/
litter 101, 84, and 103; preimplantation loss/litter 105, 185,
and 100; viable implants/litter 102, 81, and 96; nonviable
implants/litter 83, 150, and 250; post implantation loss/litter
95, 203, and 276; male/female sex ratio 108, 99, and 94; and
fetal body weight were 103, 104, and 94% of controls.
Fetal a) parietal, b) occipital, and c) sternebrae delayed
ossification; and d) absence of xiphoids indicating delayed
ossification were a) 100, 80, and 109; b) 70, 161, and 213;
c) 109, 107, and 134; and d) 85, 165, and 155%
of controls
Al exposure did not affect gestation length, litter size, or sex
ratio.
Pups born to does that received i.p. Al weighed 95% of
controls. Weight of pups born to does that received oral Al
were not significantly different from controls
GD 18 gravid uterine weight was 91, 89 and 80% of controls.
The number of litters was 85, 77, and 100; implantation sites/
litter 86, 99, and 82; resorptions 121, 106, and 186; postimplantation loss 141, 138, and 240; live fetuses/litter 84, 97,
and 77; male/female sex ratio 106, 101, and 98; and fetal
body weight/litter 102, 84, and 102% of controls.
The number of dead fetuses was 0, 0, 1, and 1.
Cleft palate, dorsal hyperkyphosis, and parietal, delayed
ossification, not seen in controls, were produced, mostly in
Al lactate-exposed offspring

Reference

Paternain
et al. (1988)

(Bernuzzi
et al. (1989)

Domingo
et al. (1989)

Donald
et al. (1989)

Gomez
et al. (1990)

Muller
et al. (1990)

Golding
et al. (1991)

Gomez
et al. (1991)

Clayton
et al. (1992)

(Colomina
et al. (1992)
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Table 3. Continued.

Al-treated subjects
THA strain rats, females

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

THA strain rats, females

0, 90, 180, or 360 mg/kg AlCl3 i.g. GD 8
to 20
0, 900, or 1800 mg/kg AlCl3 i.g. GD 15

36, 73, or 145
(473, 945, or 1891)
364 or 727
(364 or 727)

Wistar rats,
260 g, females

0 or 400 mg Al/kg/day as Al lactate in
the diet GD 1–19

400
(7600)

CBA/T6 mice, 10–12
weeks old

0 or 200 mg/kg Al2(SO4)3 i.p. GD10 to 13

31,600
(126,400)

Swiss albino mice,
28–32 g, females

0 or 103.8 mg Al/kg as Al(OH)3 or
Al(OH)3 with ascorbic acid (85 mg/kg)
i.g. GD 6–15

208
(2076)

B6C3F1 mice, 4 weeks old,
females and males

1, 2.5, 5, and 10% KAl(SO4)212H2O in
the diet for 20 months

114, 285, 570, or 1140
(69,312, 173,280, 346,560, or
693,120)

Charles River CD
rats, females

0, 5, 25, 50, 250, 500, or 1000 mg/kg Al
lactate i.g. GD 5–15

0.92, 4.6, 9.2, 46, 92, or 184
(10, 51, 101, 506, 1012, or 2024)

SPRD rats, 240–280 g, 7
weeks, females
SPRD rats,
240–280 g, females

0, 2.45, 4.9, or 9.8 mg/kg Al lactate s.c.
GD 7–15
0, 2.45, 4.9, or 9.8 mg/kg Al lactate s.c.
GD 7 to 15

47, 95, or 189
(473, 947, or 1893)
47, 95, or 189
(473, 947, or 1893)

SPRD rats,
0 or 9.8 mg/kg Al lactate s.c. GD 7 to 15
240–280 g, females
CBA/T6 and C57/BL/6J mice 0, 750, 1000, or 1250 mg/l
Al2(SO4)3 in the drinking water GD 10–17
or 200 mg/kg i.p. GD 10–13

189
(1893)
64, 86, or 107
(516, 688, or 860)
31,300
(126,400)

Swiss albino mice,
28–32 g, females

0, 37.5, or 75 mg/kg AlCl3 i.p. GD 6–15

7575 or 15,150
(75,750 or 151,500)

Charles River CD-1 mice,
25–30 g, females

0, 60, 120, or 240 mg/kg AlCl3 i.p.
GD 6–15

12,120, 24,240, or 48,480
(121,200, 242,400, or 484,800)

Charles River CD-1 mice,
25–32 g, females

0 or 398 mg/kg Al(NO3)3
9H2O
i.g. GD 6–15

57
(573)

Mouse oocytes

Al nitrate, 30 or 60 mg/l

Swiss mice, 5–6 weeks,
30–35 g, females

0 or 200 mg/kg AlCl3 i.g. for 30 days

81
(2424)

Swiss Webster mice, 8
weeks, females

0, 100, 500, or 1000 mg Al/kg diet as Al
lactate GD 0 to PND 35

20, 102, or 203
(609, 3045, or 6090)

Naval medical
research institute mice,
24–33 g, females

0 or 150 mg/kg AlCl3 i.p. on GD 10, 11,
or 12

30,300
(30,300)

Study results
There were no differences in the mean number of implantation
sites, birth rate, or mean litter size.
There were no differences in the mean number of implantation
sites, birth rate, or mean litter size.
Female and male offspring weight was 76 and 66; and 73
and 64% of controls
Litter size was 103% of controls.
GD20 fetus body weight was 97 (upper uterine horn) and 101%
of controls (lower uterine horn).
GD20 fetus calcium was 115, phosphorus 104, Al 286, copper
48, zinc 103, and magnesium were 90% of controls
Offspring birth weights were 88% of controls.

There were no significant effects on GD 18 doe body and
uterine weight, number of implantation sites, postimplantation loss %, resorptions/litter, live and dead fetuses/
litter, fetal body weight, or fetal sex ratio.
No fetal gross external, visceral, or skeletal malformations
were seen
Vaginal mucosal epithelium keratinization was 113, 94, 104, and
98% of controls.
Vaginal lymphocytic infiltration was 95, 127, 18, and 108%
of controls.
Female offspring weight was 101, 112, 103, 100, 99, and 101
and anogenital distance 100, 96, 99, 105, 95, and 93% of
controls.
Male offspring weight was 99, 105, 98, 94, 94 and 98;
anogenital distance 93, 94, 96, 97 and 90, 98 and 93,
and 97; and testicular weight 105, 112, 92, 99 and 110,
119 and 102, and 96% of controls
The number of offspring/litter was 95, 111, and 111 and their
weights were 98, 96, and 93% of controls
The number of offspring/litter was 86, 105, and 112 and their
weights were 100, 100, and 98% of controls.
The number of pups/litter and their weights were 112 and 93%
of controls
There were no effects on gestation length, litter size, sex ratio,
or pup mortality.
Offspring weights of CBA pups exposed to 750 or 1000 weighed
less than controls. C57/BL/6J pups exposed to 1250 mg/l
weighed 5% less than controls. Pups of both strains exposed
to i.p. Al in utero weighed less than controls
GD 18 gravid uterine weight was 89 and 79, implants/litter 83
and 82, live fetuses/litter 91 and 87, early resorptions/litter 0
and 438, dead fetuses/litter 875 and 125, post-implantation
loss 368 and 521, % male sex 86 and 96, and fetal body
weight was 87 and 82% of controls.
Al exposure did not increase fetal morphologic defects
GD 18 percentage of dead fetuses was 0, 0, 15, and 50;
abortions 0, 9, 30, and 43; early deliveries 0, 0, 0, and 0;
resorbed litters 0, 0, 5, and 0; and does with live fetuses
100, 91, 50 and 0%.
For the 60 and 120 mg/kg exposed does gravid uterine weight
was 84 and 76, implants/litter 104 and 98, live fetuses/litter
94 and 91, non-viable implants/litter 192 and 154 , early
resorptions 36 and 55, late resorptions 950 and 600, male/
female sex ratio 100 and 93, and fetal body weight 79 and
79% of controls.
There was an exposure-dependent increase in fetal asymmetrical
sternebrae and frontal bone reduced ossification
Al caused 56% doe mortality, abortion in 3% and early delivery
in 6% compared to 0% in controls.
The doe body, gravid uterine, and fetal weights were 67, 49,
and 58% of controls. Implants, live fetuses, and non-viable
implants per litter were 95, 82, and 727% of controls.
Of the non-viable implants Al increased early and late
resorptions and dead fetuses.
Male/female sex ratio was 112% of controls. Significant fetal
effects were internal alterations and reduced and delayed
ossification of multiple bones
First polar body extrusion was inhibited and viability affected,
but there was little effect on germinal vesicle breakdown
Ovarian protein was 69, uterine protein 59, ovarian 3bhydroxysteroid dehydrogenase 44, and 17b-HSD activities
(enzymes involved in steroid [estrogen and progesterone]
production) 46, ovarian cholesterol 198, uterine glycogen
164, phosphorylase 43, and serum estradiol 66%
of controls
There were no differences in the number of does completing
pregnancy, gestation length, or litter size at birth
Resorption rates were 25.5, 21.2, and 23.3% and 0% in vehicleexposed does.
GD 18 fetus body weights were 88, 90, and 93% of controls.
Crown-rump length was not affected.

Reference
Misawa and
Shigeta (1992)
Misawa and
Shigeta (1993)

Muller
et al. (1993)

Rankin and
Manning
(1993)
Colomina
et al. (1994)

Oneda
et al. (1994)

Agarwal
et al. (1996)

Gonda
et al. (1996)
Gonda and
Lehotzky
(1996)
Gonda
et al. (1997)
Alleva
et al. (1998)

Colomina
et al. (1998)

Albina
et al. (1999)

Belles et al. (1999)

Shen et al. (1999)
Chinoy and
Patel (2001)

Golub and
Germann
(2001)
Malekshah
et al. (2005)

(continued)

10

R. A. YOKEL

Table 3. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

Wistar rats, females (11
weeks), males
(9 weeks)

0, 40, 200, or 1000 mg/kg/day AlCl3 i.g.
from 2 weeks prior mating to 
3 PNDs

20, 98, or 494
(554, 2744, or 13832)

Wistar rats, 3
weeks, females
Japanese black cows,
411 kg, females

0 or 3 mg Al as Al(OH)3 gel s.c.

10,161
(10,161)
A) 0.18 or 0.36
(1.3 or 2.6 after 7 days)
B) 0.18
(1.3 after 7 days)
C) 0.18
(182 after 1 year)

Swiss mice, 50
days, females

0, 75, 94, or 117 mg/kg/day AlCl3 in the
drinking water for 12 weeks

30, 38, or 47
(2545, 3190, or 3971)

0, 19, or 38 mg/kg/day AlCl3 i.p. GD 0–6

3838 or 7676
(26,866 or 53,732)

Wistar rats,
females

50 (control), 200, 400, or 1000 ppb
Al as Al2(SO4)3 in the drinking
water for 6 months

0.24, 0.48, or 1.2
(44, 87, or 218)

Sprague Dawley rat, 5
weeks, females

0 or 0.1125 mg Al as Merck Al adjuvant
i.m. into each hindlimb premating
weeks 5 and 2 and GD 6. F0 females
bred at 12 weeks of age

48.6 at GD21
(450 at GD21)

Humans giving 76,788
births, females

Mean exposure to 0.042 lg/m3 in PM2.5
captured Al in Connecticut for
3.5 years

0.00021c
(0.27)

Wistar rats, females
and males

0, 200, 400, or 1000 ppb Al2(SO4)3 in the
drinking water for 3 months before
mating F0 generation. F1 offspring
had same exposure to
sexual maturity

0.24, 0.48, or 1.2
(22, 44, or 109)

Sprague Dawley rats, 5
weeks, females
and males

0, 120, 600, or 3000 ppm Al2(SO4)3
in the drinking water for 10 weeks
before mating and throughout the
lactation period for F0 and F1
generation rats, resulting in mean
14.4, 71.5, or 316 mg/kg bw/day
Al2(SO4)3 intake by F0 females and
15.3, 74.2, or 338 mg/kg bw/day
Al2(SO4)3 intake by F1 females

F0 females
4.6, 23, or 100
(319, 1582, or 6990 over 10 weeks)
F1 females
4.8, 23, or 107
(338, 1641, or 7477 over 10 weeks)

15 or 30 mg Al as Al(OH)3 gel i.m. once.
48 h later luteolysis induced, then
artificially inseminated
0 or 15 mg Al i.m. once
15 mg Al i.m. on 5 occasions every 2 to
3 months over 1 year
All with porcine FSH (pFSH) to induce
super-ovulation

Study results
Percent of Al-exposed offspring with fetal anomalies was 29,
20, and 13%. Percent of vehicle-exposed offspring with
fetal anomalies: 3.4, 4.3, and 4.1
The mating index was 100, 90, 100, and 100; number of
pregnant females/number of females paired 100, 90, 90, and
100; fecundity index 100, 90, 90, and 100; and fertility index
90, 100, 100, and 100%.
Gestation duration (number of days between confirmation of
mating and the beginning of parturition) was 100, 100 and
100%; implantation sites 95, 84, and 98; and corpora lutea
98, 81, and 91% of controls.
PND 1 male offspring weight was 93, 97, and 98; female
offspring weight 100, 104, and 100; and live offspring 102,
103, and 99% of controls. There were 0, 1.3, 0.1, and 0 dead
offspring/litter.
Microscopic assessment of cervix, clitoral gland, ovaries, uterus,
and vagina showed no significant difference from controls
Ovary weight 3 days later was 104% of controls
A). Seven days after 30 mg AI the number of corpora lutea, total
ova recovered, transferable embryos, or large follicles was
115, 83, 78, and 243% of those given 15 mg.
B) Corpora lutea, large follicles, total ova recovered, and
transferable embryos were 105, 98, 108, and 108% of
controls.
C) The number of corpora lutea was 111, 73, 79, and 97%; total
ova recovered 105, 57, 63, and 95%; and transferable
embryos 91, 58, 42, and 91% after the 2nd, 3rd, 4th, and
5th injection compared to the 1st
Body 82, 90, and 83; uterus 100, 100, and 119; and ovary
weight was 72, 89, and 89% of controls after the 12 weeks.
GD20 number of pregnant females was 50, 50, and 44;
viable fetuses 91, 52, and 83; implantation sites 107, 81,
and 116; and resorptions/implantation sites 1303, 2481,
and 1945% of controls.
Histology of ovarian sections showed highly congested blood
vessels throughout the ovary, with a large number of atretic
follicles at different stages of development
38 mg/kg/day resulted in sluggishness, paralysis, decreased body
weight, diarrhea, and death in 40% of the does.
GD20 doe body weight was 48, 35, and 28 g; placental
weight 0.17, 0.15, and 0 g; fetal weight 1.2, 1.0 and 0 g;
viable fetuses 8.3, 5.17, and 0; implantation sites 8.3, 6.7,
and 3.0; resorptions/implantation sites 0, 23 and 100%;
and pregnant females 100, 60 and 17%.
The highest Al dose caused highly congested blood vessels over
the ovaries with a large number of atretic follicles at
different developmental stages
Sexual cycle duration was 108, 116, and 114% of the control
group. The percent normal proestrous was 100, 94, 100,
and 97; estrous 62, 29, 31, and 41; diestrous I 62, 56,
62, and 47; and diestrous II (estrous cycle phases) 97, 62,
81, and 94%
No significant effect was seen on F0 female body weight.
Fecundity index was 101, GD21 corpora lutea/pregnant female
100, peri-implantation loss 104, implantations/pregnant
female 100, resorptions/implants 112, post-implantation loss
112, live fetuses/pregnant female 99, female fetal weight
101, and male fetal weight 101% of controls.
No significant differences in fetal morphology were seen.
F1 generation showed no significant reproductive effects
The interquartile range gestational exposure (0.03 lg/m3) was
associated with a 5% decrease in birthweight (95%
confidence interval) and 11% increase in risk of small-at
term birth (95% confidence interval).
The authors saw severe structural changes in F0 and F1 ovary
and uterus of Al-exposed rats, summarized as congestive
and degenerative changes.
The ovary had vacuolar epithelial cells, follicles with large
oocytes, edema of the parenchymatosa zone, and follicle
and parenchyma destruction.
The uterus showed necrosis, uterine epithelium lining
destruction, vascular congestion, connective tissue necrosis
and reduction, and uterie epithelium detachment.
The mating index was 95.8, 100, 100, and 100% in the F0
generation and 100, 95.8, 100, and 95.8% in the F1
generation.
Fertility was 95.7, 91.7, 100 and 95.8% in the F0 generation and
91.7, 82.6, 91.7, and 91.3% in the F1 generation.
There were no treatment-related differences in the number of
pups delivered.
There were no treatment-related alterations in the
histopathology of female reproductive organs or number of
primordial follicles in the ovary of F1 females between the
control and highest Al exposure group.
There was no significant effect of Al treatment on ovary weight
of F1 females.

Reference

Beekhuijzen
(2007)

Kimura
et al. (2007)

Mohammed
et al. (2008)

Trif et al. (2008)

Wise et al. (2008)

Bell et al. (2010)

Trif et al. (2010)

Hirata-Koizumi
et al. (2011b)
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Table 3. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

Sprague Dawley rats, 5
weeks, females
and males

0, 50, 500, or 5000 ppm NH4Al(SO4)2 in
the drinking water for 10 weeks
before mating and throughout the
lactation period for F0 and F1
generation rats, resulting in mean
6.52, 58.6, or 500 mg/kg bw/day
NH4Al(SO4)2 intake by F0 females and
6.65, 61.9, or 517 mg/kg bw/day
NH4Al(SO4)2 intake by F1 females

F0 females
1.5, 13.4, or 114
(104, 935, or 7980 over 10 weeks)
F1 females
1.5, 14, and 118
(106, 988, or 8251 over 10 weeks)

Sprague Dawley
rats, females

100 ll saline or AS04 (GSK Biologicals
proprietary Adjuvant System that
contains 500 lg Al(OH)3 salt and
50 lg of a lipopoly-saccharide
derivative per 500 ll) i.m. 30 days
before pairing with a male and on
GD 6, 8, 11, and 15

3.1 from each injection
(280 on GD 20)

C57BL/6 and
BALB⁄ c mice, 10
weeks, females

2% Al(OH)3 in 0.2 ml as an adjuvant in
tetanus toxoid s.c. 3 times at 2-week
intervals. Mated one day after the
last dose
0, 300, or 600 mg/kg AlCl3 in the
drinking water throughout pregnancy
0, 64, 128, or 257 mg/kg AlCl3 in the
drinking water for 120 days

14,532 for the 1 day after one
injection
(44,596)

Albino rats, 150–200 g

0 or 2% alhydrogel (Al(OH)3 wet gel
suspension) in 0.2 ml s.c. 3 times at
2- week intervals
0 or 200 mg/kg AlCl3 i.g. GD 6 to 15

14,532 for the 1 day after one
injection
(44,596)
80.8
(808)

Wistar rats, 5 weeks,
110–120 g, females

0, 64, 128, or 256 mg/kg AlCl3 in the
drinking water for 120 days

26, 52, or 103 (3103, 6205,
or 12,411)

Humans

Urine Al above (26% of subjects) and
below 9 lg/L with fetus at gestational
age > 22 weeks and birth weight
> 500 g

Swiss-Webster mice, 10–12
weeks, females
Wistar rats, 5 weeks, 110120 g, females

C57BL/6 mice, 10
weeks, females

121 or 242
(2424 or 4848)
26, 52, or 104
(3103, 6205, or 12,459)

Humans

Humans

Wistar rats, 250 g, female

Mean exposure to 0.040 and 0.042 lg/m3
Al in PM2.5 captured in Florida during
the first trimester and entire
pregnancy, respectively
0 or 1 mg Al(NO)3)3 i.p every other day
for 7 doses

0.0002c
(0.018 and 0.054)

508
(3556)

Study results
Uterus weights of Al-treated F1 weanlings were 105, 84, and
78% of controls and 102, 87, and 87% of controls
normalized to body weight.
Ovary weights of Al-treated F2 weanlings were 95, 97, and
95% of controls and 97, 98, and 93% of controls
normalized to body weight.
Uterus weights of Al-treated F2 weanlings were 105, 107, and
81% of controls and 106, 105, and 90% of controls
normalized to body weight
The mating index was 100, 100, 100, and 100% in the F0
generation and 100, 95.8, 100, and 100% in the F1
generation.
Fertility was 100, 87.5, 100 and 100% in the F0 generation and
91.7, 78.3, 95.8, and 95.8% in the F1 generation.
There were no significant differences in the number of
implantations, pups delivered, sex ratio, or pup viability on
delivery.
There were no treatment-related alterations in the
histopathology of female reproductive organs or number of
primordial follicles in the ovary of F1 females between the
control and highest Al exposure groups.
There was no significant effect of Al treatment on ovary weight
of F1 females.
Ovary weights of Al-treated F2 weanlings were 101, 98, and
83% of controls and 98, 100, and 92% of controls
normalized to body weight.
Uterus weights of Al-treated F2 weanlings were 94, 82, and
75% of controls and 92, 85, and 84% of controls
normalized to body weight
The mating index was 102, fecundity 100, fertility index 100,
post-implantation survival 105, live birth 101, and viability
index 101% of controls.
GD 20 corpora lutea were 91, implantations 94, pre- and postimplantation losses 82 and 108, live young 94, placental
weight 104, litter weight 95, female and male fetal weights
102 and 100, and minor visceral abnormalities 108%
of controls
Fecundity index and fertility were 60 and 88% in C57BL/6 mice
and 87 and 59% in BALB⁄ c mice compared to salinetreated controls
Al exposure non-statistically significantly decreased newborn
body weight
Blood estrogen was 96, 34, and 15; progestogen 91, 69
and 42; LH 77, 22, and 4, and FSH 59, 16, and 12%
of controls. Blood testosterone increased 2-, 8-, and 12-fold
of controls.
Fecundity was 56% in Al-injected mice and 83% in controls.
Fertility was 7.3 offspring in Al-injected mice and 7.0
in controls
Implantations, resorptions, live fetuses, and dead fetuses were
52/60, 11/0, 37/60, and 3/0 compared to controls
Ovary ACP activity was 96, 84, and 78; ALP 94, 83, and
78; Mg-ATPase 97, 93, and 82; Na-K-ATPase 7, 84,
and 81; and Ca-ATPase 93, 83 and 78% of controls.
Ovary FSH receptor expression was 104, 107, and 110 and
LHR 102, 105, and 109% of controls.
Ovary zinc was 90, 77, and 68; copper 103, 120, and 131;
and iron 89, 70, and 59% of controls.
Ovary ultrastructural changes in the highest exposure group
included: Margination and concentration of nuclear
chromatin showed ovary granulosa cell apoptosis. Irregular
nuclear envelope structure. Swollen mitochondria.
Disintegrated and vacuolated cristae. Dilated rough
endoplasmic reticulum with lost ribosomes. Disordered Golgi
body structure. Much higher electron density in nuclear and
cytoplasmic substances
Median cell proliferation, as a measure of oxidative stress, of
erythrocytes in umbilical cord blood was 2.3-fold in those
with higher Al.
Newborns with cell proliferation above the median were more
likely to be diagnosed as small-for-gestational age and
weighed less.
Umbilical cord blood averaged 10.9 lg/L. There was no
correlation with birth weight, crown-heel length, head
circumference, Apgar scores or gestational age
Adjusted odds ratio risk of placental abruption was 1.10 (95%
C.I. 1.02–1.18) in the first trimester and 1.06 (95% C.I.
0.94–1.19) in the entire pregnancy
Electron-dense material was seen in endometrial, myometrial,
ovary internal theca, and granulosa cell cytoplasmic
lysosomes. Increased number of endometrial and myometrial
cell cytoplasmic lysosomes, with varied shapes and sizes.
Endometrial cell swollen mitochondria with no visible cristae,
containing a very electron lucent matrix. Some endoplasmic

Reference

Hirata-Koizumi
et al. (2011a)

Segal et al. (2011)

Zivkovic
et al. (2011)

Abu-Taweel
et al. (2012)
Wang et al. (2012)

Zivkovic
et al. (2012)
Hussein and
Mahmoud
(2013)
Fu et al. (2014)

Karakis
et al. (2014)

Rahbar
et al. (2015)
Ibrahimou
et al. (2017)

Marwa
et al. (2017)
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Table 3. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a,b

Bank voles, 4 weeks,
females and males

0, 1.5, or 100 mg Al/kg/day as AlCl36H2O
in the drinking water for 12 weeks

3 or 200
(252 or 16,800)

Slc: ICR mice, females

0, 108, or 207 mg/kg Al as AlCl36H2O in
the drinking water from GD
6–PND 21

216 or 414
[3456 or 6624]

Wistar rats,
180–200 g, females
Sprague Dawley rats, 8
weeks, females

0 or 500 mg/l AlCl3 in the drinking water
from GD 6 to the end of lactation
0 or 0.25 mg Al as Al hydroxy-phosphate
sulfate (in Merck’s aluminum
adjuvant) i.m. in each hindlimb
muscle 5 and 2 weeks prior to
cohabitation with untreated males
and GD 6

28
[441]
142 at GD 21
(5021 at GD 21)

Gerbils, 3 to 4 months
old, females

0 or 20.2 mg Al/kg/day as AlCl3 orally GD
17 versus24

40.4
[323]

Humans

Study results
reticulum alterations. Myometrium cells had relatively dense,
compact cytoplasm. There were collagen fibers in the
extracellular matrix, some cells had altered mitochondria,
dilated endoplasmic reticulum, and many eosinophils as
signs of inflammation produced by the damaged cells.
Ovary internal theca cells had lysosomes of various shapes and
sizes. Nuclei were elongated, polymorphous, with random
heterochromatin distribution. Mitochondria were round,
sometimes swollen, with decreased or altered endoplasmic
reticulum. Granulosa cells had euchromatic, indented nuclei;
intercellular vacuolations; cytoplasmic organelles with
degenerative ultrastructural changes; polymorphous or
swollen mitochondria with abnormal, altered cristae and
electron lucent matrix; and enlarged endoplasmic reticulum
Uterine weights were 155 and 124% of controls. Total number
of type 6 (355–418), type 7 (527–595), and type 8 (717-867
mm diameter) uterine follicles was 112 and 93% of controls.
The number of type 6, 7, and 8 follicles was 100 and 102;
153 and 75; and 90 and 69% of controls.
Mouse follicle classification goes up to type 8 (the largest and
preovulatory follicle). (Pedersen and Peters 1968)
One animal in each Al-treatment group had an abortion.
The number of implantation sites, live offspring, and male/
female ratio were 104 and 103, 98 and 106, and 96 and
107% of control
The gestation period, litter number, males, females, and weight
were 102, 87, 83, 94, and 107% of controls
Mating index was 100%.
Fecundity was 96 to 100%.
Mated and pregnant females were 100 and 95% of controls.
Corpora lutea were 102, peri-implantation loss 175, implants 100,
resorptions 119, post-implantation loss 120, live fetuses 99,
and female and male fetal weights 98 and 98% of controls.
GD 21 live fetus/litter was 104% of controls.
Fetuses with external malformations were 2/271 versus 0/275 in
controls, visceral malformations and visceral abnormalities 1/
142 and 1/142 versus 0/143 in controls; coronal
malformations 1/131 versus 1/132 in controls; skeletal
variations 18/142 versus 17/143 in controls; and incomplete
ossification 6/142 versus 1/143 in controls
Offspring body weight, anogenital distance; and prostate
epithelial buds, mesenchyme, and smooth muscle were 85,
53, 126, 9, and 105% of controls.
Androgen receptor, estrogen receptor alpha, and proliferating cell
nuclear antigen in the prostate epithelial buds, mesenchyme,
and smooth muscle was 57, 86, and 75; not reported, 244,
and 290; and 371, 260, and 209% of control.
The results suggest Al acts as an endocrine disruptor
Maternal urinary Al concentration during the second and third
trimester positively correlated with increased umbilical cord
mitochondrial DNA number, suggesting increased reactive
oxygen species exposure

Reference

Miska-Schramm
et al. (2017)

Inohana
et al. (2018)

Kinawy and AlEidan (2018)
Wise et al. (2018)

Gomes
et al. (2019)

Liu et al. (2019)

The approximate systemic Al exposure from the additional Al was calculated as described in the text. Daily exposures that did not add more Al than expected
from the diet are in italics.
a
Percentage of Al in Al(OH)3 34.6%, AlCl3 20.2%, AlCl36H2O 11.5%, Al2(SO4)3 15.8%, Al2(SO4)316H2O 8.6%, Al2(SO4)318H2O 8.1%, Al(NO3)3 12.7%, Al(NO3)39H2O
7.2%, NH4Al(SO4)2 11.4%, KAl(SO4)2 10.5%, KAl(SO4)212H2O 5.7%, NaAl3H14(PO4)84H2O 8.5%, Al lactate 9.2%, and Al acetate 13.2%.
b
The fraction absorbed from i.g. solutions was taken to be 0.002, from food 0.001, Al(OH)3 i.m. 0.005 daily, Al phosphate and amorphous aluminum hydrophosphate sulfate i.m. 0.018 daily, i.p. 1, s.c. 0.21, and topical 0.0001, as described in the text.
c
The fraction absorbed for inhalation was taken to be 0.015–0.02, resulting in daily absorption of 0.001 lg/kg for air containing 0.2 lg/m3 (Yokel and
McNamara 2001).
Results that are statistically significantly different from controls.

Assessment of Al reproductive toxicity in
female animals
The assessment of Al reproductive toxicity focused on studies
in animals due to the lack of prospective or controlled-dose
human studies that provide insight into potential Al-induced
reproductive toxicity. Table 3 summarizes results of studies of
Al reproductive toxicity in females. The cited studies do not
consistently use the terms fecundity or fertility or their
indexes. The author could not find generally accepted
descriptions of these terms related to laboratory animals, as
noted in a review of non-clinical fertility study design
(Lerman et al. 2009). Four endpoints are used, following

published guidelines (Wolterbeek et al. 2004), and the
reported results categorized accordingly, irrespective of the
definition used by the authors. Mating (copulation) was
defined as positive mating (typically determined as sperm in
the vagina (vaginal smear) or a vaginal plug) and mating
index (%) as positive matings/cohabitated females. Fecundity
(conception) was defined as a pregnant female and fecundity
index (%) as pregnant females/successfully mated females.
Fertility was defined as the number of live offspring and fertility (gestation) index (%) as the number of live offspring/litter.
The results of all studies are categorized as to whether
they showed significant toxicity and the daily and total
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Table 4. Studies conducted in females categorized according to study report of significant findings and approximate systemic Al exposure.
Daily approximate systemic
Al exposure (mg/kg)
A. GLP compliant studies conducted following an OECD Test Guideline showing no statistically significant toxicity
Beekhuijzen (2007)
20, 98, or 494
Hirata-Koizumi et al. (2011b)
4.6, 23, or 100
Hirata-Koizumi et al. ( 2011a)
1.5, 13.4, or 114
B. No statistically significant effects from exposures similar to A. above
McCollum et al. (1928)
45
Schaeffer and Fontes (1928)
85–240
Lyman and Scott (1930)
220–468
Mackenzie (1932)
235–400
McCormack et al. (1979)
16 or 32
Nolen and Dierckman (1983)
30 or 643
Nolen and Dierckman (1983)
30, 139, or 643
Katz et al. (1984)
9.5, 30, or 92
Yokel (1985)
142, 567, or 2268
Donald et al. (1989)
102 or 203
Muller et al. (1990)
400
Misawa and Shigeta (1992)
36, 73, or 145
Colomina et al. (1994)
208
Gonda et al. (1996) and Gonda and Lehotzky (1996)
47, 95, or 189
Gonda et al. (1997)
189
Alleva et al. (1998)
64, 86, or 107
Golub and Germann (2001)
20, 102, or 203
Wise et al. (2008)
48.6
Segal et al. (2011)
3.1
Abu-Taweel et al. (2012)
121 or 242
216 or 414
Inohana et al. (2018)
Wise et al. (2018)
142
C. Study found some statistically significant results from exposures similar to A. above
Domingo et al. (1987a)
26, 52, or 104
Domingo et al. (1987b)
26, 52, or 104
Paternain et al. (1988)
26, 52, or 104
Bernuzzi et al. (1989)
96, 273, or 399; 96, 195, or 378
Domingo et al. (1989)
46, 92, or 184
Gomez et al. (1990)
133, 266, or 531
Gomez et al. 1991)
266 or 532
Colomina et al. (1992)
115
Misawa and Shigeta (1993)
364 or 727
Muller et al. (1993)
400
Agarwal et al. (1996)
0.92, 4.6, 9.2, 46, 92, or 184
Gonda et al. (1996)
47, 95, or 189
Gonda and Lehotzky (1996)
47, 95, or 189
Gonda et al. (1997)
189
Belles et al. (1999)
57
Chinoy and Patel (2001)
81
Kimura et al. (2007) (cows)
0.18 or 0.36
Mohammed et al. (2008) (i.g.)
30, 38, or 47
Trif et al. (2008)
0.24, 0.48, or 1.2
Trif et al. (2010)
0.24, 0.48, or 1.2
Wang et al. ( 2012)
26, 52, or 104
Hussein and Mahmoud (2013)
80.8
Fu et al. (2014)
26, 52, or 103
Miska-Schramm et al. (2017)
3 or 200
Kinawy and Al-Eidan (2018)
28
Gomes et al. (2019)
40.4
D. Study found some statistically significant results from higher exposure
Wide (1984)
621 or 1242
Golub et al. (1987)
84, 171, 2100, 4200, or 8400
Clayton et al. (1992) i.p.
648,000
Rankin and Manning (1993)
31,600
Colomina et al. (1998)
7575
Albina et al. (1999)
12,120, 24,240, or 48,480
Malekshah et al. (2005)
30,300
Mohammed et al. (2008)
3838 or 7676
Zivkovic et al. (2011)
14,532
Zivkovic et al. (2012)
14,532
Marwa et al. (2017)
508
E. Study found no statistically significant results from exposures similar to D. above
Clayton et al. (1992) i.g.
4860
Oneda et al. (1994)
114, 285, 570, or 1140
Kimura et al. (2007) (rats)
10,161
F. Study found statistically significant results associated with maternal mortality
Benett et al. (1975)
8080–40,400
Mohammed et al. (2008)
3838 or 7676

Total approximate systemic
Al exposure (mg/kg)
554, 2744, or 13,832
319, 1582, or 6990
104, 935, or 7980
945

80 or 160
297 or 6432
387, 1803, or 8362
1738, 5600, or 16,862
2268, 9072, or 36,288
2030 or 4060
2800, 5600, or 8,000
473, 945, or 1891
2076
473, 947, or 1893
1893
516, 688, or 860
609, 3045, or 6090
450
280
2424 or 4848
3456 or 6624
5021
700, 1400, or 2800
207, 415, or 829
233, 467, or 933
2016, 5733, or 8379; 2016, 4095, or 7938
460, 920, or 1841
1329, 2657, or 5315
2660 or 5320
1150
364 or 727
7600
10, 51, 101, 506, 1012, or 2024
473, 947, or 1893
473, 947, or 1893
1893
573
2424
1.3, 2.6, or 182
2545, 3190, or 3971
44, 87, or 218
22, 44, or 109
3103, 6205, or 12,459
808
3103, 6205, or 12,411
252 or 16,800
441
323
621 or 1242
1425, 2913, 14,700, 29,400, or 58,800
2,592,000
126,400
75,750
121,200, 242,400, or 484,800
30,300
26,866 or 53,732
44,596
44,596
3556
38,880
69,312, 173,280, 346,560, or 693,120
10,161
8080–210,080
26,866 or 53,732
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calculated systemic Al exposure (Table 4). Overall, these studies suggest limited additional Al exposure above what would
enter systemic circulation from the diet did not affect female
reproduction. The 4 studies that were GLP compliant and 3
studies conducted following an OECD Test Guideline are notable in that they reported no significant effects following
daily Al exposures that, by calculation, would increase the
systemic Al exposure by up to 25-fold (Table 4, Category A
and Table 3). Additionally, there are numerous studies that
utilized comparable Al exposures that did not report any statistically significant effects (Table 4, Category B and Table 3).
In contrast, several studies utilizing calculated added Al
exposure that was in the range of the above studies showed
some significant effects, although most of the studied endpoints were not significantly altered (Table 4, Category C and
Table 3). With seven exceptions (Bernuzzi et al. 1989; Gomez
et al. 1990; Gomez et al. 1991; Muller et al. 1993; Wang et al.
2012; Fu et al. 2014; Miska-Schramm et al. 2017), the total
calculated systemic Al exposure of these 25 studies was less
(up to 3,971 lg Al/kg) than the studies in Table 4, Category A
(6990–13,832 lg Al/kg), suggesting that the occasional significant results are not a product of greater overall Al systemic
exposure. Daily systemic Al exposures greater than the highest of the Beekhuijzen 2007 study generally demonstrated
significant effects (Table 4, Category D and Table 3), with
three exceptions. The lack of toxicity reported after gestation
day (GD) 10–17 i.g. exposure (Clayton et al. 1992) is consistent with the lower susceptibility to Al toxicity in the latter
stages of gestation, as noted by Benett et al. 1975, who
stated that GD 9–13 are critical for organogenesis and 14–18
for bone formation. With the exception of one study that
employed increased Al exposure starting at GD 14 (Domingo
et al. 1987b) and a single exposure on GD 15 (Misawa and
Shigeta 1993), all other studies in rats and mice in Table 4
category C increased Al exposure before mating or starting
from GD 3 Misawa 7. The lack of significant toxicity in one
study may be due to its limited endpoint (Kimura et al.
2007). Much higher daily and total calculated systemic Al
exposures (Table 4 category F) resulted in significant toxicity
associated with maternal morbidity or mortality (Benett et al.
1975; Mohammed et al. 2008).
The most sensitive endpoint to Al-induced toxicity in the
pregnant female was resorption, and in the fetus death.
Overall, these results suggest a positive exposure leveladverse response relationship, as would be expected. One
study is notable for having a wide exposure range from less
Al than would be expected to reach systemic circulation
from the diet to well beyond that, with exposure throughout
most of the period of fetal susceptibility (Agarwal et al.
1996). With the exception of the two lower exposures in the
Agarwal et al. (1996) study, the two-Al-dose comparison in
cows (Kimura et al. 2007), the two studies reported by Trif
et al. (2008, 2010), and the lower dose of the Miska-Schramm
et al. (2017) study, the additional daily Al systemic exposure
of all other studies that reported statistically significant
results was greater than 100-fold above the typical human
daily Al consumption equivalent (0.1 lg/kg).

Assessment of Al reproductive toxicity in
female humans
The accidental addition of Al to the drinking water of some
residents in Camelford, Cornwall, England in July 1988
(Coggon 1991) did not result in documented reproductive
effects (Golding et al. 1991). Epidemiological studies suggest
Al in airborne particulates, although resulting in an approximate daily systemic Al exposure that is 1000-fold lower than
from the typical human diet, is associated with smaller newborns and increased risk of placental abruption (Bell et al.
2010; Ibrahimou et al. 2017). Newborns of mothers who had
higher urine Al concentrations, and whose umbilical cord
blood showed greater evidence of oxidative stress, were
more likely to be smaller (Karakis et al. 2014; Liu et al. 2019).
These results are consistent with animal studies showing
smaller newborn weight after much higher Al exposures.
However, there remains a lack of correlation between umbilical cord Al concentration and newborn size (Rahbar et al.
2015). The results of these studies do not provide consistent
evidence of Al-induced reproductive toxicity or enable exposure-response determination.

Assessment of Al reproductive toxicity in
male animals
Many endpoints were quantified in the studies of Al reproductive toxicity in males (Table 5). Table 6 summarizes
reports of the assessment of Al reproductive toxicity in males.
Quantitative endpoint results are presented in the order presented in Table 5. Two studies sought to model Al intake
from drinking water (Trif et al. 2007; Mouro et al. 2018).
However, as water would provide <1% of daily total Al
intake in laboratory animals, the additional Al exposure in
water in the Trif et al. (2007) and two lowest exposures in
the Mouro et al. 2018 studies were insignificant compared to
the basal exposure from feed.
The results of all studies are categorized as to whether
they showed significant toxicity and the daily and total
approximate systemic Al exposures (Table 7). Four studies are
notable because they were GLP compliant, and/or were conducted following an OECD Test Guideline, and included
males and females (Beekhuijzen 2007; Wise et al. 2008;
Hirata-Koizumi et al. 2011a, 2011b). Two reported no statistically significant toxicity at their lower (<20 mg/kg/day;
<200 mg/kg total) Al exposures, but statistically significant
toxicity at their higher (>50 mg/kg/day, >500 mg/kg total) Al
exposures, delineating NOAEL and LOAEL exposures
(Beekhuijzen 2007; Wise et al. 2008; Hirata-Koizumi et al.
2011b, 2011a) (Table 7, Categories A and C and Table 6). Six
other studies reported no significant effects from exposures
<60 mg/kg/day (<10,000 mg/kg total), but did find some significant effects from higher within-study exposures (20 mg/
kg/day, >600 mg/kg total) (Pettersen et al. 1990; Roy et al.
1991; Hichem et al. 2013; Kumar and Singh 2015, 2016;
Falana et al. 2017). Comparing Tables 4 and 7 suggests males
are more susceptible to Al-induced reproductive toxicity than
females. The GLP compliant studies that showed statistically
significant toxicity after their higher exposures (Table 7,
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Table 5. Endpoints quantified in the studies of Al reproductive toxicity in males.
Testis





















Seminiferous tubules and sperm

Epididymis

Vas deferens
Seminal vesicle
Prostate and semen



Testis (and accessory gland) (testis tunica albuginea and parenchyma) weight
Protein content
Leydig cells/interstitial space or/testis, cell proliferation, proliferating cell area, epithelial wall thickness,
nuclear diameter, nuclear percentage, cytoplasm percentage, and visual field percentage
Non-Leydig cell visual field percentage
Calcium, copper, iron, magnesium, sodium, and zinc concentrations
MDA/reactive oxygen and nitrogen species, H2O2, and antioxidant capacity
SOD, CAT, GSH, GST, GPx, GR, thioredoxin reductase, and thiol groups
Protein carbonyls and lipid peroxides
AST, ALT, ALP, ACP, LDH, LDH isoenzyme, phosphorylase, succinate dehydrogenase, nucleotidase, gammaglutamyltransferase, gamma glutamyl transpeptidase, and 17-ketosteroid reductase
cAMP, total ATPase (ATPases), Naþ-Kþ-ATPase, Mg2þ-ATPase, and Ca2þ-ATPase activity
Vitamins C and E
Cholesterol, triglycerides, and phospholipids
Bax and Bcl-2 expression
Activated macrophages
NO content; iNOS, tNOS, cNOS activity and expression; and NO products
Putrescine, spermidine, and spermine
Testosterone, LDH, and FSH
Androgen receptor mRNA, follicle stimulating hormone receptor, and luteinizing hormone
receptor expression
3- and 17-beta-hydroxysteroid dehydrogenase, steroidogenic acute regulatory protein, cytochrome P450
cholesterol side chain cleavage enzyme, caspase-3, and proliferating cell nuclear antigen protein

















Seminiferous tubule diameter, duct diameter, luminal diameter, epithelial thickness/height, visual field
percentage, and interstitial space diameter
Sertoli cell count (number)
Spermatogenesis
Spermatogonia count (number)
Primary spermatocyte count (number)
Secondary spermatocyte count (number)
Spermatid (round) count (number)
Elongated spermatid count (number)
Spermatozoa count (number) and daily production
Testicular sperm production (count)
Motile sperm cell count (number)
Sperm mobility
Normal or abnormal sperm cell count (number)
Dead sperm or viability
Sperm plasma and acrosomal membrane intactness
Sperm MDA, SOD, CAT, AST, ALT, and ACP























Weight
Protein content
Percent epithelium
Caput epithelial height
Tubular diameter
Luminal diameter
Lumen with sperm
Empty efferent ducts
NO products
MDA/reactive oxygen and nitrogen species and antioxidant capacity
SOD, CAT, GST, GPx, and GR
ALP
Vitamins C and E
Putrescine, spermidine, and spermine
Nucleotidase and gamma glutamyl transpeptidase
ATPase
Sialic acid
Sperm/spermatozoa count/number
Sperm transit time
Cauda sperm count/number
Cauda sperm transit time




Weight
Spermatozoa count/number




Seminal vesicle and secretion weight
Fructose concentration





Weight
Prostate MDA, reactive oxygen and nitrogen species, and antioxidant capacity
Semen pH, MDA, GST, AST, ALT, and ACP
(continued)
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Bulbourethral gland
Blood/serum/plasma
Male sex performance
Female response

Fetus and offspring



Weight



Testosterone, FSH, LH, prolactin, and estradiol



Time to and number of mounts, time to and number of intromissions, time to ejaculation, and
copulatory efficiency







Percent of pregnant females, fecundity, and fertility
Corpora lutea/female
Implantations
Post-implantation loss
Resorptions




Fetal weight
Dead or live fetuses

Category C.) and other studies showing significant results
from lower exposures (2/3  20 mg/kg/day) (Table 7, Category
D.) suggest Al-induced reduction of reproductive function in
males after exposure to additional daily Al systemic exposure
less than 100-fold the typical human daily Al consumption
equivalent (0.1 lg/kg). The most common male reproduction
endpoints from the summaries in Table 6 were tested for
adherence to a normal distribution and then correlation with
daily and total systemic Al exposure. (The number in brackets
is the number of values from Table 6.) Testes weight [69],
sperm number [51], abnormal sperm [37], motile sperm [34],
sperm viability [20], testes MDA [41], testes SOD [22], testes
CAT [20], and blood/serum/plasma testosterone [34] were
tested. Sperm number and SOD values compared to the daily
and total doses were normally distributed, but correlated significantly, and negatively, only with the total Al dose
(p ¼ 0.0076 and 0.0235, respectively). Abnormal sperm were
not normally distributed but were correlated with the daily
and total Al dose (0.044 and 0.049, respectively). MDA was
consistently above, and testosterone consistently below values from subjects not given additional Al but they did not
correlate with Al exposure. These results suggest sperm number, sperm SOD, and abnormal sperm are the more sensitive
indicators of Al-induced male reproductive toxicity and that
prolonged exposure has a greater effect than short-term
exposure. More prolonged exposure is more likely to inhibit
the entire process of spermatogenesis that has a duration of
35, 50, and 64 days in the mouse, rat, and human, respectively (Adler 1996).

Assessment of Al reproductive toxicity in
male humans
A study of human semen showed sperm viability decreased
as semen Al concentration increased from averages of 18 to
101 lg/L (Table 10) (Dawson et al. 1998). A study by the
same group reporting an average semen Al concentration
among control subjects of 460 lg/L (Table 10) (Dawson et al.
2000). Other reported comparable values (540 in factory
workers and 870 lg/kg in sperm donor candidates (Hovatta
et al. 1998) and 299 in normal semen (Klein et al. 2014))

raises some doubt about the findings of Dawson
et al. (1998).
Sperm exposed to 0.125–30 mM AlCl3 showed concentration-dependent decreased motility and increased MDA (Table
6) (Jamalan et al. 2016), but these Al concentrations
(3375–810,000 lg/L) are greatly in excess of reported human
semen Al concentrations. The suggestion from animal and
these human studies of possible Al-induced reduced reproductive function in males is supported by the reduction in
normal and mobile sperm and sperm concentration of
refinery and polyolefin factory employees and positive correlations between high spermatozoa Al concentration and
decreased sperm motility and normal morphology (Hovatta
et al. 1998).

Fetal, placental, amniotic fluid, meconium, and
testes Al concentrations
Al distribution into the fetus was reported in many studies
(Table 8). The additional maternal Al exposures are not normally distributed. The log of the fetal Al concentration as a
multiple of the Al concentration in fetuses that did not
receive additional maternal Al exposure was normally distributed. Correlation analysis of the log of the additional maternal Al exposure dose and the fetal Al concentration multiple
resulted in a non-significant Pearson correlation (p ¼ 0.21).
Consequently, no relationship between the approximate
added total systemic Al exposure and fetal Al concentration
incorporating all studies was concluded. Individually, the
studies show the ability of Al to enter the fetus in an exposure-dependent manner. Added Al exposure ranged from
that  equal to exposure from the diet that did not significantly increase fetal Al concentration (McCormack et al. 1979)
or increased it up to 2-fold in some organs (Yokel 1985) to
exposures that were 1000-fold above the dietary exposure
that increased fetal Al concentration up to 6-fold in some
organs and were associated with adverse fetal effects
(Cranmer et al. 1986; Mestaghanmi et al. 2003). The highest
Al concentrations were seen in the bone of both controls
and animals exposed to additional Al.
Placental Al has been quantified in several studies
(Table 9). As in the fetus, the available studies show an
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Table 6. Results of studies of males exposed to additional Al.

Al-treated subjects
Rats, 45–55 g, males
and females

Rats, 100–120 g
Swiss strain
mice, 20–30 g

Sprague Dawley
rats, males

Rats, guinea pigs, and
rabbits, males

Beagle dogs, 7–9
months, females
and males
New Zealand white
rabbits, 2.9–4.3 kg
Sprague Dawley rats,
48 days, males

Human sperm

Rats, 120–160 g,
Leydig cells

Beagle dogs, male
and female

Albino rats, 120–150 g,
about 2 months
old, males

B6C3F1 mice, 4 weeks
old, females
and males

Swiss mice,
30–32 g, male

Al exposure
0, 0.067, or 0.063% Al as AlCl36H2O
or baking powder in the diet
started as young rats and raised
to maturity
One intra-testicular injection of
0.08 mmol/kg Al2(SO4)3 (rat) or
0.08 mmol/kg total in 30 daily
s.c. doses (mouse)

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

McCollum et al. (1928)

30, s.c.
(907)

Rat testes weight 2 and 7 days after intratesticular injection was
98 and 50% of controls, with focal (2 days) and partial (7
days) necrosis, and spermatozoa destruction.
After s.c. injections mouse testes weight 30 days later was 30%
of controls. Necrosis was not seen. Tubular shrinkage and
spermatogenic arrest were seen but there was no effect on
the interstitium
Fertility results showed no significant effects on the number of
implantation sites or average litter size

Kamboj and Kar (1964)

After 6–12-month exposure a decreased spermatozoa number
(to 74% of controls) was only seen with the highest dose.
The tubular basal membrane was thickened with a layer of
Sertoli cells. The tubular lumen had some pathological forms
of spermatogenic epithelium. There was a substantial
proliferation of Leydig cells. There was increased Leydig cell
oxidizing enzyme activity and ATPase in seminiferous tubule
basal membranes and a tendency for decreased RNA with
the highest dose
Gross autopsy and histopathological exam showed normal range
of variations of the gonads and prostate.

Krasovski%K et al. (1979)

1.5, 15, or 149
(135, 1350, or 13,410)

118, 317, or 1034 mg sodium
aluminum phosphate/kg/day in
the diet for 6 months
0 or 600 mmol/kg Al as the lactate 5
days weekly for 4 weeks s.c.,
sacrificed 2 weeks later
5 (control), 67, 141, or 288 mg Al/
kg/day as sodium aluminum
phosphates or 302 mg Al/kg day
as Al(OH)3 in the diet for 28 days
Exposed for 0, 10, 30, or 60 min to
bovine estrous cervical mucus
that had been in contact with
10, 100, or 200 lM/ml AlCl3
0, 1, 10, or 100 mM AlCl3

10, 27, or 88
(1830, 4917, or 16,040)

0, 50, 100, or 200 mg/kg Al(NO3)3
9H2O i.p. 5 days/week for 4 weeks

12, 34, or 100;
6, 18, or 54; 0.005, 0.5, or 5
(300, 850, or 2500;
150, 450, or 1350;
1.35, 135, or 1350)

Sprague Dawley rats,
300 g, males

In vitro incubation in 0, 2.5, 5, or
7.5% KAl(SO4)2
12H2O
0 or 1000 ppm AlCl36H2O in the
drinking water for 12 weeks

Dixon et al. (1979)

Katz et al. (1984)

3400
(68,000)

Testis weight was 168% of controls

Melograna and
Yokel (1984)

67, 141, 288, or 302
(1876, 3948, 8064, or 8456)

Testes calcification, degeneration with atrophy, and edema were
not significantly increased above controls

Hicks et al. (1987)

Al exposure inhibited sperm entry into the mucus. The effect
was not contact time or Al concentration (including 0 min
exposure) dependent, shedding doubt on the validity of
these results
Cell viability (trypan blue exclusion indicating live cells) was not
affected.
LH-stimulated testosterone production was 104, 90, and 104%
of controls
High dose males had a decrease (no details reported) in testis
weight and moderate seminiferous tubule germinal epithelial
cell degeneration and atrophy

Kaur (1988)

8, 20, 54, or 150
(1456, 3640, 9828, or 27,300)

Ng and Liu (1990)

Pettersen et al. (1990)

34.4–343 (240–7203)
or
57.2 or 87.2
(401–1831)

No testes histological damage up to the 530 mg/kg
Al2(SO4)318H2O or 765 mg/kg KAl(SO4)212H2O dose.
Some spermatogonial cell decrease after 21 days of 1060 mg/kg
or 14 days of 2120 mg/kg Al2(SO4)318H2O

Roy et al. (1991)

114, 285, 570, or 1140
(69,312, 173,280, 346,560
693,120)

Testes weight was 102, 102, 101, and 99% of controls.
Testes relative weight was 88, 88, 100, and 114% of
controls.
Ductus epididymis hyperplasia was 93, 107, 103, and 84% of
controls.
Epididymis atrophy was 120, 95, 98, and 43% of controls
At the end of dosing: (1) testes weight was 88, 88, and 76;
and epididymis weight 89, 97, and 79% of controls, but
not significantly different when normalized to body weight;
(2) seminiferous tubule diameter was not affected, the two
higher doses significantly increased spermatocyte/spermatid
necrosis but did not affect giant cells, germ cell hypoplasia,
or Leydig cell vacuolization; (3) spermatid count was 97, 56,
and 59% and spermatozoa count 100, 86, and 50% of
controls, but there were no significant effects on the % of
motile cells or abnormal morphologic forms.
GD 10–14 percentage of pregnant females was 120, 40, and
30% of controls.
The number of total implantations, early or late resorptions,
dead or live fetuses, or post-implantation loss was not
significantly different
Refinery and polyolefin factory employee (n ¼ 27) normal sperm
was 85, mobile sperm 97, and sperm concentration 82% of
sperm donor candidate (N ¼ 45) values.
Regression analysis showed a correlation between high
spermatozoa Al concentration (Table 10) and decreased
sperm motility and normal morphology
Time to sperm immobility was 3.4, 2.4, and 1.4% of
controls. Alum is a spermicide

Oneda et al. (1994)

3600, 7200, or 14,400
(72,000, 144,000, or 288,000)

Human sperm

Human semen

Reference

The growth, reproduction, external appearance, and autopsy of
rats on the Al-added diets were the same as controls

0, 44.8, 448, or 4476 mg/l AlCl36H2O
in the drinking water for 90 days
then housed serially with a
different virgin rat for 7-day
periods up to 70 days
0, 6, 17, or 50 mg/kg Al as AlCl3
orally to rats and guinea pigs for
20–30 days; 0, 3, 9, or 27 mg/kg
Al orally to rabbits for 20–30
days; 0, 0.0025, 0.25, or 2.5 mg/
kg orally to rats for 6–12 months

0, 4, 10, 27 or 75 mg/kg/day of Al as
basic sodium aluminum
phosphate in the diet for
26 weeks
0, 212, 265, 355, 530, 1060, or
2120 mg/kg Al2(SO4)318H2O or
503 or 765 mg/kg KAl(SO4)2
12H2O by gavage for 7, 14 or
21 days
1, 2.5, 5, and 10% KAl(SO4)212H2O

Study results

45
(945)

33
(2800)

Testis weight was 68 and seminal vesicle weight 70% of
controls.
The time to first mount was 57, number of mounts 60,
intromission latency 254, number of intromissions 41,
ejaculatory latency 104, and copulatory efficiency 88% of
controls.

Llobet et al. (1995)

Hovatta et al. (1998)

Singh et al. (1998)

Bataineh et al. (1998)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

CD-1 mice, 8
weeks, males

0, 13, or 35 mg Al/kg as AlCl3 i.p. for
12 or 16 days

13,000 or 35,000
(182,000 or 490,000)

CD-1 mice, males

0, 13, or 35 mg Al/kg as AlCl3 i.p. for
14 days

13,000 or 35,000
(182,000 or 490,000)

New Zealand white
rabbits, 7 months,
2.9 kg, males
Sprague Dawley rats,
130–150 g, males

0 or 34 mg Al/kg as AlCl3 orally
every other day for 16 weeks

68 every other day
(3808)

0 or 34 mg/kg AlCl3 orally every
other day for 30 days

14 every other day
(206)

ICR (CD-1-derived)
mice,
32–35 g, males
CD-1 mice, 8–9
weeks, males

0 or 35 mg Al/kg/day as AlCl3 i.p. for
12 days

35,000
(420,000)

0, 7, or 13 mg Al/kg/day, as AlCl3 s.c.
for 14 days, then housed with 3
non-treated females. Mated
females replaced with new
virgins, for 9 weeks

1470 or 2730
(20,580 or 38,220)

Swiss mice, 50
days, males

Ingestion of 0, 1000, 1200, or
1400 ppm AlCl3 in the drinking
water for 12 weeks, then housed
for 10 days with an untreated
virgin female, that was
killed GD20

104, 125, or 145
(8755, 10,507, or 12,258)

New Zealand white
rabbits, 7 months,
2.9 kg, males

0 or 34 mg Al/kg as AlCl3 orally
every other day for 16 weeks

68 every other day
(3808)

CD-1 mice, males

0, 7, or 35 mg Al/kg/day, as AlCl3 s.c.
for 14 days

1470 or 7350
(20,580 or 102,900)

Study results
The percent of pregnant females was 108, number of
implantations 96, number of viable fetuses 96, and
percentage resorptions 50% of controls
One day after 12 injections testis weight was 101 and 101, nitric
oxide products 422 and 1028, and testosterone 60 and
42% of controls.
Fifteen days after 16 injections testis weight was 97 and 96,
nitric oxide products 118 and 168, and testosterone 91
and 73% of controls
Testis weight was not significantly affected.
Testis zinc was 95 and 65, iron 130 and 180, copper 148
and 127, MDA 125 and 121, and angiotensin-converting
enzyme activity 68 and 58% of controls.
Testis MDA was 148, GST 69, sulfhydryl groups 77, AST 60,
ALT 78, ALP 75, ACP 69, LDH 124, and phosphorylase
74% of controls
Testis MDA was 144, GST 81, sulfhydryl groups 80, AST 71,
ALT 76, ALP 80, ACP 73, LDH 126, and phosphorylase
69% of controls
Testis weight was 104, nitric oxide products 421, cholesterol
166, cAMP 27 and testosterone 41% of controls
Testis, epididymis, and seminal vesicle weights were 94 and
87, 97 and 87, and 99 and 77% of controls 5 weeks
after dosing.
Testes showed slight, dose-dependent damage 2 weeks after
dosing.
Seminiferous tubule spermatid cell and spermatozoa necrosis
was seen 5 weeks after dosing.
Tubular diameters and epididymis were not affected.
The percentage of mated females significantly decreased from 1
to 10 weeks after dosing, to a nadir of 68 and 53% of
controls 5 weeks after dosing.
The fecundity index significantly decreased 4 weeks to 83
(13 mg/kg/day dose) and to 86 and 75% 5 weeks after
dosing.
From weeks 3 to 5 there were no significant effects on corpora
lutea/female or implantations per female.
The 13 mg dose increased pre-implantation dead embryos to
148 and 162 of controls 3- and 5-weeks post dosing.
Resorptions per female 4 weeks after dosing were 227 and
186% and at 5 weeks 254 and 313% of controls.
Dead fetuses/female were 520 and 760% of controls 5 weeks
after dosing.
Survivals/female were 88% of controls 5 weeks after 13 mg/
kg/day dosing.
Day 16 fetal weights 3–7 weeks after dosing were 88 and 88,
96 and 94, 94 and 94, 95 and 92, and 92 and 94%
of controls
Testes weight as a percentage of body weight was not affected.
Seminal vesicle weight as a percentage of body weight was
58, 43, and 59% of controls.
Testicular sperm production efficiency (sperm/g testes/day) after
6, 9, and 12 weeks averaged 70, 58, and 76% of
controls. Epididymal sperm count after 3 weeks was 88, 115,
and 57; 6 weeks 87, 74, and 63; 9 weeks 54, 50, and
62; and 12 weeks 85, 81, and 69% of controls.
Mice exposed to 1200 and 1400 ppm had congested testes
blood vessels and increased interstitial connective tissue.
Mice exposed to 1200 ppm showed seminiferous tubule and
tubule arrangement destruction.
Mice exposed to 1400 ppm had many spermatids in the center
of their seminiferous tubular lumen with few or none in the
periphery and absence of spermatozoa in the epididymis.
The percent of pregnant females was 95, 75, 80, and 56%.
There was no difference in the number of implantation sites or
viable fetuses.
The percentage of resorptions was 0, 15, 10, and 17 and the
percentage of animals with resorptions 0, 67, 62, and 70
Testes and epididymis body weight were 73 and 68% of
controls.
Weekly measurements of ejaculate volume averaged 87,
reaction time (mounting to complete ejaculation) 210,
packed sperm volume 89, sperm concentration 87, total
sperm output 76, sperm motility 91, total motile sperm
72, dead sperm 141, normal sperm 95, total functional
sperm fraction (sperm output  motility  normal
morphology) 86, and initial fructose concentration 86% of
controls. Semen pH was 8.08 versus 7.66 for controls.
Seminal MDA was 119, GST 88, AST 91, ALT 88, and ACP
91% of controls
Testes and left epididymis weight as a percentage of body
weight were not affected.
Right epididymis weight as a percentage of body weight was 82
and 68% of controls.

Reference

Guo et al. (2001)

Guo et al. (2002)

Yousef (2004)

El-Demerdash (2004)

Guo, et al. 2005a)

Guo, et al. (2005b)

Mayyas et al. (2005)

Yousef et al. (2005)

Guo et al. (2006)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Sprague Dawley
rats, males
Wistar rats, males ( 9
weeks), females

0 or 50 mg AlCl3 i.p. for 20 days

Albino rats,
100–150 g, males

0, 15, or 30 mg/kg AlCl3 i.p. every
other day for 5 weeks

3030 or 6060 every other day
(53,025 or 105,050)

Wistar rats, males

0 or 5 mg/kg Al2(SO4)3 i.p. 3 times
weekly for 2 weeks

790 3 times weekly
(4790)

Albino mice, 60
days, 25 g

Dosing (route not stated, assume
oral) of 0, 1, 2, or multiple doses
aluminum acetate 3.5 mg/kg
50 (control), 200, 400, or 1000 ppb
Al2(SO4)3
in the drinking water for 6 months

0.92

Wistar rats, males

0, 40, 200, or 1000 mg/kg/day AlCl3
i.g. 2 weeks prior to and during
mating for a total of 28 days

New Zealand white
rabbit sperm

Incubation with 0, 1, 5, 10, 15, or
20 mM AlCl3 for 2 or 4 h

Sprague Dawley rats,
235–347 g, males

0 or 4.125 pmole AlCl3 (pH 3.4)
lateral ventricle injection twice
daily for 20 days

Albino rats,
230–250 g, males
KM mice, males

0 or 0.5 mg/kg
as AlCl36H2O i.g. for 30 days
0, 50, 75, or 100 mg/kg AlCl3 i.p. for
2 consecutive days with a 1-day
interval for 2 weeks
0, 40, or 80 mg/kg AlCl3 i.g. for 30
or 60 days

Albino rats, 3–4
months,
190–215 g, males

10,100
(202,000)
20, 98, or 494
(554, 2744, or 13832)

Study results
Testicular and epididymal nitric oxide products were 165 and
282 and 119 and 179% of controls.
Testis putrescine was 87 and 79, spermidine 97 and 97, and
spermine 97 and 91% of controls.
Epididymal putrescine was 100 and 86, spermidine 98 and 97,
and spermine 99 and 94% of controls
Blood testosterone was 53, FSH 84, and LH 60% of controls
Testes weight was 99, 103, and 102; and epididymis weight 104,
106, and 103% of controls.
Microscopic assessment of testes, epididymis, prostate gland,
and seminal vesicles showed no significant difference
from controls
Low dose: Seminiferous tubules had thickened basement
membrane with fibrous connective tissue. Spermatogenic
epithelium and Sertoli cell cytoplasm had focal areas of
vacuolar degenerative changes. Abnormal spermatozoa
distribution in the seminiferous tubule lumina. Swollen and
vacuolated spermatogonia mitochondria. Primary
spermatocytes smaller with dilated endoplasmic reticulum
and Golgi apparatus and condensed mitochondria.
High dose: Severe seminiferous tubule damage and cell
vacuolation, spermatid level arrest, germinal cell
degenerative changes, a few fragmented sperm in the
lumen, and a thick, irregular basement membrane.
Spermatogenesis arrest at the spermatid level with germ cell
degenerative changes. Spermatogonia, spermatocytes, and
spermatids more affected than after the low dose.
Sertoli cells more damaged than the spermatogonia.
Nuclear membrane distortion and some rupturing and
chromatin accumulation.
No spermatozoa in the seminiferous tubules
The germinal epithelium was thinner in places where
spermatids were absent. Some germinal cells lost their
cytoplasm. Cells with pyknotic nuclei were necrotic. The
tight junctions were broken down.
Some enlarged Sertoli cell mitochondria. Enlarged Sertoli cell
rough endoplasmic reticulum. Their cisternae had fewer
ribosomes. Increased lysosome number and nuclear
membrane irregularities
Some primary spermatocyte mitochondria showed size and
shape variations with tubular or vesicular appearing cristae.
Decreased luminal sperm numbers. Spermatogonia were only
seen on the basal membrane. There were no luminal sperm.
Low spermatid numbers.
There were free cells in the lumen.
Increased rough endoplasmic reticulum in
spermatocyte cytoplasm
Testes ATPase activity was 74, 50, and 34% of controls at an
unstated time after injection

0.12
(3.4)
7214, 10,821, or 14,428
(72,140, 108,210, or 144,280)

Weights of the testes were 96, 86, and 70%; epididymis 91,
82, and 75%; seminal vesicle 79, 63, and 59%;
prostate 97, 90, and 84%; and bulbourethral gland 87, 78,
and 69% of controls.
Seminiferous tubule diameter was 96, 73, and 66%
of controls
Sperm mobility after 1–2 min was 100, 97, 94, 76, and 64;
2 h 98, 86, 83, 35, and 19; and 4 h 94, 79, 62, 18, and
8% of controls.
Sperm viability after 1–2 min was 98, 94, 88, 80, and 70; 2 h
98, 90, 78, 57, and 40; and 4 h 94, 87, 64, 35, and
22% of controls.
Sperm MDA after 2 h was 101, 108, 114, 119, and 143; SOD
100, 96, 94, 87, and 74; CAT 96, 92, 84, 75, and 53;
AST 127, 146, 198, 238, and 272; ALT 103, 110, 114,
126 and 162; and ACP 96, 94, 89, 82 and 70% of
controls.
Sperm MDA after 4 h was 109, 118, 124, 134, and 148; SOD
98, 93, 88, 77, and 65; CAT 89, 84, 78, 69, and 45;
AST 128, 149, 186, 224, and 285; ALT 110, 115, 131,
142, and 182; and ACP 86, 84, 78, 60, and 46%
of controls
Testis, epididymis, and vas deferens weights were 89, 88, and
89% of controls.
Epididymis and vas deferens spermatozoa counts were 76 and
74% of controls.
Serum testosterone was 43, FSH 59, and LH 76% of controls
Testis MDA was 368, lipid hydroperoxides 145, GSH 38, SOD
62, and CAT 45% of controls
Dose dependent increase of DNA damage and sperm nucleus
immaturity rate

16 or 32
(485 or 970 for 30 days, 970 or
1940 for 60 days)

Testis weight after 40 mg/kg for 30 or 60 days was 102 and
88%, and after 80 mg/kg for 30 or 60 days 81 and 73% of
controls.

0.002 the control, 0.009, 0.018, or
0.045
(0.4, 1.7, 3.3 or 8.4)

Reference

Reza and Palan (2006)
Beekhuijzen (2007)

Khattab (2007)

Kutlubay et al. (2007)

Sushma and
Rao (2007)
Trif et al. (2007)

Yousef et al. (2007)

Shahraki et al. (2008)

Al-Hashem (2009)
Cui et al. (2009)

Entissar et al. (2009)
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Table 6. Continued.

Al-treated subjects

CD-1 mice, males

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Wistar rats,
180–200 g, males

0, 7, or 35 mg/kg AlCl3 i.p. for
14 days
0 or 34 mg/kg AlCl3 orally for
70 days

1414 or 7070
(19,796 or 98,980)
14
(962)

Sprague Dawley
rats,160 g, males

0 or 20 mg/kg AlCl3 i.g. daily for
70 days

8
(566)

Wistar rats, males

0 or 100 mg/kg AlCl3 orally for
90 days

40
(3636)

Sprague Dawley
rats,10
weeks, males

0 or 0.125 mg Al as Merck aluminum
adjuvant i.m. into each hind limb
6 and 3 weeks and 3 days prior
to cohabitation with females

34 at cohabitation
(745 at cohabitation)

Swiss Webster mice,
25 g, males
Sprague Dawley rats, 5
weeks, males
and females

0, 300, or 600 mg/kg AlCl3 in the
drinking water for 20 days
0, 120, 600, or 3000 ppm Al2(SO4)3
in the drinking water from 10
weeks before mating to lactation
for F0 and F1 generation rats,
until parturition of paired

121 or 242
(2424 or 4848)
F0 males
2.7, 13, or 59
(247, 1179, or 5406 over 13 weeks)
F1 males

Study results
Epididymis head (caput), body, and tail weights after 40 mg/kg
for 30 or 60 days were 99 and 86, 106 and 88, and 90 and
92% of controls.
Epididymis head, body, and tail weights after 80 mg/kg for 30
or 60 days were 81 and 80, 105 and 91, and 97 and 97%
of controls.
Seminal vesicle weight after 40 mg/kg for 30 or 60 days was
114 and 82%, and after 80 mg/kg for 30 or 60 days 97 and
88% of controls.
Prostate gland weight after 40 mg/kg for 30 or 60 days was 99
and 94%, and after 80 mg/kg for 30 or 60 days 96 and 77%
of controls.
Sperm counts after 40 mg/kg for 30 or 60 days were 60 and
62%, and after 80 mg/kg for 30 or 60 days 33 and 33%
of controls.
Live sperm % after 40 mg/kg for 30 or 60 days was 83 and
65%, and after 80 mg/kg for 30 or 60 days 51 and 47%
of controls.
Abnormal sperm % after 40 mg/kg for 30 or 60 days was 157
and 133%, and after 80 mg/kg for 30 or 60 days 176 and
175% of controls.
Al exposure caused congested testes, hyperemic blood vessels,
interstitial edema, and multiplication of interstitial Leydig
cells. Seminiferous tubules showed germinal epithelium
hyperplasia and decreased tubular lumen sperm bundles.
There was desquamation and sloughing of spermatogonia into
the tubular lumen.
There was spermatogenic epithelial coagulative necrosis,
extensive sloughing into tubular lumen, absence of sperm
bundles, and inflammation cell infiltration as lymphocytic
infiltration
Testes MDA was 121 and 144; GPx 88 and 78, GR 87 and
77; and thioredoxin reductase 89 and 93% of controls
Testes, epididymis, seminal vesicle, and prostate weights were
81, 70, 57, and 88% of controls.
Testes protein content was 79% of controls.
Sperm concentration was 70; and percent motile 70, dead
179, and abnormal 146% of controls.
Testicular CAT activity was 43, GST activity 55, MDA 273,
reduced GSH 67, and testicular 17-ketosteroid reductase
activity 70% of controls.
Plasma testosterone was 76% of controls.
Interstitial space blood vessels were markedly dilated and
congested.
Some germ cells had small, darkly stained nuclei.
There was vascular degeneration of the spermatogenic and
Sertoli cell cytoplasm.
There were irregularities in the nuclear membrane, some
damaged mitochondria, a decrease of ribosomes, an increase
of lysosomes in the Sertoli cell cytoplasm, and an increase of
rough endoplasmic reticulum in the primary spermatocyte
cytoplasm.
Seminiferous tubule architecture was disorganized, with
intratubular accumulation of exfoliated germ cells,
maturation arrest, thinner germinal epithelium, near absence
of spermatids, and absence of sperm in the lumen.
There was Leydig cell hyperplasia in the interstitial tissue and
clumps of Leydig cells surrounding most
seminiferous tubules
Testis, seminal vesicle, and prostate weights were 53%, 93, and
91% of controls.
Sperm count was 46, motility 51, viability 58, and
abnormalities 279% of controls.
Testicular SOD and MDA were 46 and 157% of controls.
Serum testosterone was 50% of controls.
Testes interstitial blood vessels were congested, there was
marked degeneration and necrosis of seminiferous tubule
lining germ cells, and interstitial edema and testicular
degeneration with germ cell absence
Testis GSH and lipid peroxides were 43 and 155% of controls.
There was arrest at the spermatid level, germinal cell
degenerative changes, a few fragmented sperm in the
lumen, and a thick, irregular basement membrane
Sperm count was 107, sperm motility 99, and testis weight 99%
of controls  4 weeks after the last injection.
Testis and epididymis histomorphology were not remarkable.
There was no effect on the number of mated or
pregnant females
Blood testosterone was 52 and 6% of controls
There were no significant differences in the number of testis
sperm, percentage of motile sperm, progressively motile
sperm, swimming speed and pattern, or percentage of
morphologically abnormal sperm between treated and
control groups in F0 or F1 adults.

Reference

Guo et al. (2009)
Yousef and
Salama (2009)

Hala et al. (2010)

Thirunavukkarasu
et al. (2010)

Wise et al. (2010)

Abu-Taweel
et al. (2011)
Hirata-Koizumi
et al. (2011b)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

females, resulting in mean 0, 8.6,
41, or 188 mg/kg bw/day
Al2(SO4)3 intake by F0 males and
0, 10.7, 50.2, or 232 mg/kg bw/
day Al2(SO4)3
intake by F1 males.

3.4, 16, or 73
(308, 1444, or 6671 over 13 weeks)

Sprague Dawley rats, 5
weeks, males
and females

0, 50, 500, or 5000 ppm NH4Al(SO4)2
in the drinking water from 10
weeks before mating to lactation
for F0 and F1 generation rats,
resulting in mean 0, 8.6, 41, or
188 mg/kg bw/day NH4Al(SO4)2
intake by F0 males and 0, 10.7,
50.2, or 232 mg/kg bw/day
NH4Al(SO4)2 intake by F1 males.

F0 males
0.9, 8, or 70
(78, 695, or 6328 over 13 weeks)
F1 males
1.0, 10, or 85
(95, 867, or 7718 over 13 weeks)

Wistar
rats,190 g, males

0 or 34 mg/kg AlCl3 in the drinking
water for 70 days

14
(962)

Wistar rats, 4 weeks,
75–95 g, males

0, 64, 128, or 257 mg/kg AlCl3 in the
drinking water for 120 days

26, 52, or 104
(3103, 6205, or 12,459)

Wistar rats,
males

0, 475, 950, 1425, or 1900 mg/kg
AlCl3 i.g. for 8 weeks

192, 384, 576, or 768
(10,746, 21,493, 32,239, or
42,986)

Wistar rats, 6 weeks,
120 g, males
Humans, 600 treated
for problems
related to
fertility, males
Wistar
rats,150–200 g,
males

10 mg/kg Al in gum acacia i.g. for
2 weeks
Soil contained a mean of 3.92% Al.

20
(280)

0 or 100 mg/kg AlCl3 orally for
3 days

40
(121)

Wistar rats,
207 g, males

0 or 0.5 mg/kg AlCl3 orally for
35 days

0.2
(7.1)

Wistar rats, 6 weeks,
180–200 g, males

0 or 34 mg/kg AlCl3 orally for 30, 45,
or 60 days

14
(412, 618, or 824)

Study results
Cauda epididymal sperm number in 3000 ppm F0 adults was
11% of controls, but the number/gram epididymal cauda
was not significantly changed. No changes were observed in
F1 adults.
The mating index was 91.7, 91.7, 100, and 91.7% in the F0
generation and 95.8, 91.3, 95.8, and 87.5% in the F1
generation.
Fertility was 95.5, 90.9, 100 and 95.5% in the F0 generation and
91.3, 81.0, 91.3, and 95.2% in the F1 generation.
There was no significant effect on testis weight of F1 or F2
weanlings.
Epididymis weight of Al-treated F1 weanlings was 94, 94, and
88% of controls, and 91, 94, and 101% of controls
normalized to body weight. Epididymis weight of Al-treated
F2 weanlings was 104, 100, and 94% of controls, and 103,
100, and 104% of controls normalized to body weight
There were no significant differences in the number of testis
sperm, cauda epididymal sperm, motile sperm, progressively
motile sperm, swimming speed and pattern, or percentage
of morphologically abnormal sperm between control and Altreated groups.
The mating index was 100, 91.7, and 91.7% in the F0 and 91.7,
91.7, 91.3, and 95.8% in the F1 generation.
Fertility was 100, 91.3, 100 and 100% in the F0 and 90.1, 77.3,
95.2, and 100% in the F1 generation.
Testis weight of Al-treated F1 weanlings was 97, 97, and 90%
of controls, and 100, 100, and 104% of controls normalized
to body weight. Epididymis weight of Al-treated F1
weanlings was 94, 98, and 84% of controls, and 94, 98, and
84% of controls normalized to body weight. Epididymis
weight of Al-treated F1 weanlings was 104, 100, and 84%
of controls, and 98, 101, and 98% of controls normalized to
body weight. There was no significant of Al treatment on
testis or epididymis weight of F2 weanlings
Serum testosterone was 45% of controls.
Testes exhibited interstitial blood vessel congestion, decreased
carbohydrates, disorganized germinal epithelium, and
degenerative germinal cells. Seminiferous tubules had thick
basal lamina with fibrous connective tissue, irregular
basement membrane, fragmented spermatozoa in their
lumen, and germinal cell spermatogenesis arrest at the
spermatid level with reduction in sperm density.
Spermatogonia type A and B cell cytoplasm had swollen
vacuolated mitochondria, vascular endoplasmic reticulum,
and periphery clumped chromatin particles.
Primary spermatocytes were small. There was condensed,
periphery chromatin and some nuclear membrane
irregularity. Cell cytoplasm was vacuolated with lipid
droplets. Golgi apparatus cisternae and smooth endoplasmic
reticulum were dilated with vacuolated swollen
mitochondria.
Spermatids had dilated vascular smooth endoplasmic reticulum.
Golgi apparatus cisternae were elongated and joined in groups
with mitochondrial fragmentation
Testis androgen receptor mRNA levels were 75, 34, and 17%
of controls.
Serum testosterone was 96, 64, and 53; FSH 101, 99, and 98;
and LH 101, 84, and 81% of controls
Misshaped seminiferous tubules, alteration of epithelial lining
distribution, and vacuolar cytoplasm after the highest dose.
The epididymis histological appearance was normal
Testis MDA was 87, GSH 98, SOD 84, CAT 180, GR 73, and GPx
119% of controls
Increased soil Al correlated with decreased poor sperm quality.
The authors concluded that the anomalous Al concentration
appears to have no correlation with male fertility disorder
Testes weight was 99% of controls.
Testes MDA was 124, SOD 65, and CAT 44% of controls.
Sperm count was 51, motility 50, morphology 40, and
viability 39% of controls.
Serum testosterone was 54, FSH 28, and LH 39% of controls.
Degenerative necrosis with degeneration of spermatogenic cells
lining the seminiferous tubules was seen
Testis and epididymis weights were 101 and 100% of controls.
Sperm motility was 84, count 90, abnormalities 176, and live
sperm 70% of controls
Weights of the testes were 84, 116, and 109; epididymis 83,
143, and 100; seminal vesicles 63, 115, and 121; and
prostate gland 64, 115, and 118% of controls.
Testes MDA was 111, 108, and 163% of controls.
Sperm motility was 32, 33, and 29; live/dead ratio 18, 31,
27; and abnormalities 304, 212, and 284% of controls.
Serum testosterone was 32, 14, and 33% of controls.

Reference

Hirata-Koizumi
et al. (2011a)

Mahran et al. (2011)

Sun et al. (2011)

Buraimoh
et al. (2012b)
Buraimoh
et al. (2012a)
Chaitanya et al. (2012)
Giaccio et al. (2012)

Ige and
Akhigbe (2012)

Ighodaro et al. (2012)

Moselhy et al. (2012)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Swiss mice,
15–20 g, males

25 mg/kg AlCl3 once i.p.

5050

Wistar rats,
200–250 g, males

0, 100, 200, or 400 mg/kg AlCl3 in
the drinking water for 6, 12 or
18 months

40, 81, or 162
(7373, 14,746, or 22,119 for 6
months; 14,746, 29,492, or
44,238 for 12 months; 29,492,
58,984 or 88,476 for 18 months)

Wistar rats, 90 days,
190–210 g, males
Swiss mice, 25–30 g,
75 days
old, males

0 or 50 mg/kg AlCl3 orally for
45 days
0 or 78.4 mg/kg Al orally for 7 days
or 7.8 mg/kg Al as
Al2(SO4)316H2O i.g. for 90 days

20
(909)
157
(1098)
16
(1404)

Kunming or BALB/c
mice,
20–24 g, males

0, 20, 40, and 60 mg/kg AlCl3, i.p.
once weekly for 3 weeks

577, 1154, or 1731
(1731, 3464, or 5194)

Swiss mice, 8
weeks, males

0, 50, 100, or 150 mg/kg aluminum
acetate i.p. for 7 days

6600, 13,200, or 19,800
(46,200, 92,400, or 138,600)

Wistar rats, 90 days,
190–200 g, males

0, 50, or 100 mg/kg AlCl3 orally for
45 days

20 or 40
(909 or 1818)

Human semen

Wistar rats,
250 g, males
Wistar rats, 90 days,
190–200 g, males

0 or 28 mg/kg Al(NO3)3 i.p. every
other day for 7 injections
0, 50, or 100 mg/kg AlCl3 orally for
48 days

3556 every other day
(24,892)
20 or 40
(970 or 1939)

Wistar rats, 5 weeks,
110–120 g, males

0, 64, 128, and 257 mg/kg AlCl3 in
the drinking water for 120 days

26, 52 or 104
(3103, 6205, or 12,459)

Study results
Increased testes small DNA fragments, peaking at 60 days.
Spermatogenic cell degeneration with some exfoliated lumen.
Seminiferous tubule thinning and disorganization.
Severe degeneration of spermatogenic epithelium with necrosis.
Sperm depletion in seminiferous tubule lumen.
Marked desquamation and vacuolation of epididymal epithelial
lining, diminished to lack of intraluminal sperm.
Prostatic acini were smaller without intra-luminal secretions.
The prostatic epithelium was hardly seen and very flat with
intraluminal calcified materials
24 h later: Light microscopy showed spermatogenic and Sertoli
cell cytoplasm vacuolar generation, mild detachment of
germ cells, irregularly shaped and some atrophied
seminiferous tubules, and Leydig cell hyperplasia.
Electron microscopy showed Sertoli cell mitochondrial damage,
inter-Sertoli cell tight junction destruction, spermatogonia
and spermatocyte apoptosis, spermatid morphological
abnormalities, and Leydig cell mitochondrial damage
Testes weight at 6, 12, and 18 months was 84, 101, and 112;
89, 94, and 91; and 72, 79, and 86% of controls.
At 6 months testes showed perturbation of spermatogenesis
(200 and 400), intense necrosis (400), and adhesive junction
alterations.
At 12 months there were seminiferous tubule alterations (200),
changes seen at 6 months with 400, and degradation of
seminal epithelium (200 and 400).
At 18 months the alterations seen at 12 months were seen after
a lower Al dose
Testes ALP activity was 64, ACP 70, LDH 74, succinate
dehydrogenase 69, and MDA 135% of controls
After 7 days Al exposure sperm count and motility were 26
and 33% of control. Sperm abnormalities were 118% of
controls.
After 90 days Al exposure sperm count and motility were 70
and 79% of control. Sperm abnormalities were 188% of
controls.
90 days after completion of the 90-day Al exposure sperm
count and motility were 90 and 85% of control. Sperm
abnormalities were 139% of controls
Testes total SOD was 77, 68, and 67; GPx 71, 46, and 50;
H2O2 106, 121, and 126; and MDA 111, 117, and 114%
of controls.
Testes Bax and Bcl-2 expression were 105, 127, and 172; and
89, 84, and 80% of controls. There was a dosedependent reduced number of seminiferous tubules with
basement membrane decay or irregular shape, some with
wide lumen and without spermatocytes and filled vacuoles.
Most tubules were distorted with necrotic spermatocytes,
reduced spermatogonia, secondary spermatocyte, and
spermatid number.
The middle dose increased apoptosis (DNA laddering)
Five weeks later testis weight was 100, 92, and 96; sperm count
94, 74, and 73; and abnormal sperm 203, 291, and
328% of controls
Testis MDA was 126 and 147; SOD 76 and 60, CAT 77 and
58, GST 95 and 83, GPx 75 and 63, GR 96 and 70,
vitamin C 74 and 63; and vitamin E 58 and 49% of
controls.
Epididymis MDA was 138 and 150, SOD 84 and 70, CAT 83
and 66, GST 94 and 88, GPx 75 and 57, GR 94 and 65,
vitamin C 77 and 72, and vitamin E 61 and 56%
of controls
The authors state that patients with low sperm counts had a
statistically higher semen Al concentration than others but
also state that semen Al concentration was significantly
lower in patients with low sperm counts (based on sperm
number, progressive motility, vitality, and morphology)
Testis weight was 100, MDA 219, protein carbonyls 287, GSH
158, and thiol groups 179% of controls
Testis weight was 95 and 85, epididymis 97 and 89, seminal
vesicles 94 and 83, and prostate 98 and 93% of controls.
Testis total protein was 93 and 88% of controls.
Testes ALP was 75 and 59, 50 nucleotidase 88 and 73,
gamma-glutamyltransferase 103 and 137, and ATPase
activity 89 and 80% of controls.
Epididymis total protein was 97 and 88% of controls.
Epididymis ALP was 81 and 68, 50 nucleotidase 96 and 73,
gamma-glutamyltransferase 107 and 118, and ATPase
activity 86 and 73% of controls
Testis weight was 94, 83, and 75 and epididymis 95, 77, and
62% of controls.
Testes zinc was 90, 77, and 67; copper 105, 130, and 145;
and iron 87, 70, and 59% of controls.
Testes ACP was 97, 93, and 8; succinate dehydrogenase 102,
90, and 85; LDH 91, 89, and 82; and LDH isoenzyme
activity 85, 73, and 60% of controls.
Sperm count was 87, 29, and 12 and malformation rate 125,
170, and 209% of controls

Reference

Abdel-Moneim (2013)

Hichem et al. (2013)

Tiroumavalavane
et al. (2013)
Yadav et al. (2013)

Chen et al. (2014)

D’Souza et al. (2014)

Kalaiselvi et al. (2014)

Klein et al. (2014)

Maghraoui
et al. (2014)
Ramalingam
et al. (2014)

Zhu et al. (2014)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Mice, 12 weeks,
20–30 g, male

0, 25, 50, and 100 mg/kg AlCl3 orally
for 30 days

10, 20, or 40
(303, 606, or 1212)

Wistar rats, 3–4
months,
190–210 g, males

0 or 34 mg/kg AlCl36H20 i.g. for
10 weeks

7.8
(547)

Albino rats, 160 g

0 or 50 mg/kg Al2(SO4)3 i.g. for
45 days

16
(711)

Wistar rats
120–150 g, males
Albino rats
140–160 g, males

0 or 20 mg/kg AlCl3 orally for
28 days
0 or 30 mg/kg AlCl3 orally for
8 weeks

8.1
(226)
12
(679)

Wistar rats,
190–240 g, males
Wistar rats, 12 weeks,
male (non-diabetic
and diabetic)

0 or 75 mg/kg AlCl36H2O orally for
30 days
250 ppm AlCl3 in the drinking water
for 30 days

17
(518)
15
(439)

Rats, males

0 or 30 mg/kg AlCl3 i.p. every other
day for 8 weeks

6060 every other day
(169,680)

Wistar rats 250–260 g

0 or 100 mg/kg AlCl3 orally for
60 days

40
(2424)

Study results
Testes weight was 95, 88, and 80; epididymis 100, 81, and
66; and seminal vesicles 90, 79, and 57% of controls.
Testis MDA was 118, 124, and 169; SOD 93, 88, and 56; CAT
96, 79, and 46; GPx 89, 69, and 49%; and cholesterol 106,
113, and 127% of controls.
Sperm motility was 94, 88, and 62; viability 98, 85, and 68;
count 100, 88, and 44; and abnormalities 110, 187, and
233% of controls.
Epididymal sialic acid was 56, 54, and 37% of controls.
Seminal vesicle fructose concentration was 97, 96, and 69% of
controls.
Serum testosterone was 90, 94, and 61% of controls.
100 mg/kg/day reduced mating ability, reducing fertile females
to 20% of control and live blastocysts to 62% of control and
increased pre- and post-implantation losses to 243 and
700% of controls.
Testis histology of the 25 mg/kg/day mice was normal.
50 mg/kg/day caused mild degenerative seminiferous changes
(tunica propria thinning, germ cell loosening, and Leydig cell
regressive changes).
100 mg/kg/day caused seminiferous tubule shrinkage and
lumina devoid of spermatozoa or carbohydrate cell debris
and Leydig cell atrophy.
Seminal vesicle histology of the 25 mg/kg/day mice was normal.
50 mg/kg/day caused a slight increase of mucosal folding.
100 mg/kg/day caused increased mucosal folding and
reduced lumen secretory material
Testes weight was 75% of controls.
The number of Leydig cells/interstitial space was 24% of
controls.
Testes zinc was 66% of controls.
Testes nitric oxide was 286, GSH 38, CAT 25, GPx 35, and
SOD 25% of controls.
Testes CAT was 23, GPx 18, SOD 19, and cAMP expression
28% of controls.
Expression of testes steroidogenic genes for 3-betahydroxysteroid dehydrogenase was 26, 17 betahydroxysteroid dehydrogenase 24, steroidogenic acute
regulatory protein 15, and cholesterol side-chain cleavage
enzyme 25% of controls.
Testes testosterone was 44, LDH 26, and FSH 36%
of controls
Testis weight was 58% of controls.
Testis protein was 54, lipids 120, cholesterol 56, triglycerides
75, and phospholipids 53% of controls.
Serum testosterone was 42, FSH 73, LH 68, and prolactin
150% of controls.
Seminiferous tubules showed shrinking, vacuolation, loss of
spermatogenic cells, and increased focal Leydig cell
proliferation. The tunica propria was separated from these
structures, the seminiferous tubule lumen was very compact
with cells, and there was some spermatogenic cell pyknosis
and seminiferous tubule bleeding
Testis triglycerides were 129, cholesterol 48, and phospholipid
99% of controls
Al caused seminiferous tubule basement membrane disturbance,
disorganized germinal epithelium, interstitial vacuolation,
and an 18% decrease of diagonal diameter.
Most spermatogenic cells were undifferentiated and decreased
in number.
There were decreased polysaccharides in the seminiferous
tubule basement membrane, spermatogenic, and Leydig
cells. There was decreased germ and Leydig cell
proliferation, 68% decrease in proliferating cell area, 37%
reduction of interstitial cell number, and 29% reduction of
epithelial wall thickness
Testis weight was 85, SOD 48, GPx 43, and MDA 322%
of controls
Sperm count and epididymal spermatozoa motility were 82
and 92% of controls.
Serum testosterone and estradiol were 120 and 122% of nondiabetic controls.
Shrunken seminiferous tubules with germinal epithelium erosion
Serum testosterone was 48, FSH 65, and LH 72% of controls.
Oligospermia, hypoplasia, exfoliated tubules progressed starting
after 2 weeks.
Increased space between tubules seen after 6 and abnormal
Leydig cells after 8 weeks
Testes weight was 86, epididymis 75, seminal vesicles 88
and prostate 90% of controls.
Sperm count and motility were 80 and 60% of controls.
Sperm abnormalities (headless, banana head, bent neck, and
bent tail) were 706, live sperm 43, and dead sperm
320% of controls.
Serum testosterone was 68% of controls

Reference
Kumar and
Singh (2015)

Mohammad
et al. (2015)

Rawi and Al
Nassr (2015)

Ugbaja et al. (2015)
Afeefy et al. (2016)

Akay et al. (2016)
Akinola et al. (2016)

Al Nahari and Al Eisa
(2016) and Al-Eisa
and AlNahari (2017)
Arumugam and
Venugoapal (2016)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Guinea pigs

0 or 100 mg/l AlCl3 in the drinking
water for 13 weeks

6.1
(551)

Sprague Dawley rats,
200–250 g, males

0 or 18 mg/kg AlCl3 orally for
30 days

7.3
(218)

Albino rats, 60 days,
175 g, males

0 or 98 mg/kg Al2(SO4)3 orally for 30
or 60 days

31
(929 or 1858)

Humans

Swiss mice,
25–35 g, males

Sperm exposed to 0, 0.125, 0.25, 0.5,
1 or 5 mM AlCl3 for 2 h (motility)
Sperm exposed to 0, 0.5, 1, 5, 10,
15, 20, 25 or 30 mM AlCl3 for 2 h
(lipid peroxidation)
0, 25, 50, and 100 mg/kg AlCl3 orally
for 30 days

10, 20, or 40
(303, 606, or 1212)

Wistar rats, 280–330 g,
males and females

0, 200, 400, or 1000 ppb
Al2(SO4)318H2O in the drinking
water for 6 months to produce
F0 males, mated with females
similarly exposed during
gestation and lactation, then
offspring exposed to 6 months
(! F1 males), F1 males mated
with females similarly exposed
during gestation and lactation,
then offspring exposed to 6
months (! F2 males)

0.005, 0.009, or 0.023
(11, 21, or 53)

Albino rats,
150–200 g, males

0 or 100 mg/kg AlCl3 i.g. for 4 weeks

40
(1131)

Wistar rats,
250–300 g, males

0, 2 or 10 mg/kg Al2(SO4)3 i.v. once
or 0 or 3 mg/kg Al2(SO4)3 i.p. for
7 days

316 or 1580
474
(3318)

Wistar rats,
150 200 g, males

0 or 4.3 mg/kg AlCl3 i.p. for 21 days

869
(18,241)

Wistar rats,
240–260 g, males

0 or 10 mg/kg AlCl3 i.p. for 28 days

2020
(56,560)

Sprague Dawley rats,
adult, males

0, 75, 150, or 300 mg/kg AlCl3
presumably orally for 59 days

20, 61, or 121
(1788, 3575, or 7151)

Study results
Sperm count was 94, motility 97, and abnormal sperm 111% of
controls.
Testes steroidogenic acute regulatory protein and cytochrome
P450 cholesterol side chain cleavage enzyme protein
expression were 94 and 81% of controls.
Testes steroidogenic acute regulatory protein and cytochrome
P450 cholesterol side chain cleavage enzyme mRNA were 83
and 79% of controls.
Serum testosterone was 96% of controls.
Seminiferous tubule morphology almost normal.
Appearance of tiny cavities and decreased sperm
bundle number
Sperm count was 49, motility 67, viability 66, and
abnormalities 174% of controls.
Testes germ cell layer irregularity, distorted seminiferous
tubules, spermatogenic cell degeneration, necrotic debris in
the tubules, multinucleated giant cell appearance, interstitial
blood vessel congestion, interstitial edema, and abnormal
luminal spermatozoa distribution were seen
Testes MDA after 30 and 60 days was 369 and 610, and GSH
42 and 19% of controls.
Loss of Sertoli cell integrity. Interstitial cell size reduction with
nuclear pyknosis.
Marked distortion of seminiferous tubules with almost complete
disintegration of connective tissue between them.
After 30 days spermatogonia detached from seminiferous tubule
basal lamina, germ cell desquamation, and interstitial blood
vessel engorgement.
After 60 days seminiferous tubule cell nuclear fragmentation,
nuclear pyknosis, and germ cell cytoplasmic disintegration.
Spermatogonia and spermatocyte cytoplasm vacuolization.
Reduced sperm amount in seminiferous tubule lumen, many
totally devoid of sperm
Sperm motility was 100, 97, 93, 76, and 17% of controls.
MDA was 100, 200, 284, 432, 579, 664, 655, and 648%
of controls
Blood testosterone was 68% of controls
Testes MDA was 124, 127, and 181; SOD 90, 84, and 48; CAT
86, 69, and 38; GPx 64, 66, and 36; ALP 111, 124, and
164; and LDH 114, 203, and 312% of controls
Testes weight of F0, F1, and F2 males was 93, 85, and 80; 85,
83, and 77; and 82, 76, and 66% of controls.
Sperm count in F0, F1, and F2 males was 96, 92, and 85; 89,
85, and 72; and 72, 67, and 59% of controls.
Immobile sperm in F0, F1, and F2 males was 218, 245, and
345; 128, 193 and 175; and 507, 575, and 588% of
controls.
Serum testosterone in F0, F1, and F2 males was 87, 73, and
40; 61, 63, and 33; and 58, 49, and 27% of controls.
Testes had interstitial edema, seminiferous epithelial necrosis
and exfoliation, basal membrane disintegration, and Leydig
cell necrosis and disintegration.
Sperm abnormalities included heads without tails, broken tails,
and flexed heads
Testes had small shrunken seminiferous tubules with irregular
basement membrane, necrotic germinal epithelial cells, and
giant cell formation.
Reduced spermatogenesis (single or double germ cell layers),
necrotic and calcified tubules.
Intertubular blood vessel congestion.
Epididymal ducts had reduced density or no sperm and
sloughed necrotic germinal cells in their lumina
Acute Al reduced intracavernosal pressure/mean arterial pressure
(ICP/MAP) 39 and 71%.
Subacute Al reduced ICP/MAP  30%, serum testosterone to
45% of control and increased corpus cavernosum MDA,
GSH, and Al to 128, 119, and 354% of control
Testes MDA was 148 and 147, SOD 80 and 94, CAT 80
and 77, GST 70 and 77, and GPx 78 and 80% of
controls in the two studies.
Al produced shrunken seminiferous tubules; severe sperm cell
aplasia; basement membrane thickening and rupture; and
interstitial and peritubular tissue vacuolization and fibrosis
Testis weight was 80, sperm count 48, motility 52,
abnormalities 325, and viability 45% of controls.
The seminiferous tubule germinal epithelial thickness was 65%,
tubule diameter 87, tubule lumen 128, and spermatogonia
nuclear diameter 100% of controls.
Plasma testosterone was 35, FSH 116, LH 32, and SOD 39%
of controls
Sperm count was 100, 92, and 44; sperm motility 96, 88, and
62; normal sperm 97, 87, and 75; and abnormal sperm

Reference
Dong et al. (2016)

Hadi and Jaffat (2016)

Jakkala and Ali (2016a)
Jakkala and Ali (2016b)

Jamalan et al. (2016)

Kumar and
Singh (2016)

Muselin et al. (2016)

Oda (2016)

Senbel et al. (2016)

Arhoghro and
Sule (2017a)
Arhoghro and
Sule (2017b)

Cheraghi et al. (2017)

Falana et al. (2017)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Rats, 6–7 weeks,
90–120 g, males

0 or 30 mg/kg of AlCl3 i.p. for 35
days followed by 0 Al for
60 days

6060 first 35 days
(212,100)

Albino rats,
180 g, males

0 or 100 mg/kg of AlCl3 i.g. for
8 weeks

40
(2262)

Wistar rats, 3 months,
362 g, males

0, 1.5, or 8.3 mg/kg Al as AlCl36H2O
in the drinking water for 60 days
0 or 100 mg/kg Al i.g. daily for
42 days

3 or 17 in the 60-day study
(180 or 996)
200 in the 42-day study
(8400)

Bank voles, 4 weeks,
males and females

0, 1.5, or 100 mg Al/kg/day as
AlCl36H2O in the drinking water
for 12 weeks

3 or 200
(252 or 16,800)

Albino rats,
180–200 g, males

0 or 10 mg/kg AlCl3 i.g. daily for
3 months

4
(364)

Study results
115, 135, and 170% of controls.
Serum testosterone was 98, 95, and 73% of controls.
Testes histology was normal for the 75 and 150 mg/kg-treated
rats.
300 mg/kg resulted in severe testicular damage, abnormal
seminiferous tubules, incomplete maturation of germinal cell
layers, absence of luminal sperm and Leydig cell hyperplasia
On day 61 testes weight was 73, epididymis 54, seminal vesicle
2, and ventral prostate 24% of controls.
Testes protein was 75, MDA 177, SOD 11, CAT 50, cholesterol
140, and gamma-glutamyltransferase 44% of controls.
Epididymal protein was 63, MDA 149, SOD 14, CAT 30, and
gamma-glutamyltransferase 9% of controls.
Sperm count was 31, motility 40, and viability 22% of controls.
Libido test mounts and intromissions on day 55 were 35 and
13% of controls.
Testes showed spermatogenesis impairment and disorganized
seminiferous tubule germinal epithelium with spermatozoafree lumen, degeneration, and necrosis. There was interstitial
tissue reduction.
The epididymal tubule lumen contained immature nucleated
spermatocytic cells. Partial recovery was seen after Al
termination.
Spermatogenesis seemed to be taking place in the seminiferous
tubules. Some spermatozoa were seen in epididymal lumen
Serum testosterone was 51% of controls.
Testes exhibited completely atrophied seminiferous tubules,
with germinal epithelial necrosis and sloughing.
Interstitial edema and congestion were seen.
There was multinucleated giant cell aggregation.
Ductal germinal epithelial vacuolization and sloughing was seen
and the absence of sperm.
The lumen of some tubules had acidophilic foamy material
admixed with exfoliated necrotic germ cells.
Epididymal tissues showed alteration of most ductules that
appeared devoid of mature spermatozoa
60-day study testes were 118 and 122, epididymis 108 and 106,
full seminal vesicle 100 and 100, vesicular secretion 100 and
122, vas deferens 87 and 102%, and ventral prostate 89 and
95% of controls.
MDA in the testes was 141 and 162, epididymis 142 and
224, and prostate 136 and 156% of controls.
Reactive oxygen and nitrogen species in the testes were 138
and 160, epididymis 137 and 141, and prostate 133 and
131% of controls.
Antioxidant capacity in the testes was 73 and 83, epididymis
120 and 66, and prostate 69 and 117% of controls.
60-day study normal sperm were 96 and 90, abnormal sperm
171 and 248, testis sperm number 73 and 65, daily
production 73 and 65, sperm that were motile with
progressive movement 85 and 53, sperm that were motile
without progressive movement 122 and 167, immotile 161
and 197, epididymis sperm number 95 and 93, epididymis
transit time 128 and 162, cauda sperm number 78 and 84,
and cauda transit time 107 and 132% of controls.
For the 8.3 mg/kg subject’s testis activated macrophages were
265%, seminiferous epithelial thickness 76%, empty
seminiferous tubule number 273%, and empty epididymis
efferent ducts 100% of controls.
42-day study testes weights were 100, epididymis 93, ventral
prostate 84, full seminal vesicle 108, vesicular secretion 129,
and vas deferens 89% of controls.
Testes MDA was 177, epididymis 170, and prostate 138% of
controls.
Testes antioxidant capacity was 126, epididymis 97, and
prostate 69% of controls.
42-day study normal sperm were 89, abnormal sperm 219,
testis sperm number 78, daily production 78, sperm that
were motile with progressive movement 33, sperm that
were motile without progressive movement 173, immotile
258, epididymis sperm number 94, epididymis transit time
118, cauda sperm number 84, and cauda transit time 107%
of controls.
Testes reactive oxygen and nitrogen species were 181,
epididymis 141, and prostate 124% of controls.
Testis activated macrophages were 114% of controls
Testis seminiferous epithelial thickness was 74% of controls.
Empty seminiferous tubule number was 126% of controls.
Empty epididymis efferent ducts were 80% of controls
Testis and accessory gland weights were 102 and 104; and 103
and 117% of controls.
Sperm count was 61 and 48; sperm motility 91 and 75;
swollen sperm 91 and 70; viable sperm 85 and 64;
sperm cell head abnormalities 132 and 195; and
spermatogenic index (a measure of seminiferous epithelium
activity, spermatogenesis) 96 and 77% of controls
Testes MDA was 147, GSH 52, CAT 64, and SOD 63% of
controls.
Serum testosterone was 30% of controls.

Reference

Francine et al. (2017)

Khafaga (2017)

Martinez et al. (2017)

Miska-Schramm
et al. (2017)

Mohamed and ElMoneim (2017)
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Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Wistar rats,
100–196 g, males
Wistar rats,
160 g, males

0 or 0.5 mg/kg AlCl3 i.g. daily for
3 weeks
0 or 20 mg/kg AlCl3 orally daily for
6 weeks

0.2
(4.2)
8
(339)

Wistar rats,
160 g, males
Mice, 3 months,
30–35 g, males

40 mg/kg AlCl3 in the drinking water
for 21 days
0 or 55.45 mg/kg AlCl3 i.p. daily for
60 days

16
(339)
11,200
(78,406, 168,014, 336,027, or
672,054 after 7, 15, 30, or
60 injections)

Wistar rats, 70 days,
264–368 g, males

0, 0.000067, 0.000335, 10, and
40 mg/kg Al as AlCl3 i.g. daily for
112 days

0.000134,
0.00067, 20, or 80
(0.015, 0.075, 2240, or 8960)

Wistar rats, 3 weeks,
70–95 g, males

0, 64, 128, or 256 mg/kg AlCl3 in the
drinking water for 120 days

25, 52, or 103
(3103, 6205, or 12,411)

Sprague Dawley rats,
 8 weeks, males

0 or 0.4–0.55 mg Al as Al hydroxyphosphate sulfate (in Merck’s

77–106
(2658–4616)

Study results
Testis showed marked necrosis and degeneration of
seminiferous tubule spermatogonia lining cells, incomplete
spermatogenesis, and intraluminal spermatid giant cells
Serum testosterone was 78, FSH 43, and LH 33% of controls
Testis caspase-3 and proliferating cell nuclear antigen (a
measure of cell replication) expression were 278 and 22% of
controls.
Seminiferous tubule diameter and thickness were 58 and 48%
of controls.
Serum testosterone and LH were 18 and 33% of controls.
Testes blood vessels were enlarged and congested, tubule germ
layers were detached from the basal lamina, intertubular
spaces had blood hemorrhages, germ layers had vacuoles,
and there was a severe reduction of spermatogenic cells
with appearance of giant cells
Testis total protein was 63, MDA 148, GSH 59, CAT 43, and
SOD 27% of controls
After 7, 15, 30, or 60 injections sperm count was 72, 75, 25,
and 13; live sperm 95, 92, 78, and 60; and abnormal
sperm 91, 161, 206, and 261% of controls.
After 30 injections sperm abnormalities included amorphous
head, bent at the cephalocaudal junction, bent with
projecting filaments, microcephaly with tail defects and
defective head with tail duplication.
Testes were enlarged after 60 injections.
Testis showed fibrin deposition; seminiferous tubule
vacuolization with hyalinization; Leydig cell proliferation;
tunica albuginea fibrous thickening; lack of spermatocytes in
some seminiferous tubule lumens; spermatogenic cell
sloughing in seminiferous tubule lumens; seminiferous
tubule necrosis, interstitial fibrosis, distension, and giant cell
formation; mononuclear cell infiltration;
Epididymis showed destruction of ductal epididymal epithelia,
mild interstitial fibrosis, mononuclear cell infiltration,
spermatid loss and spermatid clumping in some tubules, and
epithelial caput destruction.
Prostate stromal tissue showed fibromuscular proliferation with
mononuclear cells aggregation and epithelial hyperplasia
Testis total weight was 92, 88, 87, and 86; tunica albuginea
118, 94, 82, and 61; and parenchyma 89, 88, 88, and
88% of controls.
Leydig cell nuclear diameter was 87, 85, 80, and 83;
nuclear percentage 105, 110, 126, and 128; and cytoplasm
percentage 117, 135, 131, and 204% of controls.
Number of Leydig cells/testis was 124, 168, 168, and 160% of
controls.
Epididymis weight was 84, 74, 78, and 77% of controls.
Epididymal caput epithelial height was 94, 98, 98, and 111;
tubular diameter 108, 96, 101, and 96; luminal diameter 111,
94, 103, and 92; lumen with sperm 93, 83, 96, and 84;
and percent epithelium 105, 118, 102, and 119% of
controls.
Normal sperm morphology was 104, 97, 100, and 96; sperm
motility 88, 90, 93, and 84; and sperm with tail defects 58,
110, 102, and 127% of controls.
Sperm with intact plasma and acrosomal (secretory vesicle of
sperm head with enzymes that digest the oocyte’s
investments) membranes were 63, 47, 12 and 9% of
controls.
Serum testosterone was 31, 31, 56, and 54% of controls
Testis volumetric proportion; tubular and intertubular volume;
tubular morphometry; and seminiferous tubule diameter,
luminal diameter, and length were not different from
controls.
Epididymal lamina propria volumetric proportions, lumen
without sperm, blood vessels, connective tissue, and smooth
muscle were not different from controls
Testes Naþ-Kþ-ATPase activity was 94, 90 and 74; Mg2þATPase 100, 72, and 66; and Ca2þ-ATPase 96 84, and
78% of controls.
Testes follicle stimulating hormone receptor and luteinizing
hormone receptor expression were 89, 73, and 64; and 86,
74 and 68% of controls.
Testes from the 64 mg/kg group stroma were slightly expanded,
with decreased spermatogenic cells and sperm count.
Testes sperm in the 128 mg/kg group were in the lumen and
sperm count was significantly decreased.
Testes from the 256 mg/kg group showed congestion, blood,
edema, and were withered.
Testicular stroma from the 256 mg/kg group were significantly
expanded, the seminiferous tubules narrow, with decreased
sperm count.
Testes showed cell disintegration, incomplete cell membranes,
foal-like structures, mitochondrial swelling, and irregular
nuclear envelope

Reference

Olawuyi et al. (2017)
Sakr et al. (2017)

Adedosu et al. (2018)
Mohammed
et al. (2018)

Mouro et al. (2018)

Sun et al. (2018)

Wise et al. (2018)

(continued)

CRITICAL REVIEWS IN TOXICOLOGY

27

Table 6. Continued.

Al-treated subjects

Al exposure

Approximate systemic Al
exposure as mg/kg/day and
(total mg/kg)a

Gerbils, 3–4 months
old, females

aluminum adjuvant) i.m. on
study days 1, 22, 43, and 64
Terminated 3 or 21 days later
0 or 20.2 mg Al/kg/day as AlCl3
orally GD 17–24

40.4
[323]

Wistar rats,
100–196 g, males

0 or 0.5 mg/kg AlCl3 i.g. daily for
3 weeks

0.2
(4.2)

Wistar rats,
180–200 g, males

0, 64, 128, or 257 mg/kg AlCl36H2O
in the drinking water for
16 weeks

15, 30 or 59
(1653, 3307, or 6613)

Kunming mice, 4
weeks,
18–23 g, males

0 or 10 mg/kg Al (form not
reported) i.g. for 4 weeks

20
(560)

Wistar rats, 8–10
weeks old,
220–250 g, males

0 or 34 mg/kg AlCl3 orally for
10 weeks

14
(962)

Albino mice, 3–4
months,
23–35 g, males

0 or 50 mg/kg AlCl3 presumably
orally for 45 days

20.2
(303, 606, and 909 after) 15, 30,
and 45 days)

Study results
There was no effect on testis or prostate weight, or testis,
epididymis, seminal vesicle, prostate, or prostate
histomorphology
Offspring body weight; anogenital distance; and prostate
epithelial buds, mesenchyme, and smooth muscle were 87,
98, 122, 80, and 131% of controls.
Androgen receptor and proliferating cell nuclear antigen in the
prostate epithelial buds, mesenchyme, and smooth muscle
were 82, 73, and 77; and 484, 174, and 267% of
control.
The results suggest Al acts as an antiandrogenic
endocrine disruptor
The visual field percentage of seminiferous tubules was 89,
Leydig cells 122, and non-Leydig cells 190% of controls. The
volume of seminiferous tubules was 89, Leydig cells 115,
and non-Leydig cells 185% of controls.
Seminiferous duct diameter was 116, luminal diameter 106,
epithelial height 24, and interstitial space diameter 992%
of controls.
Spermatogonia were 30, primary spermatocytes 60, secondary
spermatocytes 31, round spermatids 62, elongated
spermatids 14, spermatozoa 6, and Sertoli cells 33%
of controls
Progressively motile, dead, and abnormal sperm were 70, 51,
and 26; 155, 282, and 434; and 131, 163, and 220%
of controls.
Mitochondrial membrane potential and membrane permeability
transition pore were 82, 69, and 51; and 181, 238, and
423% of controls.
Al exposure increase sperm mitochondrial swelling
Testis weight was 96% of controls.
Testis Na was 151, K 77, Ca 154, and Mg content 83% of
controls.
Testis MDA was 195, H2O2 135, CAT 49, SOD 70, and total
antioxidant capacity 45% of controls.
Testes NO content was 134; activity of iNOS was 105, tNOS
177, and cNOS 270; and mRNA expression of nNOS 151,
iNOS 435, and cNOS 180% of controls.
Testes Naþ-Kþ-ATPase activity was 82, Mg2þ-ATPase 68,
Ca2þ-ATPase 55, and Ca2þ-Mg2þ-ATPase 68% of controls.
Seminiferous tubules were disorderly with loose arrangement
and damage. Mature sperm count was decreased with
enlarged and loose cells and swollen sperm heads
Testis MDA, GSH, GPX, CAT, Nrf-2, HO-1, and caspase 3 and Bcl2
expression were 125, 65, 83, 77, 47, 68, 1750 and
470% of controls.
Johnsen testicular biopsy score was 41% of controls.
Sperm motility, concentration, dead/live ratio, and abnormal
sperm were 58, 53, 220, and 209% of controls.
Tubular germ cells were largely separated from the basement
membrane, the tubulus membrane was thickened, tubules
were
closer to each other, interstitial space was narrowed, there was
significant cell loss or tubule disorganization, increased space
between Sertoli cells, increased spermatogonia, degenerated
germinal cells, spermatogonial nuclei shrinkage, halted or
decreased spermatogenesis, and interstitial edema and
vascular congestion
Testis weight and as a percentage of body weight after 15, 30,
and 45 days were 100, 99, and 90; and 80, 85, and 81%
of controls.
Epididymis and vas deferens weight and as a percentage of
body weight after 15, 30, and 45 days was 91, 87, and 73;
and 73, 73, and 70% of controls.
Seminal vesicle weight and as a percentage of body weight
after 15, 30, and 45 days was 72, 72, and 68; and 57, 63,
and 85% of controls.
Sperm count after 15, 30, and 45 days was 98, 90, and 55% of
controls.
Sperm mobility after 15, 30, and 45 days was 80, 78, and 64%
of controls.
Serum testosterone, FSH, and LH after 15, 30, and 45 days were
189, 46, and 36; 80, 79, and 62; and 13, 3, and 0.3% of
controls.
After 15 days shrunken interstitial cells and damaged basement
membrane were seen; after 30 days irregularly shaped
seminiferous tubules; and after 45 days vacuolation,
damaged spermatocytes, and irregularly shaped
seminiferous tubules

Reference

Gomes et al. (2019)

Olawuyi et al. (2019)

Yuan et al. (2019)

Cao et al. (2020)

G€
uvenç et al. (2020)

Sajjad et al. (2020)

The approximate systemic Al exposure from the additional Al was calculated as described in the text. Daily exposures that do not add more Al than expected
from the diet are in italics.
a
See the footnote in Table 3.
Results that are statistically significantly different from controls.
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exposure-dependent increase in placental Al concentration.
The considerably higher placental Al levels in mice and rats
compared to humans may be due to the higher Al content
of rodent than human diet (see the Animal diet Al content
and daily food and water consumption section). Exposure of
human placental brush-border membranes and microsomes
to 0.05–10 mM Al salts increased MDA in a concentrationdependent manner (Anand and Kanwar 2001), suggesting Alincreased lipid peroxidation could have detrimental effects
on the placenta. No association was seen between placental
Al concentration and orofacial clefts (Pi et al. 2019).
The fetus inhales and swallows amniotic fluid. In mice
exposed to topical AlCl3 solution for 20 days, estimated to
provide negligible systemic Al exposure (see Table 8), amniotic fluid was 35 compared to 29 lg/L in controls (Anane
et al. 1997). Human samples obtained at 16–19 weeks of gestation averaged 93 lg/L (Hall et al. 1983), 111 lg/L at
16–26 weeks and 160 lg/L at 21–26 weeks (Suliburska et al.
2016), 19 lg/L at 12–20 weeks (Jalali and Koski 2018), and at
birth 78 (Takacs et al. 1992) and 144 lg/L (Markiewicz et al.
2017). Amniotic fluid Al was higher for male than female
fetuses, 179 versus 107 lg/L, respectively (Suliburska et al.
2016). Amniotic fluid Al concentration did not significantly
correlate with fetal heart rate, umbilical artery pulsatility
index, biparietal diameter, head or abdominal circumference,
femur length, or estimated fetal weight (Suliburska et al.
2016). There was no relationship between Al concentration
and ultrasound measures (estimated weight, bi-parietal diameter, head circumference, abdominal circumference, and
femur length) at 16–20 or 32–36 weeks (Jalali and Koski
2018). Amniotic fluid Al in women whose fetus was found to
have congenital neural tube defects averaged 440 lg/L, significantly higher than women with healthy fetuses (256 lg/L)
(Ovayolu et al. 2019).
Infant meconium of low socio-economic mothers from 19
sites in Karachi, Pakistan, averaged 130 ppm Al (Aziz et al.
2017). The authors found a significant correlation among
maternal blood, cord blood, and meconium Al concentration
at 13 of the 19 sites.
Only two reports were found of Al concentration in female
reproductive organs. Ovary Al concentration in Wistar rats
that consumed 0, 200, 400, or 1000 ppb Al2(SO4)3 in the
drinking water for 3 months before mating was 38, 95, 101,
and 77 lg/g after offspring weaning. The corresponding
uterus and fallopian tube Al concentrations were 7.0, 8.9,
8.2, and 8.7 lg/g. Ovary Al concentration in similarly
exposed F1 offspring was 40, 99, 102, and 104 lg/g after
weaning. Uterus and fallopian tube Al concentration was 7.8,
9.2, 9.4, and 10.2 lg/g (Trif et al. 2010). Some of these
values are much higher than reported for the placenta and
non-reproductive organs of pregnant rodents (perhaps they
are expressed as dry weight, although this cannot be determined from the report). Ovary Al concentration in Wistar rats
that consumed 0, 64, 128, or 257 mg/kg AlCl3 in the drinking
water for 120 days was 0.16, 0.54, 1.14, and 1.18 mg/g.
Since the authors do not report if these are based on wet or
dry weights, these data only provide a basis for within-study
comparisons (Wang et al. 2012). Both reports show increased
female reproductive organ Al concentration as a result of

increased Al exposure, associated with structural changes in
the ovaries and uterus, and decreased female hormones and
increased testosterone in the blood (Table 3).3
There are many reports of Al quantification in mouse and
rat testes, four in rabbits, and one in humans. Details are
summarized in Table 10. Aluminum deposits in human
Leydig cells and seminiferous tubules were visualized using
laser microprobe mass analysis (Reusche et al. 1994). Many of
the reports found an Al-exposure-dependent increase in testes Al concentration. For the studies that determined testes
Al concentration shortly after completion of exposure in the
absence of citric acid, there is a strong correlation between
total systemic Al exposure and the dietary plus added Al contribution (e.g. Pearson correlation r(30) ¼ 0.67, p ¼ 0.000027
for the log10 mouse and rat total Al exposure versus log10
testes Al concentration as a fold of control). An increase in
seminal fluid Al concentration was found in humans exposed
to occupational environments that might increase Al exposure (Hovatta et al. 1998; Dawson et al. 2000), along with an
inverse relationship between sperm quality and Al concentration (Dawson et al. 1998; Klein et al. 2014). These results suggest seminal fluid Al concentration may be a sensitive
indicator of Al-induced male reproductive toxicity and that
Al-induced decreased male fertility may be fairly common.
The two studies that reported both fetal and placental Al
concentrations found higher levels in the placenta than in
the fetus and a greater increase in the placenta after additional Al exposure (Cranmer et al. 1986; Colomina et al.
1994). The logs of the fetal and placental Al concentrations
as a multiple of the Al concentration in animals that did not
receive additional Al (Tables 8 and 9) are normally distributed. The linear regression best fit slope of the placental Al
concentrations is greater than the slope of the fetal Al concentrations, further indicating greater Al distribution into the
placenta than fetus. Similarly, a study that quantified Al in
the placental body and membrane and umbilical cord found
less Al in the cord (0.56 and 0.53 versus 0.27, respectively)
(Kruger et al. 2010). A normally distributed transform of the
testes Al concentration as a multiple of the Al concentration
in animals that did not receive additional Al (Table 10) was
not identified. The slopes of the logs of the placental and
testes Al concentrations are significantly different from zero.
The slope of the log of the testes Al concentration is greater
than the placental Al concentration, suggesting greater Al
distribution into testes. Comparison of the Al-exposuredependent increased testes Al concentration (up to
>100-fold, Table 10) compared to Al-exposure-dependent
increased placental Al concentration (up to 10-fold, Table 9)
further suggests greater Al distribution into testes than
placenta.

Initial adverse outcomes pathways for Al-induced
reproductive toxicity
An adverse outcome pathway (AOP) is a conceptual construct
creating a link between a molecular initiating event (MIE)
produced by exposure to a substance and an adverse outcome (AO). It captures key biochemical and physiological
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Table 7. Studies conducted in males categorized according to study report of significant findings and approximate systemic Al exposure.
Daily approximate systemic
Al exposure (mg/kg)
A. GLP compliant studies conducted following an OECD test guideline showing no statistically significant toxicity
Beekhuijzen (2007)
20, 98, or 494
Hirata-Koizumi et al. (2011b), F0 generation
2.7 or 13
Hirata-Koizumi et al. (2011b), F1 generation
3.4 or 16
Hirata-Koizumi et al. (2011a), F0 generation
0.9 or 8
Hirata-Koizumi et al. (2011a), F1 generation
1.0 or 10
B. No significant effects from exposures similar to A. above
McCollum et al. (1928)
90
Dixon et al. (1979)
1.5, 15, or 149
Katz et al. (1984)
10, 27, or 88
Hicks et al. (1987)
67, 141, 288, or 302
Pettersen et al. (1990)
8, 20, 54, or 150
34 or 58
Roy et al. (1991) Al2(SO4)318H2O
57
Roy et al. (1991) KAl(SO4)212H2O
Wise et al. (2010)
34
Chaitanya et al. (2012)
20
Hichem et al. (2013)
40
Kumar and Singh (2015)
10
Kumar and Singh (2016)
10
Falana et al. (2017)
20
Wise et al. (2018)
77–106
C. GLP compliant studies conducted following an OECD Test Guideline showing statistically significant toxicity
Hirata-Koizumi et al. (2011b), F0 generation
59
Hirata-Koizumi et al. (2011b), F1 generation
73
Hirata-Koizumi et al. (2011a), F0 generation
70
Hirata-Koizumi et al. (2011a), F1 generation
85
D. Studies with some significant results from exposures similar to A. above
Kamboj and Kar (1964)
30
Krasovski%K et al. 1979)
5
Pettersen et al. (1990)
150
86
Roy et al. (1991) Al2(SO4)318H2O
87
Roy et al. (1991) KAl(SO4)212H2O
Bataineh et al. (1998)
33
Yousef (2004)
34
El-Demerdash (2004)
7
Mayyas et al. (2005)
104, 125, or 145
Yousef et al. (2005)
34
Trif et al. (2007)
0.009, 0.018, or 0.045
Al-Hashem (2009)
0.12
Entissar et al. (2009)
16 or 32
Yousef and Salama (2009)
14
Hala et al. (2010)
8
Thirunavukkarasu et al. (2010)
40
Abu-Taweel et al. (2011)
121 or 242
Mahran et al. (2011)
14
Sun H et al. (2011)
26, 52, or 104
Ige and Akhigbe (2012)
40
Ighodaro et al. (2012)
0.2
Moselhy et al. (2012)
14
Hichem et al. (2013)
40, 81, or 162
Tiroumavalavane et al. (2013)
20
Yadav et al. (2013)
16 or 157
Kalaiselvi et al. (2014)
20 or 40
Ramalingam et al. (2014)
20 or 40
Zhu et al. (2014)
26, 52 or 104
Kumar and Singh (2015)
20 or 40
Mohammad et al. (2015)
7.8
Rawi and Al Nassr (2015)
16
Ugbaja et al. (2015)
8.1
Afeefy et al. (2016)
12
Akay et al. (2016)
17
Akinola et al. (2016)
15
Dong et al. (2016)
6.1
Hadi and Jaffat (2016)
7.3
Jakkala and Ali (2016a)
31
Arumugam and Venugoapal (2016)
40
Kumar and Singh (2016)
20 or 40
Muselin et al. (2016)
0.005, 0.009, or 0.023
Oda (2016)
40
Falana et al. (2017)
61 or 121
Khafaga (2017)
40
Martinez et al. (2017)
3, 17, or 200
Miska-Schramm et al. (2017)
3 or 200

Total approximate systemic
Al exposure (mg/kg)
554, 2744, or 13,832
247 or 1179
308, 1444
78 or 695
95 or 867
 1890
135, 1350, or 13,410
1830, 4917, or 16,040
1876, 3948, 8064, or 8456
1456, 3640, 9828, or 27,300
721 or 1208
1204
745
280
7373
303
303
1788
2658–4616
5406
6671
6328
7718
907
1350
27,300
1803
1831
2800
3808
206
8755, 10,507, or 12,258
3808
0.4, 1.7, 3.3 or 8.4
3.4
485 to 1940
962
566
3636
2424 or 4848
962
3103, 6205, or 12,459
121
7.1
412, 618, or 824
14,746 to 88,476
909
1098 or 1404
909 or 1818
970 or 1939
3103, 6205, or 12,459
606 or 1212
547
711
226
679
518
439
551
218
929 or 1858
2424
606 or 1212
11, 21, or 53
1131
3575 or 7151
2262
180, 996, or 8400
252 or 16,800
(continued)
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Table 7. Continued.
Daily approximate systemic
Al exposure (mg/kg)
Mohamed and Abd El-Moneim (2017)
4
Sakr et al. (2017)
8
Adedosu et al. (2018)
16
Mouro et al. (2018)
0.000134, 0.00067, 20, or 80
Sun et al. (2018)
25, 52, or 103
Gomes et al. (2019)
40
Olawuyi et al. (2019)
0.2
Yuan et al. (2019)
15, 30 or 59
Cao et al. (2020)
20
G€uvenç et al. (2020)
14
Sajjad et al. (2020)
20.2
E. Study found some statistically significant results from higher exposure
Melograna and Yokel (1984)
3400
Oneda et al. (1994)
114, 285, 570, or 1140
Llobet et al. (1995)
3600, 7200, or 14,400
Guo et al. (2001)
13,000 or 35,000
Guo et al. (2002)
13,000 or 35,000
Guo et al. (2005a)
35,000
Guo et al. (2005b)
1470 or 2730
Guo et al. (2006)
1470 or 7350
Reza and Palan (2006)
10,100
Khattab (2007)
3030 or 6060
Kutlubay et al. (2007)
339
Guo et al. (2009)
1414 or 7070
Cui et al. (2009)
7214, 10,821, or 14,428
Buraimoh et al. (2012b)
768
Abdel-Moneim (2013)
5050
Chen et al. (2014)
577, 1154, or 1731
D’Souza et al. (2014)
6600, 13,200, or 19,800
Maghraoui et al. (2014)
1778
3030
Al Nahari and Al Eisa (2016)
Al-Eisa and Al-Nahari (2017)
Senbel et al. (2016)
316, 474, or 1580
Arhoghro and Sule (2017a, 2017b)
869
Cheraghi et al. (2017)
2020
Francine et al. (2017)
6060
Mohammed et al. (2018)
11,200

Total approximate systemic
Al exposure (mg/kg)
364
339
339
0.015, 0.075, 2240, or 8960
3103, 6205, or 12,411
323
4.2
1653, 3307, or 6613
560
962
909
68,000
69,312, 173,280, 346,560, or 693,120
72,000, 144,000, or 288,000
182,000 or 490,000
182,000 or 490,000
420,000
20,580 or 38,220
20,580 or 102,900
202,000
53,025 or 105,050
4790
19,796 or 98,980
72,140, 108,210, or 144,280
42,986
5050
1731, 3464, or 5194
46,200, 92,400, or 138,600
24,892
169,680
3318
18,241
56,560
212,100
78,406, 168,014, 336,027, or 672,054

Italicized entries are reports that include results at lower exposures that did not result in significant findings and higher exposures that did result in significant findings.

events (KE) and key event relationships (KER) that link the
MIE to the AO. The OECD and US EPA actively support AOP
development. The OECD maintains a wiki-based interface for
developing AOP descriptions that issues formal descriptions
of well-defined AOPs (https://aopkb.oecd.org). The OECD site,
SciFinder and Google searches, and the review of the reports
summarized in this review failed to identify an AOP for Al for
any endpoint. Unlike organic molecules whose primary activities often result from interaction with specific receptors,
such as enzymes, the biological and toxicological effects of
an element are usually not limited to a single mechanism of
action. Al-induced reproductive dysfunction is likely to be
mediated by more than one MIE, as has been suggested
(Pandey and Jain 2013). The frequency, consistency, and direction of reported changes following Al exposure summarized in Table 6 show decreased SOD and CAT and increased
MDA in the testes, and decreased testosterone in the blood,
as discussed in section Assessment of Al reproductive toxicity
in male animals. These results were incorporated into an initial proposed AOP for Al-induced male reproductive toxicity
(Figure 1). The role of oxidative stress in Al-induced male
reproductive impairment is supported by the reversal of Alinduced increased oxidative stress reported by many studies

cited in Table 6, reflected in the report titles. In the spirit of
AOP development, researchers are encouraged to challenge,
and more importantly, scientifically address, the proposed AOP.

Conclusions
The inherent Al content of the diet, and very much less the
drinking water, represent appreciable contributors to total Al
exposure, as noted in 1932 (Mackenzie 1932). The lack of
documentation of dietary Al content in most studies creates
some uncertainty about total Al exposure, complicating
extrapolation of results from animal studies to the human.
Aluminum can produce reproductive toxicity in female and
male rodents. Studies that were GLP compliant and followed
an OECD Test Guideline in females, as well as numerous
other studies that utilized comparable Al exposures, reported
no significant effects following daily Al exposures that delivered up to 25-fold the typical equivalent human daily Al consumption. In contrast, numerous studies utilizing similar Al
exposure showed some significant effects, although more
often the studied endpoints were non-significant. Generally,
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Table 8. Al concentration in fetuses of mothers exposed to additional Al.
Additional maternal Al exposure
Maternal diet Al
concentration (mg/kg)

Al species and route

Approximate added total
systemic Al exposure (mg/kg)

Fetal Al concentration (lg/g) [as multiple of no
added Al]b

Reference

Mouse
Purina 5010 rodent feed

AlCl3 i.p.

400 from the diet from GD 7 to
16 assuming it contained
100 mg Al/kg
202,000
303,000

AlCl3 i.g.

808
1212

Panlab

Al(OH)3 i.g.

400 from the diet from GD 6 to
15 assuming it contained
100 mg Al/kg
1150

Al lactate i.g.

1150

Panlab

400 from the diet from GD 6 to
15 assuming it contained
100 mg Al/kg
2076

Al(OH)3 i.g.
UAR4 chow

800 from the diet over 20 days
assuming it contained 100 mg
Al/kg

AlCl3 topically

0.0090

Lab Blox

119 from the diet GDs 6, 9, 12,
15, and 18
160

0.59 (dry weight, whole fetus)

Cranmer et al. (1986)

2.0b (dry weight, whole fetus)
[3.4]
1.3b (dry weight, whole fetus)
[2.2]
1.1b (dry weight, whole fetus)
[1.9]
0.85b (dry weight, whole fetus)
[1.4]
< 0.05 (wet weight, whole fetus)
< 0.41 dry weight

Colomina
et al. (1992)

0.18 (wet weight, whole fetus)
1.5 (dry weight)
[3.5]
17 (wet weight, whole fetus)
142 (dry weight)
[344]
0.66 (wet weight, whole fetus)
5.5 (dry weight)

Colomina
et al. (1994)

0.88 (wet weight, whole fetus)
7.3 (dry weight)
[1.3]
0.040a brain
0.040 kidney
0.031 liver
0.029 lung
Assume wet weight
0.042b brain
[1.05]
0.042b kidney
[1.05]
0.036b liver
[1.16]
0.029 lung
[1.0]

Anane et al. (1997)

Rat
119
AlCl3 in the diet

319
Extra Labo food pellets
380 from the diet from GD 1 to
19 assuming it contained 100 mg
Al/kg

Al lactate in the diet

380 from the diet from GD 1 to
19 assuming it contained
100 mg Al/kg
15,200

N GPF81 de la societe INAAM 100 from the diet from GD 9 to
13 assuming it contained
100 mg Al/kg

AlCl3 i.p.

206,122

412,245

824,490

0.68 (dry weight, whole fetus)
0.74 (dry weight, whole fetus)
[1.09]
1.37 (dry weight, whole fetus)
[2.0]
0.023 (wet weight, whole fetus)
0.19 (dry weight)
0.066 (wet weight, whole fetus)
0.55 (dry weight)
[2.9]
1.00 lg/ml Plasma
0.25 Liver
0.3 Kidneys
0.20 Intestine
(dry weight)
0.98 lg/ml Plasma
[0.98]
0.23 Liver
[0.92]
0.47 Kidneys
[1.6]
0.19 Intestine
[0.95]
(dry weight)
0.97 lg/ml Plasma
[0.97]
0.82b Liver
[3.3]
0.92b Kidneys
[3.1]
0.90b Intestine
[4.5]
(dry weight)
1.06 lg/ml Plasma
[1.06]
1.5b Liver
[6]

McCormack
et al. (1979)

Muller et al. (1993)

Mestaghanmi
et al. (2003)

(continued)
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Table 8. Continued.
Additional maternal Al exposure
Maternal diet Al
concentration (mg/kg)

Al species and route

26
26

26

Approximate added total
systemic Al exposure (mg/kg)

AlCl3 s.c.
AlCl3 s.c.

48
48

AlCl3 s.c.

3.4

Fetal Al concentration (lg/g) [as multiple of no
added Al]b
1.8b Kidneys
[6]
1.4b Intestine
[7]
(dry weight)
0.21% of dose whole fetus
0.23% of dose whole fetus
0.00038% of dose in the brain
0.0038% of dose in the liver
0.0001% of dose/gm brain
0.0002% of dose in the brain
0.0005% of dose/gm kidney
0.0008% of dose/gm liver
0.0006% of dose in the liver
0.001% of dose/gm blood
0.013% of dose/gm bone

Reference

Yumoto et al. (2000)
Yumoto et al. (2001)

Yumoto et al. (2010)

Rabbit
Purina rabbit chow

2430 from the diet GD 2–6, 9–13,
16–20, and 23–27

Al lactate s.c.

2268

1215

9072

36,288

0.6 brain (hippocampus)
39 bone
2.1 heart
1.1 kidney
1.7 liver
1.0 lung
4.9 muscle
7.5 spleen
(dry weight)
1.1b brain (hippocampus)
[1.8]
60 bone
[1.5]
1.4 heart
[0.67]
2.4b kidney
[2.2]
0.6 liver
[0.35]
1.9 lung
[1.9]
4.2 muscle
[0.86]
17 spleen
[2.3]
(dry weight)
1.4b brain (hippocampus)
[2.3]
92b bone
[2.4]
2.1 heart
[1]
4.2b kidney
[3.8]
1.7 liver
[1]
1.6 lung
[1.6]
7.9b muscle
[1.6]
13 spleen
[1.7]
(dry weight)
3.6b brain (hippocampus)
[6]
169b bone
[4.3]
6.8b heart
[3.2]
20b kidney
[18]
16b liver
[9.4]
4.7b lung
[4.7]
15b muscle
[3.1]
37 spleen
[4.9]
(dry weight)

Yokel (1985)

The maternal diet Al concentration is from the cited report or based on the assumption that the diet contained 100 mg Al/kg, as described in the text. For studies reporting the fetal Al concentration on a wet weight basis, the concentration on a dry weight basis was calculated using fetal-age-dependent dry/wet
weight ratios (Davis 1989; Gardner et al. 1999).
a
Not known if reported as wet or dry weight.
b
Results that are statistically significantly different from controls.
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Table 9. Al concentration in placentas.
Additional maternal Al exposure
Maternal diet Al
concentration (mg/kg)
Mouse

Al species and route
Purina 5010 rodent feed

Panlab

400 from the diet from GD 7
to 16 assuming it
contained 100 mg Al/kg
202,000
303,000
808
1212
240 from the diet GD 6–15

Al(OH)3 i.g.

2076

Al(OH)3 with ascorbic acid i.g.

2076

Panlab

120 from the diet GD 6–15

Al(OH)3 i.g.

1329

AlCl3 i.p.
AlCl3 i.g.
60

Rat
60

Approximate added total
systemic Al exposure (mg/kg)

27.6a (dry weight) [10]
17.8a (dry weight) [6.6]
5.9a (dry weight) [2.2]
3.1 (dry weight) [1.1]
2.35 (wet weight)
14 (dry weight)
4.49a (wet weight)
28 (dry weight)
[1.9]
4.43a (wet weight)
28 (dry weight)
[1.9]

Panlab

120 from the diet GD 6–15

Al(OH)3 i.g.

2660

Al citrate i.g.

5320

Al(OH)3 with citric acid i.g.

5320

26

AlCl3 s.c. injection

48

26

AlCl3 s.c. injection

48

0.29% of dose

5315

Guinea pig
47

2.7 (dry weight)

1.92 (wet weight)
12 (dry weight)
2.51 (wet weight)
16 (dry weight)
[1.3]
1.60 (wet weight)
10 (dry weight)
[0.83]
1.71 (wet weight)
11 (dry weight)
[0.89]
3.19 (wet weight)
20 (dry weight)
3.02 (wet weight)
19 (dry weight)
[0.95]
9.24a (wet weight)
58 (dry weight)
[2.9]
5.08 (wet weight)
32 (dry weight)
[1.6]
0.2% of dose

2657

60

Placental concentration (lg/g) [as
multiple of no added Al]a

Purina Guinea Pig Chow 5025

Reference
Cranmer
et al. (1986)

Colomina
et al. (1994)

Gomez
et al. (1990)

Gomez
et al. (1991)

Yumoto
et al. (2000)
Yumoto
et al. (2001)

0.1, 0.09, and 0.13 on GD 30 and 45 and
PND 0

Golub et al. (1996)

1.51
0.56
0.53
0.88

Ward et al. (1987)
Kruger
et al. (2010)
Pi et al. (2019)

Human
(dry
(dry
(dry
(dry

weight)
weight, placental body)
weight, placental membrane)
weight)

The maternal diet Al concentration is from the cited report or based on the assumption that the diet contained 100 mg Al/kg, as described in the text. When
reported, it enabled the approximate total systemic exposure, calculated as described in the text, and for studies citied in Tables 3 and 4. For studies reporting
the placental Al concentration on a wet weight basis, the concentration on a dry weight basis was calculated using a placenta dry/wet weight ratio of 0.16,
based on (Husain et al. 2001).
a
Results that are statistically significantly different from controls.

the additional daily Al systemic exposure of studies that
reported statistically significant results in females was greater
than 100-fold above the typical human daily Al consumption
equivalent. Three studies that were GLP compliant and followed an OECD Test Guideline studied both females and
males, delivering similar or lower Al exposures to the males.
In contrast to the lack of significant toxicity in females, significant toxicity was seen after the highest exposure in males
in two of the studies. Many other studies found significant

effects after exposures comparable to the highest exposure
in males in two of the studies, suggesting male rodents are
more susceptible to Al-induced reproductive toxicity than
females. Increased Al intake increases fetus, placenta, and testes Al concentration, to a greater extent in the placenta than
fetus, and perhaps to a greater extent in the testes than placenta. One human study showing reduction in normal and
mobile sperm and positive correlations between high spermatozoa Al concentration and decreased sperm motility and
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Table 10. Al concentration in male reproductive organs and fluids.
Additional Al exposure
Diet Al concentration (mg/kg)
Testes mouse

Al species and route
Panlab
Al(NO3)39H2O i.p.

370

Purina 5001 rodent chow
AlCl3 i.p.

370

Purina 5001 rodent chow
AlCl3 i.p.

370

Purina 5001 rodent chow
AlCl3 i.p.

370

Assume Purina 5001
rodent chow
AlCl3 i.p.
Purina 5001 rodent chow
AlCl3 s.c.

370

Purina 5001 rodent chow
AlCl3 s.c.
Purina 5001 rodent chow
AlCl3 s.c.
370

Purina 5001 rodent chow
AlCl3 s.c.

370

Purina 5001 rodent chow
AlCl3 i.p.

AlCl3 i.g.
Testes rat
170
27.9

Larsen diet
Al sulfate in the diet
AIN-76 diet

Panlab
Al(NO3)39H2O
with citric acid i.g.
Panlab
Al(NO3)39H2O with citric
acid i.g.
Panlab
Al(NO3)39H2O with citric
acid i.g.

AlCl3 i.g.

Approximate added total
systemic Al exposure (mg/kg)
800 from the diet over 20
days assuming it contained
100 mg Al/kg
72,000
144,000
288,000
1776 over 12 days
156,000
208,000
2368 over 16 days
420,000
560,000
2072 over 14 days
98,000
490,000
1776 over 12 days
420,000
2072 over 14 days
20,580
38,220
2072 over 14 days
20,580
38,220
2072 over 14 days
20,580
38,220
2072 over 14 days
20,580
102,900
2072 over 14 days
98,000
490,000
1200 from the diet over 30
days assuming it contained
100 mg Al/kg
303
606
1212

Al concentration (lg/g) [as multiple of
no added Al]a
0.10 (wet weight)
0.92a (wet weight) [9.2]
1.19a (wet weight) [12]
1.47a (wet weight) [15]
5.1c
77a 1 day after injections [15]
141a 1 day after injections [28]
5.7
32a 15 days after injections [5.6]
59a 15 days after injections [10]
5c
62a [12]
120 [24]
5c
133a [27]
5c 3 weeks later
22a 3 weeks later [4.4]
35a 3 weeks later [7]
5 5 weeks later
20a 5 weeks later [4]
28a 5 weeks later [5.6]
5 11 weeks later
8a 11 weeks later [1.6]
11a 11 weeks later [2.2]
7.7c
40a [5.2]
130a [17]
5.1c
37a [7.2]
120a [24]
0.55 (wet weight)

Reference
Llobet
et al. (1995)

Guo et al. (2001)

Guo et al. (2002)
Guo et al. (2005a)
Guo et al. (2005b)

Guo et al. (2006)
Guo et al. (2009)
Kumar and
Singh (2016)

0.90 (wet weight) [1.6]
1.1 (wet weight) [2]
2.4a (wet weight) [4.4]

952 from the diet for 28 days
15876 from the diet for
28 days
11 daily

1.7 (wet weight)
[2.8]

Ondreicka
et al. (1966)

0.61 (wet weight)

560 from the diet over 28
days assuming it contained
100 mg Al/kg
300,000 as one injection
280,000 as 28 injections
3690 from the diet over 6.5
months assuming it
contained 100 mg Al/kg
39600
79200
3690 from the diet over 6.5
months assuming it
contained 100 mg Al/kg
39600
79200
3690 from the diet over 6.5
months assuming it
contained 100 mg Al/kg
39600
79200
3650 from the diet over 6
months assuming it
contained 100 mg Al/kg
7373 over 6 months
14,746 over 6 months

1 (dry weight)

Que Hee and
Boyle (1988)
Julka et al. (1996)

198a (dry weight) [198]
126a (dry weight) [126]
< 0.001 (wet weight) 3-weeks old

Gomez
et al. (1997)

0.41a (wet weight) 3-weeks old [410]
0.58a (wet weight) 3-weeks old [580]
0.99 (wet weight) 8-months old
0.82a (wet weight) 8-months old [0.83]
0.85a (wet weight) 8-months old [0.86]
0.42 (wet weight) 16-months old
0.51 16-months old [1.2]
4.2a 16-months old [10]
0.015b,c

Hichem
et al. (2013)

0.016 [1.1]
0.021 [1.4]
(continued)
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Table 10. Continued.
Additional Al exposure
Diet Al concentration (mg/kg)

Al species and route

AlCl3 i.g.

AlCl3 i.g.

AlCl3 i.g.

AlCl36H2O i.g.

Al2(SO4)3 i.g.

AlCl36H2O i.g.

AlCl36H2O i.g.

Approximate added total
systemic Al exposure (mg/kg)
22,119 over 6 months
7300 from the diet over 12
months assuming it
contained 100 mg Al/kg
14,746 over 12 months
29,492 over 12 months
44,238 over 12 months
10,950 from the diet over 18
months assuming it
contained 100 mg Al/kg
29,492 over 18 months
58,984 over 18 months
88,476 over 18 months
2400 from the diet over 120
days assuming it contained
100 mg Al/kg
3103
6205
12,459
1400 from the diet over 10
weeks assuming it
contained 100 mg Al/kg
547
900 from the diet over 45
days assuming it contained
100 mg Al/kg
711
600 from the diet over 30
days assuming it contained
100 mg Al/kg
518
1200 from the diet over 60
days assuming it contained
100 mg Al/kg
996

Al concentration (lg/g) [as multiple of
no added Al]a
a
0.026 [1.7]
0.011 [0.73]

Reference

0.018a [1.2]
0.029a [1.9]
0.031a [2.1]
0.028
0.043a [1.5]
0.085a [3.0]
0.03 [1.1]
6.6
8.8 [1.3]
13.5a [2.0]
19.5a [3.0]
13.7 (wet weight)
37.9 (wet weight) [2.8]
0.18d (wet weight)
1.2a (wet weight) [6.7]
2.9e (wet weight)
6.1e (wet weight) [2.1]
1.79 (dry weight)

Zhu et al. (2014)

Mohammad
et al. (2015)
Rawi and Al
Nassr (2015)
Akay et al. (2016)

Martinez
et al. (2017)

3.35a (dry weight) [1.9]

Testes rabbit
Purina rabbit chow
Al chloride s.c.
Wayne rabbit food
Al chloride s.c.
Purina rabbit chow
Al lactate i.v. once
Al lactate 20 i.v. injections
Al citrate 20 i.v. injections

2440 from the diet over
20 days
68,000
15 from the diet over 28 days
14,818
122 daily
5400
54,000
54,000

0.3 (dry weight)
19a (dry weight) [63]
0.12 (wet weight)
1.8a (wet weight) [15]
3.9 (dry weight)
No significant change
39
4.0

Melograna and
Yokel (1984)
Du Val
et al. (1986)
Yokel and
McNamara (1989)
Yokel et al. (1996)

Testes human
4.2

c

Yamamoto
et al. (1959)

3.6

c

Yamamoto
et al. (1959)

Prostate human
Epididymis mouse
370

Purina 5001 rodent chow
AlCl3 i.p.

2072 from the diet over
14 days
20,580
102,900

12

c

Guo et al. (2006)

25 [2.1]
52a [4.3]

Epididymis rat

AlCl36H2O i.g.

1200 from the diet over 60
days assuming it contained
100 mg Al/kg
996

6.4 (dry weight)

Martinez
et al. (2017)

6.1 (dry weight) [0.95]

Epididymis human
5.0c

Yamamoto
et al. (1959)

2.5c

Yamamoto
et al. (1959)

3.3c

Yamamoto
et al. (1959)
Dawson
et al. (1998)
(continued)

Seminal vesicle human
Seminal fluid human
Apparently healthy 21- to 35-year olds

18 lg/L > 50% sperm viability
59 lg/L 25–50% sperm viability
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Table 10. Continued.
Additional Al exposure
Diet Al concentration (mg/kg)

Al species and route

Approximate added total
systemic Al exposure (mg/kg)

Al concentration (lg/g) [as multiple of
no added Al]a
101 lg/L < 25% sperm viability
0.87 sperm donor candidates
0.54 refinery and polyolefin
factory employees
460 lg/L medical center (control) work
environment
2200 lg/L metal ore smelter work
environment
1530 lg/L petroleum refinery work
environment
270 lg/L chemical plant work
environment
299 lg/L normal semen
385 lg/L semen with pathology

Reference
Hovatta
et al. (1998)
Dawson
et al. (2000)

Klein et al. (2014)

Spermatozoa human
2.52 sperm donor candidates
0.93a refinery and polyolefin
factory employees

Hovatta
et al. (1998)

A dry/wet weight ratio for rat testis of 0.78 was used (Takhtfooladi et al. 2015).
Results that are statistically significantly different from controls.
b
Unknown units.
c
Not known if reported as wet or (dry weight).
d
Reported as mg/g; assumed to be lg/g.
e
Reported as ng/g; assumed to be lg/g.
a

normal morphology suggest the rodent studies are predictive
of human outcomes.

Recommendations
Studies to further define the potential for Al to produce
reproductive toxicity in animals should include the following
design parameters. Female exposure should be long-term, at
least starting from sexual maturity and preferably from weaning. Male exposure duration should be at least as long as the
time course of spermatogenesis. Studies should utilize a diet
containing a known Al concentration that is comparable to
that consumed by humans. An exposure route of known Al
bioavailability, probably oral to be relevant to the human,
should be used. An Al species that is human relevant should
be used. An example might be a diet to which FDA-approved
food additives have been added at known concentrations.
Given the most sensitive endpoint to Al-induced toxicity in
the pregnant female rodent was resorption; in the fetus,
death; and in males, sperm number, sperm SOD, and abnormal sperm, these endpoints should be included in the study.
Studies verifying the contribution of oxidative stress, and/or
other molecular initiating events, and the key event relationships, mediating Al-induced reproductive toxicity are needed
to advance understanding of the AOP proposed here.
Due to concerns about potential Al toxicity, controlledexposure human studies, particularly including high exposure, create ethical concerns (Molloy et al. 2007). However,
there are humans exposed to higher Al intake than most
people who could serve as epidemiological study subjects.
Aluminum welding results in release of airborne Al, higher
exposure, and persistent elevated Al body burden (Elinder
et al. 1991). Dietary studies have identified some foods high
in Al, particularly those containing Al as a food additive, such

as baked goods including Chinese fried bread and salted
jellyfish, that could identify highly exposed subjects worth
studying. Large volume, prolonged, consumption of Al-containing antacids/phosphate binders presents another study
opportunity. For reasons noted above, those with prolonged,
high, Al exposure are of greatest potential value in
future studies.

Notes
1.

2.

3.

Benett et al. (1975), Dixon et al. (1979), McCormack et al. (1979), Katz
et al. (1984), Wide (1984), Cranmer et al. (1986), Hicks et al. (1987),
Bernuzzi et al. (1989), Muller et al. (1990), Roy et al. (1991), Misawa
and Shigeta (1992), Muller et al. (1993), Agarwal et al. (1996), Gonda
et al. (1996), Gonda and Lehotzky (1996), Gonda et al. (1997), Albina
et al. (1999), Guo et al. (2005b, 2006287), Beekhuijzen (2007), Wise
et al. (2008), Guo et al. (2009), Hala et al. (2010), Wise et al. (2010),
Segal et al. (2011), Abu-Taweel et al. (2012), Ighodaro et al. (2012),
Yadav et al. (2013), D’Souza et al. (2014), Kalaiselvi et al. (2014),
Ramalingam et al. (2014), Akinola et al. (2016), Falana et al. (2017),
Miska-Schramm et al. (2017), Inohana et al. (2018), Mouro et al.
(2018), and Gomes et al. (2019).
For the calculation of the approximate systemic Al exposure from
rabbit diet consumption of 5% of body weight daily was assumed
http://agritech.tnau.ac.in/animal_husbandry/animhus_rabbit%20feeding.html,
https://www.purinamills.com/rabbit-food/products/detail/
purina-fibre3-rabbit-feed. Daily water intake for guinea pigs was
assumed to be 0.15 l/kg. When necessary to estimate Sprague
Dawley rat body weight, Taconic Biosciences I. (2020)_. Sprague
R Outbred. was used.
DawleyV
Asterisks indicate data obtained from the abstract. The full report
was not obtained.
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C, Miguel M, Wiggers GA. 2017. Aluminum exposure for 60 days at
human dietary levels impairs spermatogenesis and sperm quality in
rats. Reprod Toxicol. 73:128–141.
Marwa M, Adrian F, Nedra B, Samira M, Horea M, Walid-Habib T, Baati R,
Leila T. 2017. The role of lysosomes in the phenomenon of concentration of aluminum and indium in the female reproductive system. An
ultrastructural study. J Trace Elem Med Biol. 44:59–64.
Mayyas I, Elbetieha A, Khamas W, Khamas A. 2005. Evaluation of reproductive and fertility toxic potentials of aluminium chloride on adult
male mice. J Anim Vet Adv. 4:224–233.
McCollum EV, Rask OS, Becker JE. 1928. A study of the possible role of
aluminum compounds in animal and plant physiology. J Biol Chem.
77(2):753–768.
McCormack K, Ottosen L, Sanger V, Sprague S, Mayor G, Hook J. 1979.
Effect of prenatal administration of aluminum and parathyroid hormone on fetal development in the rat. Proc Soc Exp Biol Med. 161(1):
74–77.
Melograna JM, Yokel RA. 1984. Effects of subchronic desferrioxamine
infusion on aluminum toxicity in rabbits. Res Commun Chem Pathol
Pharmacol. 44(3):411–422.
Mestaghanmi H, El Amrani S, Dauça M, Saile R. 2003. Effects of aluminum
chloride on pregnant rats and their offspring. STAL, Sci Tech Anim
Lab. 28(1):43–51.
Misawa T, Shigeta S. 1992. Behavioral effects of repeated aluminum
administation in the rat. Tokai J Exp Clin Med. 17:155–159.
Misawa T, Shigeta S. 1993. Effects of prenatal aluminum treatment on
development and behavior in the rat. J Toxicol Sci. 18(1):43–48.
Miska-Schramm A, Kapusta J, Kruczek M. 2017. The effect of aluminum
exposure on reproductive ability in the bank vole (Myodes glareolus).
Biol Trace Elem Res. 177(1):97–106.
Mohamed NE-S, El-Moneim AEA. 2017. Ginkgo biloba extract alleviates
oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats. Nutrition ( NY, US). 35:93–99.
Mohammad NS, Arafa MH, Atteia HH. 2015. Coenzyme Q10 and fish oil
synergistically alleviate aluminum chloride-induced suppression of testicular steroidogenesis and antioxidant defense. Free Radic Res.
49(11):1319–1334.
Mohammed AM, Al-Kaisei BI, Humadai TJ, Al-Taee EH. 2018. Effect of
chronic aluminum chloride toxicity on sperm and reproductive
markers in albino mice. Int J Biosci. 13(5):103–112.
Mohammed A, Mayyas I, Elbetieha A, Shoter A, Khamas W, Elnasser Z.
2008. Toxicity evaluation of aluminum chloride on adult female mice.
J Anim Vet Adv. 7(5):552–556.
Molloy DW, Standish TI, Nieboer E, Turnbull JD, Smith SD, Dubois S.
2007. Effects of acute exposure to aluminum on cognition in humans.
J Toxicol Environ Health Part A. 70(23):2011–2019.
Moselhy WA, Helmy NA, Abdel-Halim BR, Nabil TM, Abdel-Hamid MI.
2012. Role of ginger against the reproductive toxicity of aluminium
chloride in albino male rats. Reprod Domest Anim. 47(2):335–343.
Mouro VGS, Menezes TP, Lima GDA, Domingues RR, Souza ACF, Oliveira
JA, Matta SLP, Machado-Neves M. 2018. How bad is aluminum exposure to reproductive parameters in rats?. Biol Trace Elem Res. 183(2):
314–324.
Muller G, Bernuzzi V, Desor D, Hutin M-F, Burnel D, Lehr PR. 1990.
Developmental alterations in offspring of female rats orally intoxicated

41

by aluminum lactate at different gestation periods. Teratology. 42(3):
253–261.
Muller G, Burnel D, Gery A, Lehr PR. 1993. Element variations in pregnant
and nonpregnant female rats orally intoxicated by aluminum lactate.
Biol Trace Elem Res. 39(2–3):211–219.
Muselin F, Cristina RT, Igna V, Dumitrescu E, Brezovan D, Trif A. 2016.
The consequences of aluminium intake on reproductive function in
male rats: a three-generation study. Turk J Med Sci. 46(4):1240–1248.
Myers VC, Mull JW. 1928. The influence of the administration of aluminum upon the aluminum content of the tissues, and upon the growth
and reproduction of rats. J Biol Chem. 78:605–613.
Ng TB, Liu WK. 1990. Toxic effect of heavy metals on cells isolated from
the rat adrenal and testis. In Vitro Cell Dev Biol. 26(1):24–28.
Nieboer E, Gibson BL, Oxman AD, Kramer JR. 1995. Health effects of aluminum: a critical review with emphasis on aluminum in drinking
water. Environ Rev. 3(1):29–81.
Nolen GA, Dierckman TA. 1983. Test for aluminosilicate teratogenicity in
rats. Food Chem Toxicol. 21(5):697.
Oda SS. 2016. The influence of Omega3 fatty acids supplementation
against aluminum-induced toxicity in male albino rats. Environ Sci
Pollut Res Int. 23(14):14354–14361.
Olawuyi TS, Olotu EJ, Paul CW, Olorunfemi OJ, Aina OS. 2017.
Cytoprotective effect of Lawsonia inermis leave extract in aluminiuminduced oxidative stress on sex hormones profile in adult male Wistar
rat. Eur J Biomed Pharm Sci. 4(4):48–56.
Olawuyi TS, Ukwenya VO, Akinola KB, Jimoh AGA. 2019.
Histomorphometric evaluation of seminiferous tubules and stereological assessment of germ cells in testes following administration of
aqueous leaf-extract of Lawsonia inermis on aluminium-induced oxidative stress in adult Wistar rats. JBRA Assist Reprod. 23(1):24–32.
Ondreicka R, Ginter E, Kortus J. 1966. Chronic toxicity of aluminium in
rats and mice and its effects on phosphorus metabolism. Br J Ind
Med. 23(4):305–312.
Oneda S, Takasaki T, Kuriwaki K, Ohi Y, Umekita Y, Hatanaka S, Fujiyoshi
T, Yoshida A, Yoshida H. 1994. Chronic toxicity and tumorigenicity
study of aluminum potassium sulfate in B6C3F1 mice. In Vivo. 8(3):
271–277.
Oteiza PI, Keen CL, Han B, Golub MS. 1993. Aluminum accumulation and
neurotoxicity in Swiss-Webster mice after long-term dietary exposure
to aluminum and citrate. Metabolism. 42(10):1296–1300.
Ovayolu A, Yuce T, Ozek MA, Ovayolu G, Karaman E, Turksoy VA. 2019.
Amniotic fluid levels of selected trace elements and heavy metals in
pregnancies complicated with neural tube defects. Congenit Anom.
https://doi.org/10.1111/cga.12363
Owen LM, Crews HM, Bishop NJ, Massey RC. 1994. Aluminium uptake
from some foods by guinea pigs and the characterization of aluminium in in vivo intestinal digesta by SEC-ICP-MS . Food Chem Toxicol.
32(8):697–705.
Pandey G, Jain GC. 2013. A review on toxic effects of aluminium exposure on male reproductive system and probable mechanisms of toxicity. Int J Toxicol Appl Phrarmacol. 3(3):48–57.
Paternain JL, Domingo JL, Llobet JM, Corbella J. 1988. Embryotoxic and
teratogenic effects of aluminum nitrate in rats upon oral administration. Teratology. 38(3):253–237.
Pedersen T, Peters H. 1968. Proposal for a classification of oocytes and
follicles in the mouse ovary. J Reprod Fertil. 17(3):555–557.
Pettersen JC, Hackett DS, Zwicker GM, Sprague GL. 1990. Twenty-six
R (basic sodium aluminum phosphate)
week toxicity study with KASALV
in beagle dogs. Environ Geochem Health. 12(1–2):121–123.
Pi X, Jin L, Li Z, Liu J, Zhang Y, Wang L, Ren A. 2019. Association
between concentrations of barium and aluminum in placental tissues
and risk for orofacial clefts. Sci Total Environ. 652:406–412.
Poirier J, Semple H, Davies J, Lapointe R, Dziwenka M, Hiltz M, Mujibi D.
2011. Double-blind, vehicle-controlled randomized twelve-month neurodevelopmental toxicity study of common aluminum salts in the rat.
Neuroscience (Amsterdam, Netherlands). 193:338–362.
Priest ND. 1993. The bioavailability and metabolism of aluminium compounds in man. Proc Nutr Soc. 52(1):231–240.

42

R. A. YOKEL

Priest ND, Newton D, Day JP, Talbot RJ, Warner AJ. 1995. Human metabolism of aluminium-26 and gallium-67 injected as citrates. Hum Exp
Toxicol. 14(3):287–293.
Priest ND, Talbot RJ, Newton D, Day JP, King SJ, Fifield LK. 1998. Uptake
by man of aluminium in a public water supply. Hum Exp Toxicol.
17(6):296–301.
Provan SD, Yokel RA. 1990. Reduced intestinal calcium and dietary calcium intake, increased aluminum absorption, and tissue concentration
in the rat. Biol Trace Elem Res. 23(1):119–132.
Hee SS, Boyle JR. 1988. Simultaneous multielemental analysis of some
environmental and biological samples by inductively coupled plasma
atomic emission spectrometry. Anal Chem. 60(10):1033–1042.
Rahbar M, Samms-Vaughan M, Dickerson A, Hessabi M, Bressler J, Desai
C, Shakespeare-Pellington S, Reece J-A, Morgan R, Loveland K, et al.
2015. Concentration of lead, mercury, cadmium, aluminum, arsenic
and manganese in umbilical cord blood of Jamaican newborns.
IJERPH. 12(5):4481–4501.
Ramalingam V, Kalaiselvi A, Suganthy OM. 2014. Study of plasma membrane enzymes in the testis and epididymis of aluminium induced
rats. World J Pharm Res. 3(1):561–570.
Rankin J, Manning A. 1993. Alterations to the pattern of ultrasonic calling
after prenatal exposure to aluminium sulfate. Behav Neural Biol. 59(2):
136–142.
Rawi SM, Al Nassr FMS. 2015. Zinc sulphate and vitamin E alleviate reproductive toxicity caused by aluminium sulphate in male albino rats.
Toxicol Ind Health. 31(3):221–234.
Reiber S, Kukull W, Standish-Lee P. 1995. Drinking water aluminum and
bioavailability. J AWWA (American Water Works Association). 87(5):
86–100.
Reusche E, Lindner B, Arnholdt H. 1994. Widespread aluminium deposition in extracerebral organ systems of patients with dialysis-associated encephalopathy. Virchows Arch. 424(1):105–112.
Reza SM, Palan MJ. 2006. Effect of aluminum on testosterone hormones
in male rat. J Med Sci. 6(2):296–299.
Roy AK, Talukder G, Sharma A. 1991. Similar effects in vivo of two aluminum salts on the liver, kidney, bone, and brain of Rattus norvegicus.
Bull Environ Contam Toxicol. 47(2):288–295.
Sajjad S, Saeed L, Malik H, Farooq U, Akhtar S. 2020. Ethanolic extract of
propolis and vitamin E attenuates metal-induced testicular necrosis:
time-related study on male reproductive system in albino mice. Eur
Zool J. 87(1):138–147.
Sakr SA, El-Mesady FA, Hashem AM. 2017. Aluminum induced reproductive dysfunction in male rats: the ameliorative effect of Saffron extract.
Int J Pharm Pharm Res. 10(3):180–195.
Schaeffer G, Fontes G. 1928. Aluminum baking powders. Bull Soc Sci Hyg
Aliment Aliment Ration. 16(1–24):49–79.
Scialli AR. 2008. The challenge of reproductive and developmental toxicology under REACH. Regul Toxicol Pharmacol. 51(2):244–250.
Segal L, Wilby OK, Willoughby CR, Veenstra S, Deschamps M. 2011.
Evaluation of the intramuscular administration of CervarixTM vaccine
on fertility, pre- and post-natal development in rats. Reprod Toxicol.
31(1):111–120.
Senbel AM, Saad EI, Taha SS, Mohamed HF. 2016. Different mechanisms
for lead acetate, aluminum and cadmium sulfate in rat corpus cavernosum. Toxicology. 340:27–33.
Shahraki MR, Mony EYP, Asl SZ, Sarkaki AR, Shahraki AR. 2008. Effects of
aluminum chloride injection in lateral ventricle on serum gonadothropines, testosterone and spermatogenesis in rats. J Med Sci. 8(4):
410–414.
Shen W, Ji Q, Li C, Chen Y, Bi C, Zhang X. 1999. Effect of aluminum on
meiotic maturation of mouse oocyte in vitro. Weisheng Yanjiu (J
Hygiene Res). 28(5):267–268.
Singh HP, Singh CK, Singh RR. 1998. Effect of potash alum (aluminium
potassium sulphate) on human semen and sperm. Indian J Physiol
Pharmacol. 42(2):311–314.
Stauber JL, Florence TM, Davies CM, Adams MS, Buchanan SJ. 1999.
Bioavailability of Al in alum-treated drinking water. J AWWA
(American Water Works Association). 91(11):84–93.
Stitch SR. 1957. Trace elements in human tissue. 1. A semi-quantitative
spectrographic survey . Biochem J. 67(1):97–109.

ski P,
Suliburska J, Kocyłowski R, Komorowicz I, Grzesiak M, Bogdan
Barałkiewicz D. 2016. Concentrations of mineral in amniotic fluid and
their relations to selected maternal and fetal parameters. Biol Trace
Elem Res. 172(1):37–45.
Sun H, Hu C, Jia L, Zhu Y, Zhao H, Shao B, Wang N, Zhang Z, Li Y. 2011.
Effects of aluminum exposure on serum sex hormones and androgen
receptor expression in male rats. Biol Trace Elem Res. 144(1–3):
1050–1058.
Sun X, Sun H, Yu K, Wang Z, Liu Y, Liu K, Zhu Y, Li Y. 2018. Aluminum
chloride causes the dysfunction of testes through inhibiting the
ATPase enzyme activities and gonadotropin receptor expression in
rats. Biol Trace Elem Res. 183(2):296–304.
Sushma NJ, Rao KJ. 2007. Total ATPases activity in different tissues of
albino mice exposed to aluminum acetate. J Environ Biol. 28 (2
Suppl):483–484.
Sutherland JE, Greger JL. 1998. Effect of the size of an oral dose of aluminium on the relative importance of biliary v. urinary aluminium
excretion in conscious rats. Food Chem Toxicol. 36(6):505–512.
Sutherland JE, Radzanowski GM, Greger JL. 1996. Bile is an important
route of elimination of ingested aluminum by conscious male
Sprague-Dawley rats. Toxicology. 109(2–3):101–109.
Suzuki K, Twardowski ZJ, Nolph KD, Khanna R, Moore HL. 1995.
Absorption of iron dextran from the peritoneal cavity of rats. Adv
Perit Dial. 11:57–59.
R Outbred. https://www.
Taconic Biosciences I. 2020. Sprague DawleyV
taconic.com/rat-model/sprague-dawley (visited 7/22/2020).
Takacs S, Tatar A, Barkai L. 1992. Trace elements in the human blood,
cerebrospinal and amniotic fluid. Int J Hyg Environ Med. 193(4):
329–341.
Takahashi S, Takahashi I, Sato H, Kubota Y, Yoshida S, Muramatsu Y.
2001. Age-related changes in the concentrations of major and trace
elements in the brain of rats and mice. Biol Trace Elem Res. 80(2):
145–158.
Takhtfooladi MA, Asghari A, Takhtfooladi HA, Shabani S. 2015. The protective role of curcumin on testicular tissue after hindlimb ischemia
reperfusion in rats. Int Urol Nephrol. 47(10):1605–1610.
Tariq M. 1993. A review of reproductive toxicity of aluminum. In:
Richardson M, editor. Reprod Toxicol. Weinheim, Germany: VCH; p.
245–261.
TERA. Rat/mouse default values. https://www.taconic.com/rat-model/
sprague-dawley (visited 7/21/20).
Thirunavukkarasu SV, Venkataraman S, Upadhyay L. 2010. Effect of aluminium chloride on testicular function under the influence of
Manasamitra
Vatakam
an
indigenous
drug
formulation.
Pharmacologyonline. 1:236–242.
Tiroumavalavane M, Ramalingam V, Muthuviveganandavel V. 2013. Effect
of aluminium chloride on testicular marker enzyme in rat and the
effect of vitamin-E. Am J PharmTech Res. 3:283–289.
Trif A, Dumitrescu E, Brezovan D, Petrovici S. 2010. The consequences of
aluminum sulphate intake on exposure and integrity biomarkers in
female rats at sexual maturity (two generation study). Hum Vet Med.
2(1):11–18.
Trif A, Igna V, Dumitrescu E. 2008. The consequences of chronic exposure
to aluminum sulphate on fundamental markers of the reproductive
function in female rats. Bull Univ Agric Sci Vet Med Cluj-Napoca, Vet
Med. 65(1):457–461.
Trif A, Muselin F, Argherie D, Dumitrescu E, Macinic I. 2007. The consequences of chronic exposure to aluminium on some morphological
biomarkers of reproductive function (body, genital organs, sexual
accessory glands weight, seminiferous tubules diameter) in male rats.
Lucrari Stiinłifice Medicina Veterinara. 11:652–658.
Ugbaja RN, Olaniyan TO, Afolabi OK, Dosumu OA, Akinloye DI, Mufuatu
AO, Nwa-John, OP. 2015. Vitamins C and E attenuate lipid dystrophy
in tissues of rats administered aluminium. Biokemistri. 27(2):98–105.
Wang N, She Y, Zhu Y, Zhao H, Shao B, Sun H, Hu C, Li Y. 2012. Effects
of subchronic aluminum exposure on the reproductive function in
female rats. Biol Trace Elem Res. 145(3):382–387.
Ward NI, MacMahon TD, Mason JA. 1987. Elemental analysis of human
placenta by neutron irradiation and gamma-ray spectrometry

CRITICAL REVIEWS IN TOXICOLOGY

(standard, prompt and fast-neutron). J Radioanal Nucl Chem Articles.
113(2):501–514.
€en T, Oduro JD, Wangorsch G, Hanschmann K-MO, KellerWeisser K, Go
Stanislawski B. 2019. Aluminium toxicokinetics after intramuscular,
subcutaneous, and intravenous injection of Al citrate solution in rats.
Arch Toxicol. 93(1):37–47.
Weisser K, St€
ubler S, Matheis W, Huisinga W. 2017. Towards toxicokinetic
modelling of aluminium exposure from adjuvants in medicinal products. Regul Toxicol Pharmacol. 88:310–321.
WHO. 2012. Global Advisory Committee on Vaccine Safety, June 2012.
Wkly Epidemiol Rec. 87:281–287.
Wide M. 1984. Effect of short-term exposure to five industrial metals on
the embryonic and fetal development of the mouse. Environ Res.
33(1):47–53.
Wilhelm M, Zhang XJ, Hafner D, Ohnesorge FK. 1992. Single-dose toxicokinetics of aluminum in the rat. Arch Toxicol. 66(10):700–705.
Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM,
Arnold IMF, Momoli F, Krewski D. 2014. Systematic review of potential
health risks posed by pharmaceutical, occupational and consumer
exposures to metallic and nanoscale aluminum, aluminum oxide, aluminum hydroxide and its soluble salts. Crit Rev Toxicol S4. 44(Suppl
4):1–80.
Wise LD, Pauley CJ, Michael B, Wolf JJ. 2010. Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth
Defects Res B Dev Reprod Toxicol. 89(5):376–381.
Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ. 2008. Lack of
effects on fertility and developmental toxicity of a quadrivalent HPV
vaccine in Sprague-Dawley rats. Birth Defects Res B Dev Reprod
Toxicol. 83(6):561–572.
Wise LD, Wolf JJ, Plitnick LM. 2018. Evaluation of a 9-valent HPV vaccine
in Sprague-Dawley rats: nonclinical studies assessing general, reproductive, and developmental toxicity. Vaccine. 36(43):6401–6407.
Wolterbeek APM, Roberts A, Korte H, Unkila M, Waalkens-Berendsen DH.
2004. Prenatal developmental toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats. Regul Toxicol Pharmacol.
40(1):1–8.
Wu X, Li J, Hu J-N, Deng Z-Y. 2012. The effects of glutamate and citrate
on absorption and distribution of aluminum in rats. Biol Trace Elem
Res. 148(1):83–90.
Yadav A, Sharma S, Sharma S, Pandey A, Yadav N, Ravi K, Sharma KP.
2013. Effects of subacute and subchronic aluminum exposure on mice
sperms and their recovery via spirulina. Indian J Environ Sci. 17(2):
161–169.
Yamamoto T, Watsuji T, Ishikawa M, Harina Y, Yabuki T. 1959. Zinc, copper, and aluminum contents of various human organs, especially of
the male genital organs. Kobe Ika Daigaku Kiyo (Bull Kobe Med
College). 16(2):185–190.
Yokel RA. 1985. Toxicity of gestational aluminum exposure to the maternal rabbit and offspring. Toxicol Appl Pharmacol. 79(1):121–133.
Yokel RA. 2013. Aluminum. In: Benjamin Caballero E-i-C, editor.
Encyclopedia of human nutrition. 3rd ed. Waltham (MA): Academic
Press; p. 57–63.
Yokel RA, Florence RL. 2006. Aluminum bioavailability from the approved
food additive leavening agent acidic sodium aluminum phosphate,
incorporated into a baked good, is lower than from water. Toxicology.
227(1–2):86–93.
Yokel RA, Hicks CL, Florence RL. 2008. Aluminum bioavailability from
basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese. Food Chem Toxicol. 46(6):
2261–2266.
Yokel RA, McNamara PJ. 1985. Aluminum bioavailability and disposition
in adult and immature rabbits. Toxicol Appl Pharmacol. 77(2):344–352.
Yokel RA, McNamara PJ. 1988. Influence of renal impairment, chemical
form, and serum protein binding on intravenous and oral aluminum
kinetics in the rabbit. Toxicol Appl Pharmacol. 95(1):32–43.

43

Yokel RA, McNamara PJ. 1989. Elevated aluminum persists in serum and
tissues of rabbits after a six-hour infusion. Toxicol Appl Pharmacol.
99(1):133–138.
Yokel RA, McNamara PJ. 1990. The influence of dietary calcium reduction
on aluminum absorption and kinetics in the rabbit. Biol Trace Elem
Res. 23:109–117.
Yokel RA, McNamara PJ. 2001. Aluminum toxicokinetics: an updated
mini-review. Pharmacol Toxicol. 88(4):159–167.
Yokel RA, Meurer KA, Skinner TL, Fredenburg AM. 1996. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of
aluminum intoxication than does desferrioxamine. Drug Metab
Dispos. 24:105–111.
Yokel RA, Rhineheimer SS, Brauer RD, Sharma P, Elmore D, McNamara PJ.
2001. Aluminum bioavailability from drinking water is very low and is
not appreciably influenced by stomach contents or water hardness.
Toxicology. 161(1–2):93–101.
Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ. 2001.
Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure . Toxicol Sci. 64(1):77–82.
Yousef MI. 2004. Aluminum-induced changes in hematobiochemical
parameters, lipid peroxidation and enzyme activities of male rabbits:
protective role of ascorbic acid. Toxicology. 199(1):47–57.
Yousef MI, El-Morsy AMA, Hassan MS. 2005. Aluminium-induced deterioration in reproductive performance and seminal plasma biochemistry
of male rabbits: protective role of ascorbic acid. Toxicology. 215(1–2):
97–107.
Yousef MI, Kamel KI, El-Guendi MI, El-Demerdash FM. 2007. An in vitro
study on reproductive toxicity of aluminium chloride on rabbit sperm:
the protective role of some antioxidants. Toxicology. 239(3):213–223.
Yousef MI, Salama AF. 2009. Propolis protection from reproductive toxicity caused by aluminium chloride in male rats. Food Chem Toxicol.
47(6):1168–1175.
Yuan H-X, Yuan H-X, Pang Y-F, Chen W-C, Wang J-L, Chen W-C. 2019.
Impacts of aluminum on sperm quality and sperm mitochondria in
male rats. Zhonghua Nan Ke Xue (Natl J Androl). 25(7):579–585.
Yumoto S, Nagai H, Kakimi S, Matsuzaki H. 2010. 26Al incorporation into
the brain of rat fetuses through the placental barrier and subsequent
metabolism in postnatal development. Nucl Instrum Methods Phys
Res B. 268(7–8):1328–1330.
Yumoto S, Nagai H, Matsuzaki H, Kobayashi T, Tada W, Ohki Y, Kakimi S,
Kobayashi K. 2000. Transplacental passage of 26Al from pregnant rats
to fetuses and 26Al transfer through maternal milk to suckling rats.
Nucl Instrum Methods Phys Res B. 172(1–4):925–929.
Yumoto S, Nagai H, Matsuzaki H, Matsumura H, Tada W, Nagatsuma E,
Kobayashi K. 2001. Aluminium incorporation into the brain of rat
fetuses and sucklings. Brain Res Bull. 55(2):229–234.
Zapatero MD, Garcia de Jalon A, Pascual F, Calvo ML, Escanero J, Marro
A. 1995. Serum aluminum levels in Alzheimer’s disease and other
senile dementias. Biol Trace Elem Res. 47(1–3):235–240.
Zhou Y, Harris WR, Yokel RA. 2008. The influence of citrate, maltolate
and fluoride on the gastrointestinal absorption of aluminum at a
drinking water-relevant concentration: a 26Al and 14C study. J Inorg
Biochem. 102(4):798–808.
Zhu YZ, Sun H, Fu Y, Wang J, Song M, Li M, Li YF, Miao LG. 2014. Effects
of sub-chronic aluminum chloride on spermatogenesis and testicular
enzymatic activity in male rats. Life Sci. 102(1):36–40.
Zivkovic I, Petrusic V, Stojanovic M, Inic-Kanada A, Stojicevic I,
Dimitrijevic L. 2012. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied
adjuvant. Innate Immun. 18(2):333–342.
Zivkovic I, Stojanovic M, Petrusic V, Inic-Kanada A, Dimitrijevic L. 2011.
Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice. Am J Reprod Immunol. 65(5):
492–502.

